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Recent evidence from international literature suggests an elevated prevalence of adverse 
respiratory conditions among military personnel during and following deployment to the 
Middle East. Australian Defence Force (ADF) members may also be at risk for developing 
respiratory conditions. However, there is a paucity of prospective studies regarding the level of 
respiratory distress and identification of potential factors leading to adverse respiratory 
outcomes among ADF members post- deployment.  
 
Aims and hypotheses  
The aims of this thesis are: 1) To investigate if, similar to the reported international literature, 
there is an increase in subjective respiratory symptoms (self-reported respiratory symptom 
measured using a medical and respiratory questionnaire) of ADF members from pre- to post-
deployment to the MEAO between 2010 and 2012 and whether these are accompanied by any 
changes in objective function (FEV1/FVC lung function measured by spirometry), possibly at a 
sub-clinical level. (Chapter 3 presents and discusses this topic). 2) To examine the predictors of 
adverse respiratory outcomes among this cohort in the context of combat environmental and 
psychological trauma exposures (Chapter 4 provides detailed investigation of predictors of 
adverse respiratory outcomes). 
 
In light of findings from the existing literature, it was hypothesised that there would be an 
observable decline in both objective and subjective respiratory function of contemporary ADF 
members from pre-to post-deployment to MEAO between 2010 and 2012. Further, it was also 
postulated that environmental and psychological trauma exposures would independently and 
combined contribute to changes in self-reported respiratory symptoms and objective respiratory 




Data from the MEAO prospective study were analysed to investigate the effect of deployment 
related exposures on adverse respiratory outcomes. From a total sample of 3074 who were 
deployed to the MEAO between 2010 and 2012, a specific subsample was utilised in this thesis, 
including the 202 ADF members in combat roles with complete reliable spirometry results at 
pre-and post-deployment, who also completed self- reported questionnaires.  
Self-reported respiratory symptoms, and objective measures of respiratory function (Forced 
Expiratory Volume in one second (FEV1), Forced Vital Capacity (FVC), and FEV1/FVC ratio) 
were assessed at both pre and post-deployment. Self-reported environmental and psychological 
trauma exposures incurred during deployment were assessed at post-deployment. 
 
Results 
While the majority of individuals were still within the normal range of objective respiratory 
function, analyses of both objective and subjective data showed that there were significant 
decreases in both objective and self-reported respiratory function following deployment. In 
addition, the decline in objective function was found to be significantly associated with self-
reported respiratory symptoms. The results showed that environmental and psychological 
trauma exposures experienced on deployment were independently associated with adverse 
respiratory outcomes on both objective and self-report measures. Importantly there was also a 
significant interaction, with the association between environmental exposures and both 
objective and self-reported respiratory measures stronger under conditions of high compared to 
low psychological trauma exposure. 
 
Conclusions 
The findings of this study support the hypothesis that there would be a decline in objective and 
subjective respiratory function of ADF members following deployment to the MEAO. 
Furthermore, environmental and psychological trauma exposures experienced on deployment 
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both contributed to these changes. The results suggest that psychological trauma may increase 
vulnerability to the effects of environmental exposures on respiratory outcomes.  One possible 
mechanism underpinning the association between psychological stress and reduced respiratory 
function could be increased levels of systemic inflammatory mediators, leading to increased 
susceptibility to environmental exposures, via a compromised immune system.  Another 
possibility is that the cumulative burden of all exposure types impacts respiratory function.  
However, it is also important to consider that it is likely that environmental and psychological 
exposures were somewhat confounded due to the nature of the deployed environment; 
environmental exposures such as being exposed to blast or toxins is likely to have carried a 
burden of psychological stress.  
 
While the aetiology behind the findings showing that psychological trauma exposures are 
associated with physical health changes remains unclear, the effect of psychological factors on 
the relationship between environmental exposures and respiratory function cannot be excluded 
as a potential contributing factor, suggesting that strategies should be developed and 
implemented to reduce the effects of these exposures on military personnel during deployment. 
A decrement in lung function below 70% is quite considerable. A recommendation could be to 
detect possible adverse respiratory health at an early stage to prevent long-term respiratory 
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Abbreviation   Description 
 
ADF      Australian Defence Force 
CTSS      Centre for Traumatic Stress Studies 
MEAO      Middle East Area of Operations 
PTSD      Post Traumatic Stress Disorder 
FEV1      Forced Expiratory Volume in 1 second 
FVC      Forced vital Capacity  
US      United States 
UK      United Kingdom 
MilHOP         Military Health Outcomes Program  
PCL-C      Post-traumatic Stress Disorder Check List Civilian  
AUDIT      Alcohol Use Disorders Identification Test 
ADHREC    Australian Defence Human Research Ethics Committee 
ICD-9      International Classification of Diseases-9 
OIF      Operation Iraqi Freedom 
OEF      Operation Enduring Freedom 
NYC      New York City 
SMOIL      Smoke from Oil 
GW1      First Gulf War 
COPD      Chronic Obstructive Pulmonary Disease  









Current international literature suggests a higher prevalence of respiratory conditions among 
military personnel during and subsequent to deployment to the Middle East for reasons that are 
not well understood. Most research has focussed on the role of environmental exposures such as 
air pollution from local combustion sources, including burn pits, fire, fuel used in vehicles and 
cigarette smoking ubiquitous to the deployed environment that may be implicated in adverse 
health outcomes. However, little research has focused on the potential role of psychological 
stress and trauma on these effects, despite a large body of literature highlighting the 
comorbidity between poor psychological and physical health, and a growing understanding of 
the links between stress exposure and respiratory conditions.  
 
This thesis addresses a gap in knowledge regarding a lack of understanding of how 
psychological trauma may contribute to changes in respiratory health in the deployed 
population, particularly considering that psychological stress and trauma are high in this 
population. The use of a prospective design allows documentation of sub-clinical changes in 
health that may be precursors to later health problems or indicators of early distress. This would 
help in understanding the respiratory health of deployed populations, particularly as one 
requirement for deployment is a high level of physical health. Cross-sectional designs widely 
used in military medical research do not allow for the documentation of sub-clinical changes, 
and, likewise, considering „ill health‟/clinical outcomes may miss these more subtle shifts in 
health.  
 
The overall objective of this thesis is to understand how deployment may impact on respiratory 
health outcomes in military populations. This thesis begins by exploring the existing literature 
regarding both deployment-related environmental and psychological trauma exposures, and 
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how these could be associated with the respiratory health of Middle East Area of Operation 
(MEAO) deployed Service members. 
 
The aim of this introduction is to provide the reader with the background literature and 
reasoning behind the assumption that there would be changes in both objective and subjective 
respiratory function and symptoms following deployment to the MEAO. Using a prospective 
design and a healthy deploying ADF cohort, allowed for investigation of the specific 
hypotheses that there would be a decline in objective and subjective respiratory function of 
ADF members from pre-to post-deployment to the MEAO and that deployment exposures may 
impact respiratory function in this cohort of ADF members. The findings from this thesis may 
apply to a wider international military population.  
 
By investigating these topics in the context of previous literature, this thesis provides a deeper 
understanding of the importance of adverse respiratory outcomes, their relevance to deployment 
exposures and possible underlying mechanisms involved. 
 
1.2 Background  
During the last two decades, over 2.5 million United States (US) and coalition troops have 
deployed to Iraq and Afghanistan as part of global response to terrorism in the Middle East (1-
3). In addition to combat injuries, the delayed health effects of operational service are of 
concern, particularly the psychological and physical effects of deployment exposures (4).  
 
The importance of examining physical health concerns is highlighted by the consistent findings 
from post-deployment studies of personnel deployed in support of the First Gulf War (GW1) 
(1990-91) which involved increased reporting of all somatic symptoms, including respiratory 
symptoms, by GW1 veterans compared with non-Gulf War comparison groups (5-8). This 
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finding has been consistently replicated in a number of follow-up studies conducted many years 
after the end of the GW1 (3, 5, 6, 8, 9). This indicates that there may be some characteristics of 
deployment that are associated with adverse health outcomes. 
 
The reasons underlying the adverse respiratory symptoms and conditions (e.g. shortness of 
breath, wheezing, coughing, asthma, chronic and acute bronchitis, and emphysema) 
documented among military personnel during and following deployment to the Middle East are 
not well understood (10-12). An important concern for veterans is that these symptoms may be 
indicative of the early onset of potentially serious debilitating diseases caused by environmental 
exposures, such as asthma, bronchitis and Chronic Obstructive Pulmonary Disease (COPD) (10, 
13-15). Nonetheless, to date, in both the GW1 and the Iraq and Afghanistan conflicts, no 
specific association has been established between particular MEAO exposures and adverse 
respiratory outcomes, despite extensive epidemiological research (3, 8, 9, 16). Due to the 
limitations in standardising exposures, the cross-sectional, retrospective medical review, and 
self-reported nature of many studies, it is difficult to discriminate associations with specific 
deployment-related exposures and to reach a robust conclusion regarding the relationship 
between exposure and adverse respiratory outcomes. Therefore, before considering the potential 
role of exposures on health outcomes, determining if in fact there are deployment related 
changes to respiratory health outcomes still needs to be established. This can be realized by a 
prospective study design with specific data collection methods which has the advantage of 
being tailored to collect specific exposure data. 
 
There are many characteristics of deployment that may be associated with adverse respiratory 
outcomes, including exposure to various airborne contaminants, burn pits, dust, particulate 
matter (PM), industrial fires and traumatic exposure (10, 13). In addition, evidence suggests that 
tobacco smoking, physical activities and other individual susceptibility factors such as age, sex, 
body mass index (BMI), blood pressure, physical fitness, pre-existing conditions and personal 
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characteristics may also increase the risk of respiratory symptoms and may enhance 
susceptibility to environmental exposures (11, 17-19). Some of these risk factors and how they 
affect respiratory function will be explained further later in this chapter. 
 
Several international studies have documented an increased incidence of non-specific 
respiratory symptoms, asthma and constrictive bronchiolitis in deployed military personnel, 
with evidence that exposures while on deployment contribute to this via several pathways 
including physical destruction of respiratory tissues or distortion of the immune system (9, 11-
13, 19). 
 
In a review article by Korzeniewski et al. (2013), the authors concluded that military members 
deployed to the Middle East are at a particularly high risk of developing respiratory tract 
syndromes because of the stressful nature of their duties, the harsh environment, and exposure 
to novel pathogens during deployment. These psychological and physical factors  may 
contribute to a broad spectrum of changes in the immune system and the occurrence of 
respiratory tract diseases in a military environment (11). 
 
In a retrospective study by Abraham et al. (2014), the authors concluded that changes in 
behaviours during deployment (e.g. smoking tobacco), high particulate matter exposures, and 
high gaseous pollutant exposures among deployed personnel, relative to personnel stationed in 
the US, were plausible explanations for the higher prevalence of adverse respiratory outcomes 
(12). 
 
In another retrospective study by Korzeniewski et al. (2013), the prevalence of respiratory 
diseases among Polish military members deployed to Iraq and Afghanistan was closely related 
to environmental factors, such as sand and dust storms, extreme temperature changes, 
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unsatisfactory sanitary conditions, and common disregard of basic principles concerning disease 
prevention (10). 
Overall, the current literature suggests that an increase in adverse respiratory outcomes among 
military members following deployment may be associated with exposure to environmental 
factors (10-12, 20-25). In regard to adverse respiratory outcomes, exposure to psychological 
trauma has been less investigated than environmental exposures despite being highly prevalent 
among deployed military populations, and potentially being directly and indirectly related to 
impairment in respiratory function (10-12, 20-24, 26-30). The proposed mechanisms 
underpinning the effects of both environmental and psychological stressors may include similar 
effects via changes in immune function. 
 
To begin, this thesis summarises the existing evidence regarding environmental and 
psychological trauma exposures, and other factors including physical activity, smoking, and 
individual susceptibility factors relevant to the military and deployed environment, and how 
these could be associated with the respiratory health of MEAO deployed military members. 
 
1.3 Environmental exposures  
Previous studies have indicated an association between deployment environmental exposures 
and adverse respiratory outcomes (10, 11, 18, 20, 24, 25, 31-36). Commonly experienced 
environmental exposures during deployment to the MEAO include air pollution (from local 
combustion sources, including burn pits, fire, fuel used in marine/aviation vehicles, natural gas 
and oil, bomb blasts and other explosions); sand and dust storms, and cigarette smoking (12, 13, 
20-22, 37). Air pollution sources release smoke, gases and chemicals close to the ground, where 
they are easily inhaled and have been linked to neurological disorders, respiratory and heart 




Air sampling studies, conducted by US researchers suggest that multiple sources of air pollution 
including smoke from oil well fires, sand and dust storms, burn pit emissions, contribute to poor 
air quality in the deployed environment (21, 38). These findings are supported by independent 
work from investigators outside of the US (22), however, there is no data available from 
longitudinal research studies with objective pulmonary assessments comparing lung function 
between those deployed to the Middle East and non-deployed personnel. A review article by 
Falvo et al. (2015) summarised current knowledge about the impact of service and 
environmental exposures on respiratory health of military Service members deployed to Iraq 
and Afghanistan (39). The report reviewed 19 studies published from 2001 to 2014. While 
studies of environmental exposures, in particular airborne pollutants, have shown an association 
with an increased burden of acute respiratory symptoms, studies reporting chronic respiratory 
diseases do not provide conclusive results, mainly because of the non-representative sample of 
the study populations.  
 
One of the key exposures identified in the GW1 Australian studies by Kelsall et al. (2004) was 
the smoke from oil wells (SMOIL) that were set alight by the Iraqi troops in Kuwait. This cross-
sectional research was completed over 10 years after GW1, comparing 1456 Australian GW1 
veterans with a randomly sampled military comparison group (n = 1588). Authors identified 
those who were exposed to SMOIL by inspecting the timing of a veteran‟s deployment which 
provided the likelihood of SMOIL exposure, as oil wells were set on fire after the air campaign 
had commenced on 17
th
 of January 1991. Authors also reported that SMOIL was a reliably 
recalled exposure, assessed using kappa (k) as a measure of agreement over time in both UK 
(k=0.79) and US (k=0.69) Gulf War veterans. This suggests that recall bias would have had 
minimal impact on the reporting of SMOIL over time and on the association between reported 




In addition to SMOIL, there were also concerns about dust storms in the desert and exposure to 
burn pits (7, 40, 41). The study conducted by Kelsall et al. (2004) together with two other 
follow up Australian GW1 studies by the Monash Centre for Occupational and Environmental 
Health (2003) and Sims et al. (2015) which used the same sample of ADF deployed to the 
MEAO, showed no association between self-reported SMOIL exposure and overall objective 
lung function. The authors commented that despite an increase in self-reported respiratory 
symptoms, any effect of exposures such as SMOIL or dust storms were not reflected in the 
objective respiratory function of the population (7).  
 
These findings suggest that environmental exposures did not (on this occasion) impact 
respiratory health and the self-reported impacts likely reflect somatisation. However, as the 
measures were cross-sectional, and there were no clinically meaningful associations, this does 
not answer the question of whether there were possibly changes in objective respiratory 
function, below clinical cut-offs (9). This is a gap in knowledge that the current thesis is able to 
address.  
 
A study by Lange et al. (2002), 5 years after the GW1, examined a sample of 1896 US military 
members who served between August 1990 and July 1991 within the Gulf War theatre (i.e. Iraq, 
Kuwait, Saudi Arabia, Oman, Bahrain, Qatar, United Arab Emirates, the Persian Gulf, the Red 
Sea, and the Gulf of Oman). Approximately 94% of the study cohort were still in the gulf 
theatre during the time of the oil-well fires, and 21% remained there for more than 100 days 
during the fires. This study found an association between self-reported SMOIL exposure and 
asthma, chronic bronchitis and major depression (31). However, when using a more rigorous 
measure of modelled exposure (modelled exposures were exhaustively developed using a 
geographic information system to integrate spatial and temporal records of smoke 
concentrations with troop movements ascertained from global positioning systems records), no 
associations with health outcomes were identified. Thus, one explanation for the relationship 
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between self-reported smoke exposure and depression was that those meeting the case 
definition for major depression might have been prone to increased reporting of exposures and 
symptoms due to somatisation. The authors also speculated that associations observed between 
self-reported exposures and respiratory health outcomes may have been due to recall bias (i.e. 
unequal reporting of exposure between sick and healthy people). No examination or assumption 
was made regarding the link between respiratory symptoms and psychological exposures or 
major depression despite showing the association between SMOIL with both respiratory 
symptoms and major depression. Overall this study did not find a conclusive association, as it 
was only self-reported, with no objective measures of health outcomes. While the findings of 
studies that examined the effect of SMOIL exposure (7, 9, 40, 41), did not find convincing 
evidence of a long-term effect of SMOIL exposure in GW1 on respiratory health, the finding of 
an association between respiratory health and mental health (depression) by Lang et al raises the 
question of whether changes in respiratory symptoms may have been influenced by 
psychological factors as a confounder. As mentioned above, this association may occur due to 
changes to the immune system (9). 
 
The limited available evidence suggests that exposure to dust or sand does not adversely 
affected the long-term respiratory health of GW1 veterans. In a US study by Petruccelli et al. 
(1999), among those who reported sandstorms to be their main perceived problem during 
deployment, there was no increase in prevalence of cough, wheeze or shortness of breath (42). 
None of the comparative studies, including Australian GW1 studies, in which spirometry was 
undertaken, showed any evidence that respiratory function was effected by deployment (7, 40, 
41). This suggests that the exposures experienced in GW1 may not have been sufficient to 
produce objective evidence of respiratory disease. It is possible that any effects were sub-
clinical, particularly given that these populations comprise individuals cleared as physically 
healthy to deploy.  Therefore, it is important to investigate sub-clinical changes to health as an 
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indicator of reactivity/distress and potentially as a precursor to future emergence of health 
issues. 
 
While no convincing evidence was found of exposures being associated with objective 
respiratory health,  an overview of the long-term follow up studies examining the effect of GW1 
deployment on respiratory health (i.e. irrespective of exposure to SMOIL or sand) did show an 
association between GW1 deployment and wheeze and/or diagnosis of asthma longer term: 10 
years later in Australia (7, 8, 41), 7 years later in the UK (43), and 4-5 years later in the US 
(44). The Karlinsky study conducted 10 years after GW1 found no increase in self-reported 
asthma or chronic bronchitis, but a significant increase in self-reported wheeze (45). The fact 
that these results consistently find self-reported respiratory impacts but little or no evidence of 
objective declines suggests that factors other than deployment alone or environmental 
exposures are likely to contribute to the observed respiratory symptoms.  
 
Despite inconsistent findings regarding environmental exposures and respiratory conditions 
among GW1 military personnel, studies of the Iraq and Afghanistan conflict since 2001 have 
provided more comprehensive evidence that exposure to airborne particulate matter in the 
deployed environment may explain some of the increased respiratory symptoms and conditions 
documented in military populations. The concerns and controversy regarding a possible 
association between environmental exposures and respiratory symptoms following GW1 was 
one of the reasons why there was such care put into the monitoring of respiratory health and 
exposures following the Iraq and Afghanistan conflicts. 
 
Overall toxicological, epidemiological and clinical data are limited and prevent reliable 
evaluation of the prevalence or severity of adverse effects of environmental exposures in 
military personnel deployed to Iraq and Afghanistan. The current clinical evidence on the effect 
of deployment on respiratory health is primarily retrospective and does not provide clarity 
11 
 
regarding specific causative factors or the effect on the deployed population as a whole (39). 
Taken together, these findings suggest that environmental exposures including burn pits and air 
pollution may be associated with subjective health outcomes. Regardless of the source, it seems 
likely that higher levels of air pollution are common in many deployment areas and could 
contribute to future pulmonary and other health effects not yet identified (38). 
 
A range of studies demonstrated evidence of environmental exposures and negative effects on 
respiratory outcomes. For example, in a descriptive case series by King et al. (2011), 49 US 
soldiers who returned from Iraq and Afghanistan with unexplained respiratory symptoms 
underwent extensive evaluation of their medical and exposure history, physical examination, 
pulmonary-function testing, high-resolution computed tomography and lung biopsy. Thirty-
eight of these soldiers subsequently received diagnoses of constrictive bronchiolitis, an 
otherwise uncommon diagnosis, especially among a relatively young and otherwise healthy 
military population. The majority of biopsy samples showed polarisable material consistent 
with the inhalation of particulate matter (14). Therefore, it appears that exposure to airborne 
particulate matter in the deployed environment may explain some of the increased respiratory 
symptoms and conditions documented in the military. However, not all respiratory impacts are 
so specific.  
 
Another US study reported that a majority of US Service personnel (94%) deployed to the 
MEAO as part of Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF) 
reported exposure to high levels of airborne pollution from a range of sources (24) that may 
have exceeded environmental, occupational, and military exposure guidelines (24, 46, 47). 
Given the nature of deployment exposures and known triggers for asthma, such as air pollution 
sources, deployed populations may be at risk of increased inflammation due to air pollution-
inducing local respiratory reactions via the release of inflammatory mediators, which in turn 
may impact on respiratory function (12, 13, 20, 21, 28, 33, 48-51). A retrospective review of 
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medical diagnoses by Szema et al. (2010) reported that deployment to Iraq was associated with 
a higher risk of having a new International Classification of Diseases-9 (ICD-9) diagnosis of 
asthma post-deployment among US military personnel (34). This study showed that out of 6233 
military personnel who served in Iraq or Afghanistan between 2004 and 2007 and were 
followed at the Northport Veterans Affairs Medical Centre, NY, 290 new-onset asthma cases 
were identified. Deployment to Iraq was associated with a significantly higher risk of asthma 
compared with stateside military personnel (6.6% versus 4.3%; with a crude odds ratio, 1.58; 
95% CI, 1.18, 2.11). These associations persisted when stratified by gender and age group (34). 
 
Asthma is a form of intermittent and reversible airway hypersensitivity. Increased airway 
hyper-reactivity in response to non-specific stimuli is a feature of asthma and, indeed, the 
diagnosis of asthma is often defined on the basis of the presence of such hyper-reactivity. In a 
US study of the causes underlying respiratory symptoms in military personnel returning from 
duty in Iraq and Afghanistan by Morris et al. (2013), 42% of US veterans reported non-specific 
respiratory symptoms that did not reach the threshold for a specific clinical diagnosis. The 
authors suggested that these sub-threshold issues of nonspecific airway hyper-reactivity may 
reflect development of a new airways disease, or aggravation of pre-existing conditions. The 
underlying mechanism of airway hyper-reactivity is thought to be hyper-activation of the 
immune system (36, 52). Similar findings were documented in occupationally exposed first 
responders to the World Trade Center (WTC) disaster (32, 35, 39). 
 
In a longitudinal study by Banauch et al. (2003), rescue and recovery efforts after the WTC 
collapse resulted in the exposure of many individuals, including 14,000 NYC Fire Department 
rescue workers to respirable particulates and products of combustion. This study used a 
representative sample of 179 rescue workers stratified by exposure intensity (high, moderate, 
and control) without current smoking or prior respiratory disease (highly exposed workers 
arrived within 2 hours of collapse, moderately exposed workers arrived later on Days 1–2; 
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control subjects were not exposed). The study concluded that development and persistence of 
hyper-reactivity and reactive airways dysfunction at one, three, and six months post-collapse 
were strongly and independently associated with exposure intensity, i.e. the volume and type of 
exposure, size of particles, co-pollutants, climate variations, etc. (32). This suggests that even 
brief dust exposures can cause significant respiratory morbidity if the exposures are intense 
enough (34, 35). Although studies of GW1 regarding SMOIL and dust exposure (7, 31, 40, 42) 
also report increased respiratory symptoms, they were mainly descriptive or cross-sectional and 
detailed investigation of the intensity of exposures seems to be a common omission in these 
studies. 
 
 In addition to the environmental exposure intensity, psychological exposures may also play a 
role in the adversity of respiratory outcomes (9, 26, 27, 53). However, the impact of 
psychological trauma exposures as a confounder on the relationship between environmental 
exposures and adverse respiratory outcomes has not been thoroughly investigated in these 
studies.  
 
The key consistent messages that come from the Iraq and Afghanistan military respiratory 
health studies include decline in respiratory function associated with environmental factors. 
Despite evidence of high levels of stress in this population and general links between 
psychological trauma and adverse respiratory outcomes, this has not been thoroughly 
investigated. 
 
Synergistic effects among different environmental exposures and interactions between 
environmental exposures and stress or other influences are probable and deserve further study 
(9, 36). For example, stress may increase the individual‟s susceptibility to familiar or novel 
pathogens, such as those that may be first encountered on deployment (54, 55). Increased 
psychological stress could be the consequence of being in a deployed war zone or intense 
14 
 
combat training. Deployed environments can be mentally and physically demanding, involving 
not only prolonged periods of physical activity but also exposure to psychological stressors 
(11), sleep deprivation (11, 28, 56), shifts in daily rhythm, and exposure to thermal extremes 
(19, 57) and high- altitude environments (19, 21, 58, 59). The effects of such challenges on a 
soldier‟s health are complex and may result in a broad spectrum of changes in the immune 
system, which could, in turn, increase vulnerability to various diseases and respiratory tract 
infections (11). 
 
1.4 Psychological trauma and stress 
In addition to ambient airborne hazards, one of the factors unique to military service that may 
increase the vulnerability of military personnel to respiratory health risk is high levels of 
psychological stress (39, 53). There are a wide range of deployment-related stressors that may 
be considered psychologically traumatic. These include: being exposed to threatening 
situations; stressful events; vulnerable situations; witnessing killing death and violence; suicide; 
torture; and other atrocities. 
 
Recently, a number of studies have found positive associations between psychosocial stress and 
respiratory symptoms (28, 34-36, 47, 53), suggesting that, in the specific context of military 
service and deployment, in addition to the established risk of environmental exposures, the 
psychological stress of deployment should be considered as an important contributing factor. 
 
There is growing evidence for an association between exposure to psychological traumatic 
stress, such as combat experience, and respiratory symptoms and conditions, including 
shortness of breath, asthma, chronic bronchiolitis and COPD (29, 30, 53, 60, 61). This 
relationship has also been demonstrated in adult research populations exposed to the September 
11, 2001 WTC terrorist attack. More specifically, moderate associations between post-traumatic 
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stress disorder (PTSD) and respiratory symptoms have been observed in first responders to the 
WTC (14, 32, 60, 62). However, while dust exposures would be a more likely cause of adverse 
respiratory health outcomes observed in this cohort, the combined effect of the psychological 
trauma of the situation on objective respiratory function has not been thoroughly investigated 
(9). 
 
With respect to biological mechanisms, PTSD is characterised by changes in the hypothalamic– 
pituitary–adrenal axis and the sympathetic–adrenal–medullary system (63). It has been 
suggested that these alterations can lead to a pro-inflammatory state (64-67), and in fact may 
also be implicated in the aetiology of PTSD and other disorders. Thus, inflammation is a 
common link between trauma exposure and both PTSD and airflow limitation, which itself is 
associated with inflammatory processes (60, 68).  
 
A cross-sectional study by Spitzer et al. (2011) provides evidence for this association between 
PTSD and respiratory function (60). This study examined the associations between self-reported 
respiratory symptoms, objective lung function, trauma exposure, and PTSD in 1,772 civilian 
adults randomly selected from a sample population based in north-eastern Germany. This study 
used standardised questions and spirometry testing. Of the 1,772 community residents included 
in this study, 915 (51.6%) subjects had been exposed to at least one traumatic event and 28 
participants met criteria for PTSD (1.6% of the total study population and 3.6% of those with 
trauma exposure). Those with a diagnosis of PTSD had a significantly greater risk of having 
asthma symptoms than those without PTSD. However, those with a history of psychological 
trauma, but not a diagnosis of PTSD, did not have an elevated risk, suggesting that this 
association is specific to disorder status rather than symptomatology or trauma exposure per se. 
Analyses indicated that subjects with diagnosed PTSD had a significantly increased risk for 
airflow limitation independent of its definition. The authors suggested that inflammation may 
be the link between trauma exposure, PTSD and air flow limitation. While the findings inform 
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relationships between trauma exposures and adverse respiratory outcomes, there are several 
limitations in cross-sectional studies mainly in terms of their reliability and validity. Due to the 
cross-sectional nature of this study, the reported associations do not allow any causal inferences 
as the temporal relationship of self-reported respiratory symptoms and respiratory function 
findings relative to psychological trauma exposure and PTSD onset was not available (60).  
Using a prospective design could have further confirmed these associations.  
 
The prevalence rate for PTSD in deployed military members varies widely, ranging from 2% to 
35% (69), with such discrepant findings at least partly influenced by factors, such as 
measurement methods, and sample characteristics, such as service role (70, 71). In particular, 
the role of PTSD in adverse respiratory outcomes is uncertain in the military population.  With 
the current indication of links between trauma exposures, PTSD and adverse respiratory 
outcomes, it is important to investigate these relationships as the prevalence of such disorders 
are high within the military populations. 
 
As the available evidence suggests that  both environmental and psychological exposures during 
deployment could be associated effect respiratory health outcomes, more comprehensive 
prospective studies are needed to further clarify the association between environmental 
exposures, psychological trauma, PTSD and adverse respiratory outcomes in the military 
population.  
 
In addition to deployment-specific exposure risks, evidence also suggests other factors such as 
physical activity, (72) increased tobacco use (18, 73) and other individual susceptibility factors 
(74) may increase the risk of respiratory symptoms and enhance susceptibility to environmental 




1.5 Physical activity 
Researchers have suggested that physical activity performed in stressful environments, such as 
during military training, may alter immune function and can be a contributing factor to 
suboptimal neurologic and overall long-term health (28, 72). Light physical activity or moderate 
environmental stress stimulates immune responses, but exhausting physical activity or severe 
environmental stress can have immune suppressant effects, manifested by a temporary increase 
in susceptibility to respiratory infections (19). Multiple physical and psychological stressors, 
such as those encountered on deployment, may induce alterations in immune parameters and/or 
neurological and endocrine responses; these common exertion-induced pathways could result in 
respiratory tract syndromes (11). For example, there is evidence that vaccination seroconversion 
rates are decreased when the vaccinations are given during extensive military training before 
deployment (77, 78). This is biologically significant for the deployed population because it 
could result in sub-optimal immunity against several antiviral/bacterial vaccines, including 
influenza vaccine, and hence result in increased reported respiratory symptoms and conditions 
which have been recently found in military studies (77, 78). 
 
1.6 Smoking 
Cigarette smoking is a well-established carcinogen and, as well as causing non –malignant 
respiratory diseases (COPD, emphysema, chronic bronchitis, and asthma), there is clear 
evidence linking it to both morbidity and mortality (10, 13, 39, 54, 75, 79). Pathological 
mechanisms of smoking, including immune changes, and its adverse health effects, such as 
asthma, bronchitis and COPD, generally overlap with environmental air pollution (73, 75). 
Smoking has also been related to increased susceptibility to respiratory insult from airborne 
hazards (75). Smoking is a major risk factor for acute respiratory tract syndrome and other 
systemic infections; active and passive smoke exposure increases the risk of infection (80). The 
mechanisms by which smoking increase risk are multifactorial and include structural and 
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immunologic alterations (81). Smoking suppresses immune responses and impairs host 
defences, e.g. by exhausting  the removal of contaminants from the respiratory tract (82). It also 
produces a chronic inflammatory state, including chronic bronchitis and aggravation of asthma. 
Smokers are also more likely to become ill with and die from influenza and bacterial 
pneumonia (81).  
 
Since the 1960s, the rate of tobacco smoking has declined in the US, including in the military 
(73). However, the rate of tobacco smoking among active duty military personnel remains 
higher (32%) compared to the general population (~20%) (73). Within the US military 
population, the prevalence of smoking is approximately 40% higher among veterans (22%) (a 
veterans is defined as “a person who served in the active military, naval, or air service and who 
was discharged or released under conditions other than dishonourable”) and 50% higher among 
deployed military personnel compared with their non-deployed counterparts (73). In a cross-
sectional study by Sanders et al. (2005), it was reported that 47.6% of US military personnel 
deployed to Iraq and Afghanistan began or resumed smoking while deployed (54). High rates of 
tobacco smoking are not restricted to US military personnel; the rates are also increased by 
40%–60% among coalition militaries (83).  
 
Although cigarettes are sold excise free to ADF personnel through Frontline Defence Services 
and unit canteens during deployment, smoking in all Defence establishments has been banned 
for several years. This policy also applies to contractors and visitors. In addition, while ADF 
members are still able to smoke outside Defence establishments, smoking is actively 
discouraged and ADF members receive financial and therapeutic support if they undertake 
'Quit' programs during and after deployment (84, 85). Similar smoking restrictions and policies 
were put in place for the US military in 1997 when the use of tobacco was banned during basic 
training, along with an increase in the number of designated non-smoking areas, and a 
prohibition on health care providers smoking on duty (86, 87). However, despite these attempts, 
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decades of the tobacco industry lobbying and targeting the US military has driven smoking rates 
significantly higher among service members than the rest of the population (32% vs 20% 
respectively) (86, 87). In 2010–2011, the MEAO Census Study found that smoking was more 
prevalent among 18- to 24-year-old men (34%) and women (29%) than among the same sex/age 
groups in the Australian population (24% and 22%, respectively) (3, 88). In addition, 38% of 
respondents reported smoking more than usual during deployment, and 17% reporting 
beginning or re-starting smoking (88). 
 
Findings from a prospective study of Australian military personnel deployed to the MEAO (the 
same sample used in the current thesis) showed that those respondents who began or resumed 
smoking while on deployment were also likely to have more psychological co-morbidities 
compared to those who did not smoke on deployment. Comorbidities were defined as having 
one, two or three psychological conditions including alcohol disorder, anxiety disorder, or 
affective disorder, including depression and anxiety (3). Similarly, those who smoked more 
than usual were likely to have more co-morbidities compared to those who did not smoke (3). 
Nevertheless, in the MEAO prospective report (2012) the relative impact of different exposures 
and other non-smoking related risks were not examined in this population. This will be further 
examined in the current thesis. 
 
While specific factors contributing to smoking rates have not been ascertained, the significant 
smoking uptake among deployed military members observed in a number of studies is thought 
to relate to deployment stress, particularly among those with prolonged deployments, or combat 
exposures (73). Combat exposure, military stressors and PTSD have all been identified as 
predictors for cigarette smoking (74, 75). As discussed above, these same psychological risk 
factors and mental health disorder have also been associated with respiratory symptoms, 
abnormal lung function and conditions such as asthma (53, 75). Although tobacco smoke may 
differ in many respects from the ambient air pollution in deployed settings, the contribution of 
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tobacco smoke exposure to the cumulative exposures to airborne hazards experienced by 
military personnel while on deployment cannot be excluded as a potential contributing factor, 
given the prevalence and intensity of tobacco use in stressful combat situations (41). The 
potential for smoking to interact with and/or exacerbate other environmental or stress exposures 
is of importance to examine. However, there is currently insufficient information or 
standardisation of data (e.g. type and intensity of environmental exposures, number of cigarettes 
smoked per day, etc.).  Since the MEAO prospective study which analysed the same sample of 
ADF members as the current thesis, showed no significant association between smoking status 
or smoking behaviour and change in FEV1/FVC (the FEV1/FVC ratio which represents the 
proportion of a person's vital capacity that they are able to expire in the first second of forced 
expiration to the full, forced vital capacity), this thesis did not focus on what was found 
previously, and cigarette smoking was included as one of the environmental exposures and 
analyses were adjusted for cigarette smoking where appropriate. 
 
1.7 Individual susceptibility factors 
In addition to the environmental and psychological factors that may affect respiratory health of 
military members, individual susceptibility factors such as age, sex, BMI, blood pressure, 
physical fitness, pre-existing conditions and personal characteristics may also play a role in 
adverse respiratory outcomes.  
 
In a case control study of active duty and retired US military members, increasing BMI, 
younger age, gender, non-active duty beneficiary status, and arthritis were significant 
independent predictors of asthma in this population (89). Similarly, Abraham et al. (2012) 
reported that gender, and serving in the army remained independent predictors of having a new 
obstructive pulmonary disease encounter (90). Age and combat occupations were not associated 
with the likelihood of a post-deployment obstructive pulmonary disease diagnosis. The fact that 
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combat occupations would be likely to have the highest level of traumatic deployment 
exposures makes this finding relevant to the argument of this thesis. i.e., this would suggest that 
perhaps environmental exposures are not relevant to more severe respiratory problems, at least 
in the short term. This aligns with the GW findings concerning environmental exposures not 
being associated with clinically significant impairment in lung function.  
 
In a cross-sectional study, data collected from a European Community Respiratory Health 
survey of 16 countries were examined. The aim of this study was to estimate the age and sex-
specific incidence of asthma from birth to the age of 44 in men and women across several 
countries. This study demonstrated that there are different patterns of asthma incidence in men 
and women. During childhood, girls had a significantly lower risk of developing asthma than 
boys. Around puberty, the risk was almost equal in the two sexes, while after puberty, the risk 
in women was significantly higher than that in men (77). While the sample is not comparable to 
the military population (i.e. military members are generally younger, healthy male etc.) the 
findings inform the possibility of age and sex as factors influencing respiratory outcomes. 
 
Studies regarding the association between respiratory health conditions and individual factors in 
the population and deployed military personnel generally focus on single respiratory outcomes 
and are usually assessed using different methods, e.g. using medical record reviews that are 
predominantly retrospective (10, 12, 34), and are therefore also subject to potential biases 
(reflected in documentation and health care seeking). 
 
The way in which the above-mentioned factors might interact with deployment exposures to 
influence respiratory health outcomes has not been thoroughly studied. This deserves further 
attention in larger epidemiological studies, particularly given emerging evidence of their 




Although most studies reviewed in this chapter are from the US, Australian troops have also 
been actively involved in GW1, Iraq and Afghanistan conflicts and shared bases and 
geographical location. Given the average deployment lengths are similar between both 
militaries (5-18 months) and assuming the exposure risks were similar, ADF members may be 
at similar risk to US military personnel (38, 92-94). 
 
1.8 Immune response  
Previous studies suggest that the potential underlying mechanisms for association between 
environmental/ psychological trauma exposures and adverse respiratory health outcomes may 
involve alteration in the immune system (9, 11, 19, 28). The following paragraphs will discuss 
the possible changes in the immune system as a result of environmental and psychological 
stress and how they may influence respiratory outcomes. 
 
The immune system protects the host from pathogens and helps eliminate toxic or allergenic 
substances that enter through mucosal surfaces. There are two types of immune responses, 
innate and adaptive. The innate immune response is non-specific. It consists of cells and 
proteins that are always present and ready to mobilise and fight offending bodies at the site of 
infection. The main component of the innate immune system includes surface barriers (skin and 
mucous membrane) and internal defenses (phagocytes, dendritic cells, Natural Killer (NK) 
cells, antimicrobial proteins, fever and inflammation). The adaptive immune system, on the 
other hand, is called into action against pathogens that are able to evade or overcome the innate 
immune defense. It is directed at specific targets and is systemic. After initial exposure and 
activation, a more rapid response is made to subsequent exposures to pathogens. There are two 
types of adaptive immune responses: humoral immunity, mediated by antibodies produced by B 




Inflammation is the body's way of signaling the immune system to repair damaged tissue, as 
well as protect the body against foreign invaders, such as harmful pathogens. Inflammation is 
mostly considered as a mechanism of innate immunity that can be triggered by a variety of 
factors, including pathogens, damaged cells, toxic compounds, irritation and stress. These 
factors may induce acute and/or chronic inflammatory responses in different organs of the body 
(96, 97). Acute inflammation is a quick response of the body to tissue injury, usually appearing 
within minutes or hours. It is characterised by five cardinal signs: redness, immobility, pain, 
swelling and heat (96-98). 
 
Usually, during acute inflammatory responses, cellular and molecular events and interactions 
efficiently minimise impending injury. This mitigation process contributes to restoration of 
tissue homeostasis and resolution of the acute inflammation. Chronic inflammation happens 
when this response lingers, leaving the body in a constant state of alert and potentially leading 
to tissue damage or disease (96, 99). 
 
Several studies have shown that, in addition to direct particulate or chemical effects, air 
pollution induces local respiratory and systemic immune reactions via the release of 
inflammatory mediators (9, 33, 48-51, 100-105). Therefore, potential connections between an 
increase in environmental exposures and adverse respiratory health outcomes may partly be 
explained by alteration in levels of inflammatory mediators, such as cytokines, via structural 
and functional respiratory changes (54, 101, 106-111). 
 
Regarding environmental exposures, the mechanism that initiates the local and systemic 
inflammation is believed to involve stimulation of epithelial cells and alveolar macrophages by 
particulate matter. Alveolar macrophages play a key role between the inflammatory processes 
in the lung and the systemic response because they are the cells responsible for ingesting and 
clearing inhaled particles (112). The interaction of alveolar macrophages with particulate matter 
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increases their phagocytic activity (i.e. ingesting other cells or particles), oxidant production, 
and the release of inflammatory mediators such as cytokines, chemokines, proteases and 
eicosanoids that then elicit both local and systemic inflammatory responses (103, 104, 109, 113, 
114). These substances play a role in recruiting inflammatory cells such as neutrophils, 
monocytes, mast cells and eosinophils to the lung (115, 116). Interactions between 
macrophages and epithelial cells enhance these responses. Repeated exposures and increases in 
lung inflammation cause tissue destruction and may reduce lung function in the long term (33, 
115, 116).  
 
The systemic inflammatory response is characterised by activation and mobilisation of 
inflammatory cells (116-118), the production of acute-phase proteins and the production of 
circulating inflammatory mediators (119). An integral component of this response is stimulation 
of the hematopoietic system, specifically, the bone marrow resulting in a temporary increase in 
circulating leukocytes. Several large population-based studies have shown that a persistent high 
level of leukocytosis is a predictor of total mortality, independent of smoking (113, 120). 
Military personnel exposed to high concentrations of particulate matter air pollution during the 
forest fires in Southeast Asia in 1997 developed leucocytosis, that was associated with hyper-
stimulated bone marrow (121).  
 
In general, PM exposure may alter respiratory function by a variety of different mechanisms. 
Potential pathways for the effects of PM on the respiratory system include: airway remodelling, 
allergic disorders, impaired host defence and infection, progression of pre-existing lung disease 
and DNA damage. In the short-term, airway hyper-responsiveness may ensue due to the 
influence of inflammatory mediators. In the long-term, morphological changes may occur, in 




1.8.1 Immune response to psychological trauma exposures  
While a number of studies have provided general evidence of a link between stressful 
psychological exposures and negative respiratory outcomes (28, 34, 36, 39, 47, 53, 54), the 
uncertainty about the association is complicated by the relative lack of data regarding the 
underlying mechanisms.  
 
One possible mechanism underpinning the association between stress and reduced respiratory 
function could be increased levels of systemic inflammatory mediators (53, 107, 108, 111, 113). 
Excessive pro-inflammatory responses may cause airway damage and consequently structural 
and functional pulmonary changes (54). Hypothetically, higher levels of stress during 
deployment among personnel may in part explain the increased rate of respiratory symptoms 
reported in recent studies. There is increasing evidence of associations between stress related 
mental disorders and altered immune responses, and elevated circulating inflammation. 
However, the direction of this association is not conclusive (53, 66, 107, 108, 113). Regardless, 
low level inflammation and altered immune response provides plausible mechanisms by which 




The rapidly emerging field of neuro-immunology has shown evidence of associations between 
low-level inflammation and psychological symptoms, with evidence of bi-directional effects. 
Reported effects of psychological symptoms on inflammation or vice versa were mainly 
described in terms of psychological disorders, including PTSD (122, 123). PTSD is mainly 
characterised by persistent hyperarousal, autonomic dysregulation and elevated heart rate. 
Similar to PTSD, panic disorder (PD) is also an anxiety disorder with prominent 
psychophysiological symptoms, including respiratory abnormalities (123-125). 
 
The general mechanism of imbalance in biological homeostasis as a result of traumatic 
psychological exposures in humans involves the sympathetic nervous system and the 
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hypothalamic-pituitary-adrenal axis (HPA), which has been shown to mediate the physiological 
response of the body to psychological stress via entering a state of hypervigilance. This forms 
the foundation of the metabolic response to trauma exposure. In PTSD, the state of 
hypervigilance is known to maintain abnormal HPA function (124, 126, 127). 
 
A mechanism of interest is sensitisation, a process where individuals who are repeatedly 
exposed to a risk factor may develop progressively greater responses over time, resulting in a 
lasting change in response amplitude. Heim and Nemeroff (1999) described how the process of 
sensitisation, arising from multiple trauma exposures, is supported at a biological level. The 
core underlying biological systems that are often involved include inflammatory mediators such 
as Interleukin 1 beta (IL-1β), Interleukin 6 (IL-6), Tumour Necrosis Factor – alpha (TNF-α), 
and C Reactive Protein (CRP) (127). Evidence is beginning to emerge showing that circulating 
inflammatory mediators respond to acute psychological stress. However, research published to 
date has varied greatly in the composition of study groups, the timing of samples, methods, and 
the type of challenge imposed. Therefore, the potential underlying mechanisms of stress, 
increased levels of circulating inflammatory mediators and negative respiratory health 
outcomes, remain an area that needs further investigation (53, 54, 101, 106, 107, 109, 111, 128, 
129).  
 
High levels of inflammation as a result of psychological stress have been shown to lead to 
greater susceptibility to risk factors such as environmental exposures. In a study by Clougherty 
et al. (2010) a double-exposure paradigm was used, where rats were subjected to social stress 
and concurrent exposure to particulate matter air pollution. Compared with non-stressed 
controls, exposed rats demonstrated altered breathing patterns (i.e. rapid and shallow) and a 
systemic inflammatory response (e.g. elevated CRP, TNF-α and white blood cells) consistent 
with adverse respiratory outcomes. Although in humans additional studies are needed to further 
elucidate these pathways, an inflammatory-mediated mechanism for enhanced susceptibility to 
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air pollution is tenable (76). It is important to understand that the cumulative impact of 
deployment exposures and subsequent minor symptoms and objective indications, may tip over 
at some point into clinically significant symptoms or probable disorders. Identifying markers of 
risk in still healthy individuals allows for mitigation strategies aimed at ultimately preventing 
poor health trajectories. 
 
Adverse respiratory outcomes in military personnel, linked with deployment exposures, would 
highlight the need for a risk management approach to the deployment environment. Risk 
management strategies could focus on reducing exposures, ensuring recovery, and increasing 
resilience to these risk contributors to minimise adverse respiratory outcomes in vulnerable 
military personnel. 
 
1.9 Limitations  
A number of studies in this review were of cross-sectional design; consequently, any respiratory 
health issues in existence before an exposure were not accounted for. Without baseline data, it 
is not possible to accurately assess the impact of specific deployment exposures on an 
individual‟s respiratory health. Cross-sectional studies are carried out at one period and do not 
indicate the series of events. Therefore, it is difficult to determine the relationship between 
exposure and outcome as they lack the time element. In addition, without baseline data, 
subclinical changes are difficult to identify. The issue of subclinical symptoms in otherwise 
healthy populations is of importance, particularly when deploying military populations are 
largely healthy. 
 
Previous studies have largely relied on self-report data to measure the impact of exposures on 
respiratory health. This type of measurement is open to recall bias, particularly when data is 
collected well after exposures have occurred. In addition, it is also difficult to standardise the 
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reported symptoms, for example, what one person might consider „shortness of breath‟, another 
person might regard as normal (54, 106). These could limit the reliability and validity of 
findings. Using a prospective design and objective measures could minimise the recall errors as 
well as determining the baseline health status before exposure or condition events occur. In 
addition, medical record reviews are predominantly retrospective (10, 12, 34) and therefore also 
subject to potential biases (reflected in documentation and health care seeking). 
 
1.10 Conclusion  
The objective of this literature review was to summarise the key respiratory health concerns and 
exposures in the military population. It also summarises the underlying biological mechanisms 
that may be involved in adverse respiratory health outcomes reported in this population. The 
information in the background and introduction was used for a published systematic review 
(See last section of this thesis under Publication). 
 
Current evidence indicates that deployment-related environment, combat and other exposures, 
and psychological trauma more generally, may be associated with adverse respiratory outcomes 
and other health effects not yet identified. These associations may be via direct actions (local 
effects such as deposition of particulate matter) or initiation of pulmonary inflammation 
systematically due to psychological factors and disturbance of the immune system. It is 
particularly important to further investigate the role of psychological trauma and its association 
with respiratory manifestation as psychological stress, while highly prevalent in relation to 
deployment, is a less investigated risk factor for respiratory health outcomes. Further, the 
potential mechanisms underlying associations, as well as potential predictors of good or adverse 




1.11 Thesis hypothesis, aims and questions 
1.11.1 Hypotheses 
In light of findings from the existing literature, it was hypothesised that there would be an 
observable decline in both objective and subjective respiratory function of contemporary ADF 
members from pre-to post-deployment to MEAO between 2010 and 2012.  Further, it was also 
postulated that environmental and psychological trauma exposures would independently and 
combined contribute to changes in self-reported respiratory symptoms and objective respiratory 
measures in this cohort of ADF members.   
 
1.11.2 Aims 
The aims of this thesis are:  
1) To investigate if, similar to the reported international literature, there is an increase in 
subjective respiratory symptoms (self-reported respiratory symptom measured by questionnaire) 
of ADF members from pre- to post-deployment to the MEAO between 2010 and 2012 and 
whether these are accompanied by any changes in objective function (FEV1/FVC measured by 
spirometry), possibly at a sub-clinical level. (Chapter 3 presents and discusses this topic).  
 
2) To examine the predictors of adverse respiratory outcomes among this cohort in the context 
of combat environmental and psychological trauma exposures (Chapter 4 provides detailed 
investigation of predictors of adverse respiratory outcomes). 
 
1.11.3 Research questions 
The specific questions that will be addressed in the following chapters include:  
1. Is there a change in respiratory function among ADF personnel deployed to the 
MEAO between 2010 and 2012 from pre-to post-deployment?  
2. What are the impacts of deployment exposures on respiratory outcomes of 
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ADF members deployed to the MEAO between 2010 and 2012? 
 
The overall objective of this thesis was to understand how deployment may impact on 
respiratory health outcomes in military populations.  
 
A major outcome of this study was to identify if psychological trauma exposures are associated 
with negative respiratory health outcomes in the short-term following deployment to the 
MEAO. This was the first Australian prospective study to investigate the effect of psychological 
trauma exposures on respiratory health outcomes and whether psychological responses to 
deployment exposures moderate the association between environmental exposures and 
respiratory health outcomes. 
 
By investigating these topics in the context of previous literature, this thesis provides a deeper 
insight into the importance of adverse respiratory outcomes, their relevance to deployment 








2.1 Introduction  
The previous chapter summarised the key respiratory health concerns and exposures in the 
military population. It also summarised the underlying biological mechanisms that may be 
involved in adverse respiratory health outcomes reported in this population. 
 
In light of findings from the existing literature, this study tested the hypothesis that there would 
be an observable decline in objective and subjective respiratory function of contemporary ADF 
members from pre-to post-deployment to MEAO between 2010 and 2012. Further, it is also 
postulated that environmental and psychological trauma exposures (independently and 
combined) may impact self-reported respiratory symptoms and objective respiratory measures 
in this cohort of ADF members.  This chapter will describe the methodology used to answer the 
specific study questions in the next two chapters:  
  
1. Is there a change in respiratory function among ADF personnel deployed to the 
MEAO between 2010 and 2012 from pre-to post-deployment?  
2. What are the impacts of deployment exposures on respiratory outcomes of 
ADF members deployed to the MEAO between 2010 and 2012? 
 
To the author‟s knowledge this was the first Australian perspective study to investigate the 
effect of psychological trauma exposures on respiratory health outcomes and whether 
psychological responses to deployment exposures moderate the association between 
environmental exposures and respiratory health outcomes. By investigating these topics in the 
context of previous literature, this thesis provides profound understanding regarding the 
importance of respiratory health in deployed populations, how various types of deployment 
exposures contribute to this, and the possible underlying mechanisms involved. Beyond the 
military context, it will contribute to understanding of the relationship between stress and 
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trauma, and physical and mental health in general, including the mechanisms by which 
exposure to stressors may lead to poor respiratory health outcomes over time. 
 
The following chapter provides a detailed summary of parts of the MEAO Prospective Study 
dataset utilised in this thesis. Details pertaining to research hypotheses and statistical analyses, 
including a description of the final sample and measures used for analysis, are also outlined. 
The detailed data analyses for each chapter are discussed in the methodology section of the 
corresponding chapter. 
 
2.2 Middle East Area of Operations prospective study  
The MEAO prospective study was commissioned by the Australian Department of Defence, 
and undertaken by the Centre for Traumatic Stress Studies, University of Adelaide, between 
2010 and 2012, in order to provide insight into the impact of deployment and combat exposures 
in the MEAO on the health of ADF members (3). The MEAO prospective study, together with 
the 2010 ADF Mental Health Prevalence and Wellbeing Study (131) and the MEAO Census 
Study (88), formed part of a series of health studies funded by Australian Defence which were 
collectively referred to as the Military Health Outcomes Program (MilHOP). MilHOP was 
conducted to examine the physical and mental health of all ADF members. It was designed to 
add to the growing body of knowledge that has already been collected under the Deployment 
Health Surveillance Program (3, 71, 88) and to overcome many of the challenges faced by other 
health studies conducted by Australia and its coalition partners. These challenges include:  
 the ability to control for exposures and risk factors that exist prior and during  
deployment; collection of objective as well as self-report health measures; and  
 collection of information about hazards and exposures in close temporal proximity to 




This thesis utilises data drawn from the MEAO prospective study and focuses on factors 
associated with respiratory health outcomes among a sample of ADF members deployed to the 
MEAO.  
 
Many previous studies into health effects of deployment have been prompted by reports of ill-
defined self-reported symptoms that were attributed to service in the area of operations, but 
were without a clear causal or diagnostic link  (which was subsequently known as First Gulf 
War Syndrome) (5, 6, 132). The MEAO prospective study focused on a range of potential 
health outcomes of direct relevance to the nature of the deployment, including those identified 
by the Institute of Medicine (e.g. neurocognitive and neurobehavioral effects, hypertension and 
chronic respiratory effects etc) (93). The MEAO prospective study is the only prospective 
health study involving ADF members. Both objective and self-reported data were collected on a 
range of physical, biological, psychological and social health outcomes (only a small cohort of 
the larger MEAO completed the objective health data). In order to ensure that any changes in 
health outcomes could be attributed to deployment to the MEAO, this study assessed a subset of 
individuals prior to deployment and again on their return to Australia (approximately 1 month 
prior to deployment, and again approximately 4 months after return) (3, 133).
 
This design 
provides a unique opportunity to gain more insight on the short-term impacts of deployment-
related exposures on the respiratory health of ADF members. To date, there has been very 
limited analysis of the respiratory health outcomes of ADF members following deployment. 
However, initial findings from the GW1 and MEAO prospective studies indicated increases in 
self-reported respiratory symptoms (7, 9), as well as possible negative shifts in objective 
measures of respiratory function following deployment to the MEAO (3, 88).  
 
The data used in the current study included objective (spirometry test) and subjective (self-
reported questionnaire) measures. These data were used to address how different deployment 




iFigure 2.2 Data used in this study 
 
Data approval was provided by the Military and Veterans‟ Health Research Data Access 
Committee (MVHRDAC) for the current study. 
 
2.3 Sample 
All ADF members (n=3074) who deployed to the MEAO after June 2010 and returned from 
that deployment by June 2012 received a survey regardless of: service (Navy, Army or Air 
Force); rank; gender; length of deployment; country where most time would be spent (i.e. the 
person could have been in Afghanistan or in an area/country outside Australia supporting these 
operations); role (combat, support, technical, etc); and/or whether the ADF member had 
previously deployed to the MEAO. Out of the total number of ADF members deployed, 1324 
individuals completed the questionnaire component (3). 
 
To be invited to participate in the physical testing (including height, weight, waist and hip 











(past 12 months) 
 Doctor diagnosed 
conditions (past 12 
months) 
Completed objective 







cardiovascular fitness assessment), individuals must have been eligible to participate in the 
questionnaire component (as listed above), and be assigned to one of the following: A Navy 
ship; either of the two Special Forces Commando Units (1CDR and 2CDR); either of the two 
Special Forces Special Air Services (SAS) Units (1SAS and 2SAS); either of the two Army 
Mentoring Task Force Units (MTF2 and MTF3); or Army Force Communications Unit (1FCU) 
(3). This subsample was selected on the basis of being in primarily combat roles, thus having a 
greater likelihood of exposures. 
 
Due to the extensive training commitments and short lead-up time associated with many 
deployments, not all personnel could participate. Prior to deployment, 1871 ADF 
members (60.9% of all deployed) participated in the MEAO study. Of these, 1324 
(70.8% retention rate) also participated within 4 months following their return from 
deployment (134). As the research presented in this thesis is related to deployment-
specific respiratory health outcomes of ADF members, data from only those who 
completed both pre- and post-deployment spirometry tests and self-reported 
questionnaire components were filtered and included in the final analysis.  
 
The MEAO study population had been deemed mentally and physically fit to deploy (12) .The 





iTable 2.3.1 - Demographic and service characteristics of the entire MEAO 
prospective study sample who were deployed to the MEAO between 2010 and 2012 
(n total=3074) 
Characteristics Sub-group Population number 
Total sample  3074 




Sex  Female  250 
Male 2824 
Service  Army  2289 
Navy 233 
 Airforce 552 
 
Of the total sample, 399 participants completed the physical test both pre- and/or post-
deployment. Of the 399, 197 were excluded due to the fact that they did not complete the 
spirometry test at both pre- and post-deployment, or they did not meet the criteria of 2005 
American Thoracic Society (ATS) and European Respiratory Society (ERS) (which includes a 
statement on the standardisation of spirometry) for valid spirometry (3, 135-137). The following 
are numbers of excluded participants and the reasoning behind exclusion from the final 
analysis.  
 53 participants did not complete spirometry at pre-deployment. 
 22 did not complete spirometry at post-deployment. 
 5 physical testing participants did not complete spirometry at both pre- and post-
deployment.  
 50 pre-deployment, 27 post-deployment and 40 pre- and post-deployment tests were 
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completed, but upon review by the Professor of Clinical Respiratory Physiology at the 
University of South Australia, they were deemed not to meet the American 
Thoracic Society and European Respiratory Society (ATS/ERS) 2005 criteria (135) for 
valid spirometry, and were therefore excluded from the analyses (3). For valid 
spirometry, participants had to produce 3 acceptable (i.e. deep enough inspiration 
without hesitant or cough with maximum effort and long enough exhalation) and 2 
reproducible tests (i.e. result must have been reproducible after maximum of 8 attempts 
according to the ATS/ERS guideline).  
 
The remaining 202 participants with complete reliable data were eligible for analysis, having 
completed both pre- and post-deployment spirometry tests and meeting the ATS/ERS criteria. 
 
The following table is a summary of demographic and service characteristics of responders 





iiTable 2.3.2 – Demographic and service characteristics of responders who 
completed both pre- and post-deployment spirometry and self-reported 
questionnaire and were in combat role (n total=202) 
 
  
Characteristics Sub-groups N pre-post deployment 
Total   202 




Sex  Female  3 
Male 175 
Missing 24 
Service  Army  192 
Navy 10 
Prior deployment  No prior dep 54 
1-2 prior dep 75 
3-4 prior dep 25 
4+ prior dep  16 
Missing number of prior 
deployment 
32 
Current smoking Yes 85 
 No 103 
 Missing 14 
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iiiTable 2.3.3 – Demographic and service characteristics of responders who 
completed both pre- and post-deployment spirometry and self-reported 
questionnaire and were excluded pre- or post-deployment (n total=192) 
Characteristics Sub-groups Number of excluded participants with 
complete spirometry and self-reported 
questionnaire pre- and post-deployment 
Total   192 




Sex  Female  3 
Male 173 
Missing 16 
Service  Army  183 
Navy 9 
Prior deployment  No prior dep 41 
1-2 prior dep 70 
3-4 prior dep 24 
4+ prior dep  24 
Missing number of prior deployment 33 
Current smoking Yes 69 
 No 103 
 Missing 20 
Note: Out of 399 physical testing participants, 5 did not complete spirometry at both pre- and 




2.4 Measures  
Self-reported measures 
Self-report questionnaires were designed to collect measures of physical and psychological 
health and deployment experiences. The pre-deployment questionnaire (Appendix 2.1) covered 
participants‟ deployment history, their pre-deployment health status, including physical, 
psychological, social function, and health risk factors. Information was then gathered on 
individual factors of personality and prior life experiences that could contribute to each 
particular health outcome.  
 
The post-deployment questionnaire (Appendix 2.2) covered post-deployment health status, 
including physical and psychological health, social function and risk factors since the beginning 
of their last deployment. Recent deployment experiences were covered to capture the health risk 
factors and threats that occurred in relation to their latest deployment to the MEAO. 
 
In both pre- and post-deployment questionnaires, participants were assessed on their 
psychological distress (K10) (138),
 
depressive symptoms (PHQ-9) (139), PTSD symptoms 
(PCL-C) (140), alcohol use (AUDIT)(141) and smoking status. For the purpose of this thesis, 
data pertaining to demographic, exposures, respiratory function and PTSD, as extracted from 
the MEAO questionnaire were utilised. A more detailed description of these measures are 
presented in the MEAO prospective study report (3, 133), and further detail about the measures 
used for the current study is outlined below. 
 
Respiratory symptoms 
This study gathered respiratory related data from three sections of the MEAO prospective 
questionnaire. The three sections assessing current respiratory symptoms include: “Recent 
Health Symptoms” (67-item questionnaire); “Your Health Now”, a questionnaire comprising 
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self-reported doctor diagnoses; and “Your Respiratory Health” questionnaire (European 
Respiratory Health survey 2-screening questionnaire) (40, 142, 143).  
 
Items assessing current respiratory symptoms were taken from the European Respiratory Health 
survey 2-screening questionnaire (143) and the 2011 Australian Gulf War Veterans Health 
Study follow-up (40). The 67-item adapted version of the self-report symptom questionnaire 
was originally based on the Hopkins Symptom Checklist developed and used by the King‟s 
College Gulf War Illness Research Unit (40, 43, 142). This questionnaire asks about recent (in 
the past month) respiratory, cardiovascular, musculoskeletal, dermatological, gastrointestinal, 
genitourinary, neurological, neuropsychological or cognitive, and psychological symptoms. The 
respiratory symptoms/conditions drawn from this questionnaire include: persistent cough, 
shortness of breath, wheezing, unable to take deep breath, fast breathing, coughing, asthma, 
asthma attack, hay fever, tightness in chest, bronchitis, and sinus problems (see appendix 2.1 
and 2.2 for more details). Items assessing current respiratory symptoms were also taken from 
the European Respiratory Health survey 2-screening questionnaire (37, 50).  
 
For the purpose of this study, a measure of respiratory symptoms, including items from the 
Hopkin Symptom Checklist and the European Respiratory Health Survey, was created by 
grouping the symptoms as presented in Table 2.4.1. Respiratory symptoms were analysed both 
as a continuous measure (sum number of respiratory symptoms i.e. coughing, shortness of 
breath, hypersensitivity, tightness in chest, wheezing and sinus problems), with a total score of 
0-6 as well as dichotomous (yes/no answer for presence or absence of any respiratory symptom 
listed in Table 2.4.1). Individual symptoms were not investigated due to the limited sample size, 
and because the purpose of this study was to investigate the association between deployment 
exposures and the overall shift in respiratory outcomes from pre- to post-deployment rather than 




ivTable 2.4.1– Categories of self-reported respiratory symptoms 
Categories  Specific self-reported symptoms 
Coughing Persistent cough 
Bronchitis (including both self-reported infective bronchitis 
and chemical induced bronchitis) 
Shortness of breath  Unable to take deep breath 
Fast breathing 
Hypersensitivity  Asthma attack (attacks of asthma in the past 12 months/ not 
being able to breathe due to sudden tightening of muscles 
around airways) 
 Asthma (currently taking medication for asthma) 
 Hay fever (nasal allergy)  






Sinus problems  
 
Post-Traumatic Stress Disorder 
This study used the PCL-C which is a 17-item self-report measure designed to assess the 
symptomatic criteria of PTSD. The 17 questions of the PCL-C are scored from 1 to 5 and are 
summed to give a total symptom severity score of between 17 and 85, with higher scores 
indicating increased severity (140).  
 
In this study, PCL scores were used as both continuous and dichotomous variables. In 
accordance with the ADF post-operational screening, severity categories are able to be 
calculated from the PCL, with scores from 17 to 29 considered to be low, 30 to 39 medium, 40 
to 49 high, and 50+ very high (144), however, due to the small number of participants (less than 
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0.5 %) meeting the diagnostic threshold for PTSD at pre-deployment and 1% at post 
deployment, scores on the PCL-C were instead categorised into 2 severity bands (Low and 
High) at pre- and post-deployment. Dichotomous categories were determined by plotting the 
distribution curve. This plot was not normally distributed, and therefore, a cut-off value of the 
75th percentile was used to work out a score for high and low PCL (PCL scores over 25 = high; 
PCL scores equal or below 25 = low).  
 
Psychological trauma exposures 
The post-deployment self-report questionnaire contained 26 questions about specific traumatic 
deployment related experiences (3, 145). The 26 items were grouped into nine broad categories 
which were considered to be of a similar nature (Table 2.4.2). These groupings were based on 
previous research on combat exposures by Wilk et al. (2010) and were also used in the MEAO 
census study and prospective study reports (146).  
 
The nine categories of traumatic deployment exposures include: coming under fire, discharging 
own weapon in direct combat at enemy, unable to respond to a threatening situation, vulnerable 
situations or fear of events, in danger of being killed/injured, seeing/handling dead bodies, 
casualties among those close to you, human degradation, and actions resulting in injury or death 
(Table 2.4.2). 
 
Participants were asked if they had experienced each of the exposures while on deployment, 
and how many times they had experienced that exposure. A total score was calculated by 
summing the number of exposure types endorsed (minimum=0 maximum=9)(144, 147). This 
was then dichotomised using the median value to categorise exposure levels as low (≤ 2) or 





v Table 2.4.2 – Categories of Traumatic Deployment Exposures 
Category  Items in the survey 
Coming under fire  Came under small arms or anti-aircraft fire 
Came under guided or directed 
mortar/artillery fire 
Experienced indirect fire (e.g. rocket attack) 
Experienced an IED/EOD that detonated 
Experienced a suicide bombing 
Experienced a landmine strike 
Encountered small arms fire from an unknown enemy 
Discharging own weapon  Discharged your own weapon in direct combat 
Unable to respond to a 
threatening situation 
Experienced a threatening situation where you were unable to 
respond due to the rules of engagement 
Vulnerable situations or fear of 
events 
Seriously feared you would encounter an IED 
Went on combat patrols or missions 
Participated in support convoys (e.g. re-supply, VIP escort) 
Concerned about yourself or others (including allies) having an 
unauthorised discharge of a weapon 
Cleared/searched buildings 
Cleared/searched caves 
In danger of being killed/injured In danger of being killed 
In danger of being injured 
Seeing/handling dead bodies  Handled dead bodies 
Saw dead bodies 
Casualties among those close to 
you 
Heard of a close friend or co-worker who had been injured or killed 
Present when a close friend was injured or killed 
Heard of a loved one who was injured or killed 
Present when a loved one was injured or killed 
Human degradation Witness to human degradation and misery on a large scale 
Actions resulting in injury or 
death 
Believe your action or inaction resulted in someone being seriously 
injured 






Environmental exposures  
The environmental exposure scale was developed from MEAO Preliminary Study Focus 
Groups (3) and the Kings College London Phase 2 questionnaire (142). Environmental 
exposures included: local combustion sources (burn pits/fire), dust storm, inhaled fine dust 
fibres, cigarette smoking, diesel exhaust (aviation, marine or automotive fuel), aircraft fumes, 
toxic industrial chemicals, solvents (e.g. thinners, sealer, paints), live in an area recently 
sprayed with pesticides, and exposed to explosion (140). 
 
Participants were asked if they had experienced each of the exposures while on deployment, 
and how many times they had experienced that exposure. For the purpose of this study, number 
of exposure times was not used, with the total score calculated by summing the number of 
exposure types endorsed (minimum=0 maximum=10) (3, 43, 148). The sum of exposure types 
was then dichotomised using the median value to categorise exposure levels as low (< 5) or 
high (≥ 5). 
 
Objective respiratory measures 
Participants underwent a series of physical testing components and neurocognitive assessments 
to evaluate the impact of deployment on health outcomes, including height, weight, waist and 
hip circumference recording, blood pressure testing, lung function spirometry testing, and 
cardiovascular fitness assessment. Photographs were also taken of each participant to assess 
dermatological skin changes. A 40ml blood sample was taken to measure chronic infections, 
inflammation markers and biochemistry. Of relevance to this thesis were the spirometry test and 
the measure of height and weight. The rest of the data were not utilised as they were not 
relevant to the purpose of this thesis. However, a summary of results and more information 
regarding the measures and protocols can be found in the MEAO health study: Prospective 





Spirometry measures were performed and collected by a nurse during the pre- and post-
deployment physical testing of ADF members. The test was performed according to the 
guidelines for conducting spirometry specified by Miller et. al, (2005) (135). 
 
Height and age were recorded to calculate predicted respiratory function, and participants 
underwent spirometry using an Easy One™
 
spirometer. The ATS/ERS guidelines for 
conducting spirometry testing were used (136, 137). The use of the EasyOne spirometer, which 
corrects for gender, age and ethnicity using predicted normal, for all tests removed confounding 
factors such as age, gender, height, weight and ethnicity. Healthy Caucasian Australian 
population was set into the Spirometer as the reference population.  
Three measures for evaluating respiratory health collected via spirometry were: forced 
expiratory volume at one second (FEV1) which is a measurement that calculates the amount of 
air a person can force out of their lungs in 1 second; forced vital capacity (FVC) is defined as 
the amount of air that can be forcibly exhaled from the lungs after taking the deepest breath 
possible; and the FEV1/FVC ratio which represents the proportion of a person's vital capacity 
that they are able to expire in the first second of forced expiration to the full, forced vital 
capacity. 
 
Guidelines from the Global Initiative for Chronic Obstructive Lung Disease and from the 
International Consensus Statement sponsored by the ATS and the ERS suggest that airflow 
obstruction is present when the ratio of FEV1 to FVC is less than 70% of „Predicted Normal 
Values‟ (136, 137). This criterion is set regardless of age and gender in an attempt to simplify 
the diagnosis. However, as the FEV1/FVC ratio is inversely proportional to age, the use of a 
fixed cut-off would be expected to „over call‟ obstruction in older  subjects and „under call‟ 
obstruction in young individuals (137). The issue of overestimation or underestimation will not 
be of concern in this study as the majority of participants are young and fit military members, 
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meaning that by convention, an individual‟s lung function is taken to be low or „abnormal‟ if it 
is below 70%, which could be suggestive of airflow limitation with obstructive pattern. A ratio 
above 70% is usually considered to be a „normal‟ lung function measure (135, 137). 
 
The FEV1/FVC ratio was used as a continious measure of respiratory function. In addition, 
dichotomous variables (sub-groups) were created by using the „Global Initiative for Chronic 
Obstructive Lung Disease‟ (GOLD) standard cut off of 70% for FEV1/FVC. Participants were 
then divided into the following 2 sub-groups: „Normal‟ = FEV1/FVC >70% pre- and post-
deployment; „Abnormal‟ = FEV1/FVC 70% pre- and post-deployment. Two additional sub-
groups were created using the mean FEV1/FVC at pre- and post-deployment. „Increased‟ = 
respiratory function measures (FEV1/FVC) increased at post deployment; and „Decreased‟ = 
respiratory function measures declined at post deployment. The reason for creating these 
subgroups was that, in addition to the GOLD standard cut-off for Normal/Abnormal respiratory 
function, this study aimed to investigate the change in respiratory function and association with 
respiratory symptoms (136, 137).  
 
2.5 Data Analysis  
This section describes general statistical methods used in this thesis.  
 
In order to answer the study questions, a number of analytical methods were employed. All 
analyses were performed using the statistical software package SPSS Statistics version 21 (IBM 
SPSS Statistics for Windows, Armonk, NY: IBM Corp) and Microsoft Excel 2016. For each 
outcome variable, the effect size was estimated with 95% confidence limits. Statistical 
significance was assessed at a level of p≤0.05. Descriptive analyses, linear, Poisson and binary 
logistic regressions were used depending on the nature of the specific question and variables 




Paired data were tested using a paired samples t-test or McNemar‟s test. For continuous 
outcomes, where appropriate, descriptive statistics including mean and confidence intervals are 
presented.  
 
Descriptive statistics (including mean and confidence intervals) were provided for the 
demographic and service characteristics of the ADF members who completed both the 
spirometry test and questionnaire. The scores on these measures were compared between pre- 
and post-deployment. Standard error of mean and standard deviation were also reported where 
appropriate. 
 
Mixed models for repeated measures were used for continuous outcomes This approach allows 
for the use of repeated measures on the same individual (i.e. pre- and post-deployment) in order 
to investigate changes in respiratory outcomes over time. 
 
Univariate and multiple linear regression and Poisson regression methods were used to 
investigate the relationship between deployment exposures and FEV1/FVC and self-reported 
respiratory health outcomes post-deployment. In addition to show whether the FEV1/FVC 
means were increasing or decreasing across levels of respiratory symptoms and PCL scores, a 
univariate linear regression was performed. 
 
A logistic regression model was used for dichotomous outcomes, (e.g. present, absent of 
respiratory symptoms) and the number and percentage of participants experiencing the outcome 
of interest is shown. 
 
To plot the interaction effect of exposures and respiratory outcomes, linear regressions and 2-




Independent sample t-tests were used to assess mean differences between sub-groups (e.g. 
Normal, Abnormal, Decreased lung function, and Increased lung function).  
 
In order to determine if the differences in means were significant from pre- to post-deployment, 
paired sample t-tests were used.  
 
As suggested by the literature, a number of demographic factors can impact on outcomes, 
therefore, all regression analyses were adjusted for age, cigarette smoking and pre-deployment 
measures where appropriate. 
 
Listwise deletion was used in SPSS which did not include cases that have missing values on the 
variables under analysis. The small numbers in some of the sub-groups may mean that there 
was insufficient power to detect statistically significant differences. 
 
Note: the MEAO prospective study (3), which analysed the same sample of ADF members, 
showed no significant association between smoking status or smoking behaviour and change in 
FEV1/FVC. Therefore this study did not repeat what was found previously. In this study, 
cigarette smoking was included as one of the environmental exposures and all regression 
analyses were adjusted for cigarette smoking where appropriate. 
 
2.6 Summary  
This thesis utilises data drawn from the MEAO prospective study and focuses on factors 
associated with respiratory health outcomes among a sample of ADF members deployed to the 
MEAO.This chapter has detailed all aspects of the research methodology used to investigate the 
research questions regarding the change in respiratory function among ADF personnel deployed 
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to the MEAO between 2010 and 2012 from pre-to post-deployment and the impacts of 
deployment exposures on respiratory outcomes. The detailed data analysis for each chapter is 
discussed in the methodology section of the corresponding chapter. 
 
The results of the research study conducted in accordance with this methodology are reported in 
the next two chapters.  
 
2.7 Ethics approval and consent to participate 
This thesis is reporting studies involving human data, and therefore a low-risk Ethics approval 
was obtained from Joint Health Command Low-Risk Ethical Review Panel for Defence Health 




Chapter 3 – Change in respiratory function from pre- to post-




3.1 Commentary  
Recent studies suggest that respiratory function decline among military members may be the 
result of deployment, and indicative of future risk of respiratory conditions. Therefore, 
determining the level of respiratory distress (decline in objective respiratory function and 
increase in respiratory symptoms) following deployment of ADF members to the MEAO and 
predictors of these adverse respiratory outcomes is of theoretical importance and practical 
utility.  
 
This chapter addresses the first aim of this study which is to investigate if similar to the reported 
international literature, there is an increase in subjective respiratory symptoms (self-reported 
respiratory symptom measured by questionnaire) of ADF members from pre- to post-
deployment to the MEAO between 2010 and 2012 and whether these are accompanied by any 
changes in objective function (FEV1/FVC measured by spirometry), possibly at a sub-clinical 
level. The following chapter (Chapter 4) will investigate the second aim of this study which is 
to investigate the specific predictors of decline in respiratory function. 
 
The use of MEAO prospective study data allowed a longitudinal analysis of both the objective 
and subjective measures of respiratory function. In addition to the prospective design of this 
study, the subset sample (n=202) selected for respiratory analyses was relevant as it represented 
a predominantly healthy, non-symptomatic cohort who were in combat roles and exposed to a 
variety of potentially traumatising factors, both physical and psychological. Identifying patterns 
of symptoms and predictors is important, because it may allow better monitoring and 
management of individuals who are at risk of developing further adverse respiratory outcomes 
following deployment.  
 
This chapter summarises the existing literature on adverse respiratory health concerns within 
international and Australian military populations. Following that, short descriptive analyses of 
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the MEAO dataset will be presented to describe the features of the dataset relating to the 
respiratory health of ADF members. In addition, the analyses will address the study question of 
whether there is a change in respiratory function among ADF personnel deployed to the MEAO 
between 2010 and 2012 from pre-to post-deployment. While initial analyses of this dataset in 
the MEAO Prospective Study report (1) summarised changes in respiratory health, this chapter 
extends these findings, and is limited to the specific subsample utilised in this thesis. 
 
3.2 Introduction 
Australian troops have been actively involved in operations in the MEAO since 2001 as part of 
a global response to terrorism. In addition to combat injuries, the delayed health effects of 
operational service are of concern, particularly the psychological and physical effects of 
deployment exposures, such as environmental exposures, psychological trauma and other 
deployment exposures which may impact on the long-term respiratory health of military 
personnel (3, 4, 12, 13, 20-22, 37). The importance of examining health concerns is highlighted 
by consistent findings from post-deployment studies of personnel deployed in support of the 
GW1). These studies reported an increase in all somatic symptoms, including respiratory 
symptoms, by GW1 veterans compared with non-Gulf War comparison groups (5-7). The 
findings have been consistently replicated in a number of follow-up studies conducted many 
years after the end of the Gulf War (9, 40, 41, 43-45), which indicate that there may be 
characteristics of deployment that are associated with adverse health outcomes.  
 
Current international studies regarding the more recent MEAO conflict (the Iraq and 
Afghanistan conflict since 2001), have also documented an increased incidence of respiratory 
symptoms (e.g. shortness of breath, wheezing, coughing, etc.) that may be indicative of early 
onset of a potentially serious disease, such as asthma, bronchitis, COPD, etc. (10, 13-15, 60).  
55 
 
Because of limitations in GW1 studies (i.e. difficulties in standardising exposures; cross-
sectional, retrospective medical review; and the self-reported nature of many studies) (7, 9, 31, 
40-45), it is difficult to discriminate associations with specific deployment-related exposures or 
to reach a robust conclusion regarding the relationship between exposure and adverse 
respiratory outcomes. The concerns and controversy regarding the respiratory symptoms 
following GW1 was one of the reasons why respiratory health and exposures following the Iraq 
and Afghanistan conflicts were monitored closely (3, 71, 88).  
 
The current analyses utilised data from the MEAO prospective study to investigate if, in 
concurrence with international literature, that indicated both objective and subjective respiratory 
decline among military members after deployment to the Middle East, there is also a decline in 
objective and subjective respiratory functions of ADF members post-deployment to MEAO 
between 2010 and 2012.  
 
To provide context for this study, the key adverse respiratory outcomes relevant to the 
international military personnel deployed to MEAO is first briefly described. Following this, 
MEAO prospective study data is used to determine the level of respiratory distress at pre- and 
post-deployment using both subjective and objective measures. Further background literature, 
including that pertaining to environmental and psychological and other exposures, are presented 
in Chapter 1 (literature review) of this thesis.  
 
3.3 Method  
The following is a summary of the sample and measures used in this chapter.  Detailed 
methodology, including description of the sample, objective and subjective measures has been 





The sample was drawn from the MEAO prospective study which assessed the physical and 
mental health of ADF members deployed to the MEAO (3). The total eligible population was 
n=3074 which consisted of those units and ships that deployed to the MEAO during the study 
period (June 2010- June 2012). Of the eligible population n=1871 participants competed the 
pre-deployment survey. Of these 1324  participated post-deployment (133, 134).  
 
This sample was further reduced at post-deployment to the final sample used for the current 
study which included 399 participants who completed the physical test at pre- and/or post-
deployment. Of the 399, 197 were excluded due to not completing the spirometry test at both 
pre- and post-deployment, or they did not meet the criteria of 2005 American Thoracic Society 
(ATS) and European Respiratory Society (ERS) (3, 135-137). The remaining 202 participants 




This study used both self-reported and objective measures to collect all pre and post deployment 
data for this study.  Self-reported measures used in this chapter include respiratory symptoms 
gathered from three sections of the MEAO prospective questionnaire. The three sections 
assessing current respiratory symptoms include: “Recent Health Symptoms” (67-item 
questionnaire); “Your Health Now” (a questionnaire comprising self-reported doctor 
diagnoses); and “Your Respiratory Health” (European Respiratory Health survey 2-screening 
questionnaire) (40, 142, 143).  See Table 2.4.1 Categories of self-reported respiratory symptoms 





The objective measure included spirometry which was performed according to the guidelines 
for conducting spirometry specified by Miller et. al, (2005) (135). Height and age were 
recorded to calculate predicted respiratory function, and participants underwent spirometry 
using an Easy One™ spirometer. ATS/ERS guidelines for conducting spirometry testing were 
used (136, 137). Three measures for evaluating respiratory health collected via spirometry were: 
Forced Expiratory Volume at one second (FEV1), Forced Vital Capacity (FVC); and 
FEV1/FVC ratio.  For more information about self-reported questionnaires and spirometry 
please refer to chapter 2 of this thesis, section 2.4 Measures. 
 
Data Analysis  
In order to describe the basic features of the data in this chapter descriptive analyses were used. 
Descriptive analyses provided simple summaries about the sample such as proportion and 
percentile and determined measures of central tendency, including mean and measures of 
dispersion including standard deviation and/or standard error of the mean. Descriptive statistics 
were provided for the demographic and service characteristics of the ADF members who 
completed both spirometry test and questionnaire. The scores on these measures were compared 
between pre- and post-deployment. Standard Error of Mean and Standard Deviation were also 
reported where appropriate. For the outcomes of the FEV1/FVC ratio and sum of respiratory 
symptoms, assumptions of a linear model were found to be upheld by inspection of histograms 
and scatter plots of predicted values and residuals (Tables 3.4.1 and 3.4.2). 
 
Mixed models for repeated measures were used for continuous outcomes. For FEV1/FVC ratio 
and sum of self-reported respiratory symptoms and interaction between pre-post period within 
the characteristic sub-groups (i.e. age, sex, service, etc), a linear mixed-effects model of 
outcomes was used.This approach allows for the use of repeated measures on the same 
individual (i.e. pre- and post-deployment) in order to investigate changes in respiratory 




To demonstrate the Proportion N (%) of „Normal‟ and „Abnormal‟ respiratory function 
(FEV1/FVC) and the difference in mean FEV1/FVC from pre- to post-deployment, in addition 
to descriptive analysis, the McNemar test was used to calculate the significant difference from 
pre- to post-deploment (Table 3.4.3). 
 
A paired sample T-test was performed in order to distinguish between the proportion of 
participants who showed „Normal‟ or „Abnormal‟ respiratory function results at pre- and/or 
post-deployment and to identify new cases of „Abnormal‟ lung function at post-deployment. 
Participants were broken down into four distinct groups and the results reported the frequency 
and percentage of ADF members who had „Abnormal‟ respiratory function at: pre-deployment 
only, post-deployment only, at both pre- and post-deployment, or neither („Normal‟ at both pre-
and post-deployment) (Table 3.4.5).  
 
To determine the proportion of ADF members and the number of respiratory symptoms (1-6 
respiratory symptoms) reported at pre- and post-deployment, simple descriptive statistics 
(frequencies on SPSS) were used. Respiratory symptoms include coughing, shortness of breath, 
hypersensitivity, tightness in chest, wheezing and sinus problems. Differences from pre- to 
post-deployment were calculated using multivariable regression. See Table 3.3.3 for more 
details of respiratory symptom groups (Table 3.4.6).  
 
In order to further determine whether the onset of respiratory symptoms preceded or followed 
deployment, this study examined the development of symptoms at post-deployment in those 
who were symptom-free versus symptomatic at pre-deployment. The paired analysis (McNemar 
test) addressed which lung function subgroups (i.e. Normal, Abnormal, Increased, Decreased) 
had a significant increase in incidence of newly reported respiratory symptoms at post-
deployment as well as whether or not new respiratory symptoms at post-deployment reflects 
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clinical diagnosis guidelines using the GOLD standard cut off of 70% for FEV1/FVC (Table 
3.4.7). 
 
As suggested by the literature, a number of demographic factors can affect respiratory 
outcomes; therefore, all regression analyses were adjusted for age, cigarette smoking and pre-
deployment measures where appropriate. Listwise deletion was used in SPSS, which did not 
include cases that have missing values on the variables under analysis. 
 
Note: the MEAO prospective study (3) which analysed the same sample of ADF members, 
showed no significant association between smoking status or smoking behaviour and change in 
FEV1/FVC. Therefore, this study did not repeat what was found previously. In this study, 
cigarette smoking was included as one of the environmental exposures and all regression 
analyses were adjusted for cigarette smoking where appropriate.  
 
3.4 Results 
The following investigation aimed to establish evidence of change in respiratory health of ADF 
members between pre- and post-deployment to the MEAO. 
 
The results in Tables 3.4.1 and 3.4.2 shows the change in the total sample mean FEV1/FVC and 
respiratory symptoms between pre- and post-deployment and whether demographic factors such 
as age, sex, service, prior deployment and smoking status affect adverse respiratory outcomes 
(decline in FEV1/FVC and increase in self-reported respiratory symptom) within a subset 
sample of ADF members deployed to MEAO (n=202). 
 




There were no significant differences in the change in FEV1/FVC ratio between pre- and post-
deployment due to age, sex, service, prior deployment and current smoking status (Table 3.4.1). 
 
viTable 3.4.1 The effect of deployment on FEV1/FVC for responders who 
completed both pre- and post-deployment spirometry test (n total=202) 





















Total sample  80.4 ± 0.5 (202) 80.0 ± 0.5 (202) 0.72  
Age  16-24    80.7 ± 0.8 (86) 81.6 ± 0.7 (86) 0.20 0.52 
25-34 80.5 ± 0.8 (86) 80.3 ± 0.7 (86) 0.75  
35-44 79.0 ± 1.5 (26) 78.1 ± 1.3 (26) 0.45  
45-54 81.8 ± 3.8 (4) 81.6 ± 3.2 (4) 0.94  
Sex  Female 82.5 ± 4.5 (3) 82.9 ± 3.8 (3) 0.93 0.97 
Male 80.0 ± 0.6 (175) 80.1 ± 0.5 (175) 0.67  
Missing  (24) (24)   
Service  Army 80.4 ± 0.6 (192) 80.5 ± 0.5 (192) 0.81 0.60 
Navy 81.2 ± 2.4 (10) 82.3 ± 2.1 (10) 0.56  
Prior 
deployment  
No 80.8 ± 1.0 (54) 81.4 ± 0.9 (54) 0.44 0.82 
1-2 80.0 ± 0.8 (75) 79.9 ± 0.8 (75) 0.95  
3-4 79.8 ± 1.4 (25) 80.0 ± 1.3 (25) 0.82  
4+ 80.0 ± 1.8 (16) 81.4 ± 1.6 (16) 0.54  
Missing (32) (32)   
Current 
smoking 
Yes 80.9 ± 0.8 (85) 81.0 ± 0.7 (78) 0.807 0.537 
 No 80.1 ± 0.7 (103) 79.7 ± 0.6 (99) 0.496  
Key: 
a
 marginal means ± S.E.M. n = number of ADF participants. 
b 
linear mixed-effects models 




No significant change was identified in the overall self-reported sum of respiratory symptoms 
from pre- to post-deployment. There was also no effect of age, sex, service or deployment 
category on the change in respiratory symptoms between pre/post deployment, with the 
exception of age sub-group 35-44 years, who reported a significant increase in respiratory 
symptoms at post deployment (p=0.047) (by the use of interaction models; Table 3.4.2). 
 
viiTable 3.4.2 The effect of deployment on self-reported respiratory symptoms for 
ADF members who completed self-reported questionnaires (n total=202) 

















Total sample  0.6 ± 0.08 (202)  0.76 ± 0.09 (202) 0.130  
Age  16-24 0.58 ± 0.12 (86) 0.63 ± 0.13 (86) 0.738 0.26 
25-34 0.65 ± 0.12 (86) 0.83± 0.13 (86) 0.265  
35-44 0.46 ± 0.21 (26) 1.04 ± 0.25 (26) 0.047  
45-54   0.75 ± 0.55 (4) 0.00 ± 0.60 (4) 0.310  
Sex   Female   1.00 ± 0.63 (3) 2.00 ± 0.69 (3) 0.243 0.39 
Male   0.60 ± 0.08 (175)  0.78 ± 0.09 (175) 0.103  
  Missing (24) (24)   
Service  Army   0.59 ± 0.08 (192)  0.77 ± 0.09 (192) 0.089 0.31 
Navy 0.70 ± 0.34 (10) 0.40 ± 0.38 (10) 0.522  
Prior 
deployment  
   No 0.83 ± 0.15 (54) 0.96 ± 0.16 (54) 0.522 0.72 
   1-2 0.52 ± 0.13 (75) 0.60 ± 0.14 (75) 0.643  
   3-4 0.68 ± 0.22 (25) 0.64 ± 0.25 (25) 0.899  
   4+  0.62 ± 0.27 (16)  0.99 ± 0.31 (16) 0.334  
  Missing (32) (32)   
Current 
smoking 
   Yes  0.08 ± 0.3 (85)     0.13 ± 0.3 (78) 0.183 0.509 
   No   0.05 ± 0.2 (103)     0.08 ± 0.3 (99) 0.630  
Key: 
a
 marginal means ± S.E.M. n = number of ADF participants. 
b 




In order to examine the extent to which objective respiratory function changed in relation to 
clinical diagnosis guidelines, categories of respiratory function were assessed.The following 
table shows proportion N (%) of ADF members at pre- and post-deployment within objective 
respiratory function sub-groups „Normal‟ and „Abnormal‟ at pre- and post-deployment. This 
will provide a snapshot of the overal FEV1/ FVC status in the cohort of 202 participants in 
combat roles who have completed both the objective and subjective components of the study 
pre- and post-deployment. 
 
viiiTable 3.4.3 Proportion N (%) of ‘Normal’ and ‘Abnormal’ lung function 
(FEV1/FVC) at pre- and post-deployment 









194 (96%) 193 (95.5%) 8 (4%) 9 (4.5%) 
Key: 
a
 Data are proportion N (%) of ADF participant at pre- and post-deployment within 
objective respiratory function sub-groups „Normal‟ and „Abnormal‟ at pre- and post-
deployment. 
b
 Differences from pre- to post-deployment calculated using McNemar test. 
*P<0.05, ** P<0.001. (P=0.1 for both Normal and Abnormal sub-groups). 
 
In addition to the GOLD standard cut-off for Normal/Abnormal respiratory function, this study 
investigated the shift in objective respiratory function. This provided further support in 
answering the question of this study regarding the change in respiratory outcomes from pre- to 
post-deployment. The mean FEV1/FVC at pre- and post-deployment was used to determine the 
proportion of ADF members who had an increase or decrease in objective respiratory function 
at post-deployment. The descriptive results in Table 3.4.4 showed that 55.7% of service 
members had a decrease in their respiratory function at post-deployment, while 44.3% showed 




ixTable 3.4.4 Proportion N (%) of ‘Increased’ and ‘Decreased’ respiratory 
function measures at post-deployment 
FEV1/FVC increased at post-deployment FEV1/FVC decreased at post-deployment 
N % N % 
78  44.3 98  55.7 
Key: 
a
 Data are proportion N (%) of ADF participants at post-deployment within objective 
respiratory function sub-groups „Increased‟ and „Decreased‟ respiratory function post-
deployment. 
 
The following results presented frequency and percentage of participants who had „Abnormal‟ 
FEV1/FVC at pre-deployment only, post-deployment only, at both pre- and post-deployment, or 
neither. 
 
In order to further distinguish between the proportion of participants who showed „Normal‟ or 
„Abnormal‟ respiratory function results at pre- and/or post-deployment and to identify new 
cases of „Abnormal‟ respiratory function at post-deployment, participants were broken down 
into four distinct groups. The following results report the frequency and percentage of 
participants who had „Abnormal‟ respiratory function at: pre-deployment only, post-deployment 













 4 2.0 
At post c 5 2.5 
At both 
d
 4 2.0 
Neither 
e
 189 93.5 
Total 202 100.0 
Key: 
a
 Data are frequency N (%) of ADF participants with „Abnormal‟ respiratory function: 
b 
at 
pre- deployment only, 
C
 post-deployment only (new cases of „Abnormal‟ respiratory function), 
d 
at both pre-and post-deployment, 
e
 Normal at both pre-and post-deployment. 
 
The purpose of the following  descriptive table was to determine what proportion of ADF 
members reported one, two, three, four, five and six respiratory symptoms at pre- and post-
deployment and whether the proportion of ADF members with more than one respiratory 
symptom increased from pre- to post-deployment. 
 
Table 3.4.6 shows that the number of ADF members who reported 3 and 4 respiratory 
symptoms increased  significantly from pre- to post-deployment p<0.001. The number of ADF 
members with 3 respiratory symptoms increased from pre- to post-deployment P<0.001, B=2.9, 
95% CI (2.2, 3.5), marginal means S.E.M. ± 0.3. The number of ADF members with 4 
respiratory symptoms increased from pre- to post-deployment P<0.001, B=4.5, 95% CI (3.1, 





xiTable 3.4.6 Proportion N (%) of respiratory symptoms reported by ADF 
members pre- and post-deployment. 












0 131 64.9 121 61.1 
1.00 45 22.3 38 19.2 
2.00 14 6.9 18 9.1 
3.00 6 3.0 11 5.6**
b
 
4.00 2 1.0 8 4.0**
b
 
5.00 2 1.0 1 0.5 
6.00 2 1.0 1 0.5 
Total 202 100.0 198 100.0 
Key: 
a 
Data are frequency N (%) of ADF participants with 1-6 self-reported respiratory 
symptoms. Respiratory symptoms include: coughing, shortness of breath, hypersensitivity, 
tightness in chest, wheezing and sinus problems. See Table 3.3.3 for more details of grouping 
respiratory symptoms. 
b
 The differences from pre- to post-deployment were calculated using 
multivariable regression. Significant at *P<0.05, ** P<0.001.  
 
The following analysis further established evidence of change in respiratory outcomes from pre- 
to post-deployment by investigating the prevalence of respiratory symptoms within the 
objective respiratory function sub-groups („Normal‟, „Abnormal‟, „Increased‟ and „Decreased‟ 
respiratory function). These analyses determined whether the onset of self-reported respiratory 
symptoms preceded or followed deployment, by examining the development of symptoms at 
post-deployment in those who were symptom-free versus those who were symptomatic on 
objective respiratory function tests at pre-deployment (table 3.4.7). As can be seen in Table 
3.4.7, the proportion of respondents who were symptom-free at pre-deployment but developed 
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at least one respiratory symptom at post-deployment increased by 20.4% in the „Normal‟ 
subgroup, by 14.2% in the „Abnormal‟ sub-group, 16.6% in those who had „Increased‟ 
objective respiratory function at post-deployment, and by 27.5% in those who had „Decreased‟ 
objective respiratory function at post-deployment. However, the only significant increase was 
observed among those with „Decreased‟ objective respiratory function at post-deployment 
(p=0.02) (Table 3.4.7).   
 
In relation to the findings in Table 3.4.7, indicating that those with newly reported respiratory 
symptoms at post-deployment had significantly decreased objective respiratory function at post-
deployment, this study further investigated if there was a linear relationship between the 4 
objective respiratory function sub-groups and an increase in respiratory symptoms at post-
deployment. The findings only showed a significant association between increased self-reported 
respiratory symptoms and decreased objective respiratory function at post-deployment (p=0.03, 
B= -0.86, 95% CI (-1.63,-0.09)), providing evidence of a link between changes in subjective 
and objective respiratory outcomes at post-deployment.   
 
This study also observed that when considering self-reported respiratory symptoms among the 
various objective respiratory function subgroups, those with „Abnormal‟ respiratory function 
more commonly reported at least one respiratory symptom compared to respondents with 





xii Table 3.4.7 Development of respiratory symptoms at post-deployment in those 





 Symptomatic at post N (%) 
b
  
Normal 191  39 (20.4) 
Abnormal 7 1 (14.2) 
Increased 78 13 (16.6) 
Decreased 98 27 (27.5)* 
Key: 
a
 Data are number of ADF participants pre- to post-deployment (paired data) within 
objective respiratory function subgroups. b proportion N (%) of those who were symptom-free 
at pre-deployment and symptomatic at post-deployment, significant value calculated by using 
the McNemar test, *P<0.05.  
 
3.5 Discussion 
This chapter aimed to establish evidence of change in respiratory health in a subset sample of 
relatively healthy MEAO deployed ADF members by summarising the self-reported and 
objective respiratory health prior to, and following deployment.  
 
To date, there has been very limited prospective analysis of the respiratory health outcomes of 
ADF members following deployment. However, preliminary findings from the GW1 and 
MEAO prospective studies indicated an increase in self-reported respiratory symptoms (7, 40), 
as well as a decline in objective measures of respiratory function, following deployment to the 
MEAO (3, 88). 
 
This study found no significant change in the overall mean FEV1/FVC and respiratory 
symptoms from pre- to post-deployment among a subset sample of ADF members deployed to 
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the Middle East from 2010 to 2012. Since the total sample analyses may not have adequately 
captured intragroup variabilities, in addition to examining the whole sample, this study utilised 
a common method used internationally (135-137) to further investigate the objective respiratory 
shifts within sub-groups. This method used the GOLD standard „70% cut-off‟ which 
distinguished between „Normal‟ and „Abnormal‟ FEV1/FVC sub-groups. Using this method, 
the ADF members were broken down into sub-groups according to their objective respiratory 
results.  
 
Examination of the „Normal‟ and „Abnormal‟ sub-groups showed that while there are health 
restrictions in place for ADF enrolment, (i.e the ADF has historically precluded asthmatics from 
particular services or service roles) this study found that 4% met the global initiative for airway 
obstruction (FEV1/FVC 70%) at pre-deployment. This number increased to 4.5% at post-
deployment (Table 3.4.5). While this is not a substantial increase, it highlights the fact that 
some ADF members with abnormal respiratory functions were deployed to MEAO and there is 
a possibility that this number increases at post deployment. This needs more careful 
investigations in a much larger cohort of ADF members to determine the possible risks of 
increase in respiratory function abnormality.  
 
Deployment of ADF members with sub-optimal respiratory function may be the result of less 
stringent recruitment procedures compared to the UK and US military recruitment process. For 
example, since 2004, US military candidates diagnosed with asthma after the age of 13 have 
been excluded from military enlistment unless exempted via medical waiver (34). In the UK 
military, candidates may be disqualified from joining the military if suffering or having ever 
suffered from asthma (149). 
 
Based on clinical evidence, medical standards for entry to the ADF are more relaxed, allowing 
some people with mild asthma to enter the ADF under guidelines (150). Since 2007, candidates 
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with mild asthma may be considered for entry to the ADF subject to certain criteria, including 
normal spirometry and negative bronchial provocation testing (150). While the medical process 
is quite detailed for the recruiting process, spirometry is not mandatory unless the candidate 
presents with a history of respiratory condition, such as asthma. Currently, if there is no history 
of asthma symptoms in the past 3 years, candidates are considered fit and continue through 
processing. Candidates with a history of any symptoms or treatment within 3 years have 
spirometry performed. In addition, only entry to some jobs at the ADF require spirometry, such 
as aircrew, divers, submariners and special forces (150). 
 
Further analysis of the „Abnormal‟ subgroups showed that from the total 9 (4.5%) „Abnormal‟ 
cases identified at post-deployment, 4 (2%) had „Abnormal‟ respiratory function results at both 
pre- and post-deployment while 5 (2.5%) were new cases of „Abnormal‟ respiratory function at 
post-deployment (Table 3.4.5). Although these changes are small, the increase in new cases of 
abnormal respiratory function could be an indication of possible deployment risk factors 
influencing adverse respiratory outcome. Taking into consideration that the abnormalities in 
respiratory function are sub-threshold and not clinically evident, unless comprehensive medical 
tests such as spirometry are used. These sub-threshold respiratory abnormalities and symptoms, 
usually result in no reduction in ability to pass military fitness testing. However early 
identification of respiratory distress in military members may prove useful in determining 
strategies for prevention of adverse respiratory outcomes and aids earlier intervention, including 
recruitment guidelines, such as those followed by the US and UK. 
 
Although the overall increase in the sum of self-reported respiratory symptoms among ADF 
members was not significant, further analysis of the number of respiratory symptoms within this 
cohort showed that the proportion of ADF members who reported 3 and 4 respiratory symptoms 
had significantly increased from pre- to-post deployment (Table 3.4.6). This is in line with 
increased reporting of respiratory symptoms in both GW1, and the Iraq and Afghanistan 
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conflict (5-9, 31, 151, 152). Previous military studies, i.e. GW1 studies, were generally limited 
by the lack of prospective design, meaning that it was not possible to determine the timing of 
symptoms. However, the design of the MEAO prospective study allowed determination of 
whether respiratory symptoms do in fact precede or follow deployment. This study was able to 
examine the development of respiratory symptoms at post-deployment in those who were 
symptom-free prior to deploying. The analysis addressed which respiratory function sub-groups 
had a significant increase in incidence of newly reported respiratory symptoms at post-
deployment, as well as whether or not new respiratory symptoms at post-deployment reflects 
clinical diagnosis guidelines using the GOLD standard cut off of 70% for FEV1/FVC. The 
results showed a significant (27.5%) increase in incidence of newly reported respiratory 
symptoms within the sub-group with decreased respiratory function at post-deployment 
(p=0.02) (Table 3.4.7). This is further supported by the significant association observed 
between overall increase in respiratory symptoms and decrease in objective respiratory function 
p=0.03, B=0.86, 95% CI (-1.63, -0.09). In the other sub-groups „Normal‟, „Abnormal‟ and 
„Increased‟, respiratory function also showed an increase in incidence of newly reported 
symptoms, however, these increases were not significant.  
 
It is notable that even though the subgroup with „Normal‟ objective respiratory function met the 
criteria for being clinically healthy, some participants in this sub-group were symptomatic. 
Therefore, if respiratory symptoms reflected the actual changes in respiratory function, it would 
be expected that people with „Normal‟ or „Increased‟ respiratory function would be 
asymptomatic. There are a number of possible explanations for this. It may be that self-reported 
respiratory symptoms are reflective of somatic distress rather than any actual impairment (9). 
However, it is possible that the presence of respiratory symptoms within the „Normal‟ 
respiratory function group could reflect early respiratory decline, not yet manifesting as 




In addition to establishing evidence of change in objective and subjective measures of 
respiratory function, this study has also found that respiratory function as measured by the 
FEV1/FVC ratio and sum of self-reported respiratory symptoms, between pre- and post-
deployment, was not influenced by age, sex, service, prior deployment or current smoking 
status. This suggests that any possibility of increased risk of adverse respiratory outcomes may 
involve more specific exposures during deployment, such as environmental particulate matter or 
psychological stress of deployment, additional to the characteristics of ADF members or 
deployment alone (Table 3.4.1 and 3.4.2). Given the healthy state of military members at 
recruitment, existing research suggests that exposures such as environmental (particulate matter, 
metal particles, burn pit, air pollution), combat stress, and other exposures (physical activity, 
military living conditions and smoking) might be related to impairments in respiratory function 
among military members (10, 11, 20, 28, 57, 60, 152).  
 
Even though this study found very little change in objective and subjective respiratory function, 
there was some indication of a shift in symptoms and possibly objective function. Considering 
the possible role of exposures from the literature, and the likely variations in levels of exposure 
within the sample, the next chapter will explore this further.  
 
Although similar findings have been seen in other studies (3, 5-7, 9, 21, 31, 40, 45, 60), it is not 
possible to determine whether the higher rates of self-reported respiratory symptoms and 
reduced respiratory function were due to a higher occurrence of new respiratory conditions, 
somatisation, higher baseline prevalence, or reporting, selection, or confounding bias. Given the 
strengths of a prospective study with known base-line information, including descriptive, self-
reported symptoms and objective data, this study demonstrates that there are some significant 
self-reported increases and minor and subtle decreases in objectively assessed respiratory 
function following deployment. Bearing in mind that deployment-related respiratory symptoms 
and conditions were expected to be subtle and that abnormalities in respiratory function may 
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have presented in a sub-syndromal form among otherwise healthy populations. In order to 
determine how meaningful these small changes and patterns are, careful evaluation of this 
cohort is required over time to determine the long-term impacts of deployment on syndromal 
respiratory conditions.It is important to understand that the minor increase in respiratory 
symptoms and decrease in objective indications may tip over at some point into clinically 
significant symptoms or probable disorders (131, 154). Identifying indicators of risk in still 




Overall, the findings of this chapter have established limited evidence of change in respiratory 
function via both subjective and objective respiratory measures from pre- to post-deployment 
among a subset sample of MEAO deployed ADF members between 2010 and 2012. Although 
the overall analyses of this cohort as a whole showed little decline in both the objective and 
subjective respiratory function post-deployment, further investigation of „Normal‟ and 
„Abnormal‟ respiratory function sub-groups showed significant changes in both the objective 
and subjective respiratory function which may have been masked if this study only considered 
the cohort as a whole. 
 
There is a possibility that psychological trauma exposures or conditions such as PTSD influence 
respiratory function via changes in autonomic and immune systems (as discussed in the 
introduction to this thesis). In addition, the possibility of somatisation and self-reported 
symptoms reflecting mental distress rather than any actual respiratory impairment also remains. 
Therefore, the link between deployment exposures, psychological conditions, immune changes 




Early identification of potential underlying differences in affected and non-affected ADF 
members may prove useful in determining strategies for prevention of adverse respiratory 
outcomes and aid earlier intervention, including recruitment guidelines, such as those followed 
by the US and UK. These results together with investigation of possible risk factors may 
contribute significantly to long term respiratory health outcomes of the deployed ADF 
population. Therefore, next chapter (Chapter 4) of this thesis aimed to examine predictors of 
adverse respiratory health in the context of combat environmental and psychological trauma 





Chapter 4 – Impacts of deployment exposures on adverse 
respiratory outcomes of ADF members deployed to the 




4.1 Commentary  
Current international studies suggest that there is strong evidence on the cause of adverse 
respiratory outcomes among otherwise healthy military members deployed to the MEAO 
(3)Given the healthy state of service members at recruitment, existing research suggests that 
one contributing factor to the observed decreases in objective lung function measures and 
increases in self-reported symptoms may be the impact of deployment exposures. 
 
Following on from the findings of Chapter 3, which suggested that deployment may increase 
the risk of adverse respiratory outcomes among a subset of ADF members deployed to the 
MEAO, the aim of this chapter was to examine the predictors of adverse respiratory outcomes 
among ADF members deployed to the MEAO between 2010 and 2012, in the context of 
environmental, psychological trauma and other exposures on deployment.  
 
The findings are of importance to the ADF, providing evidence that deployment exposures and 
subtle adverse respiratory outcomes should be a focus of clinical intervention and assessment of 
individuals who are at risk, post deployment, in order to prevent future respiratory burden. 
 
4.2 Introduction  
Military research and clinical practice have aimed to systematically document physical and 
mental problems experienced by deployed service members. Given the evidence from the GW1  
studies regarding the higher prevalence of respiratory symptoms (5-9) and the nature of military 
service which involves the prolonged and repeated exposures of individuals to a wide and 
potentially extensive level of exposures, recently, much attention has been paid to the health 




Together, findings (discussed in detail in chapter 1) suggest that there may be some 
characteristics of deployment that are associated with adverse physical health outcomes (5, 6, 8, 
9).  
 
While  the underlying reasons for the high prevalence of adverse respiratory symptoms and 
conditions (e.g. shortness of breath, wheezing, coughing, asthma, chronic and acute bronchitis, 
and emphysema) among military personnel during and following deployment to the Middle 
East are not well understood (10-12), it has been suggested that the main cause of these 
respiratory conditions may be the environmental exposures (e.g. silicosis caused by breathing in 
tiny particles of silica, a mineral that is a component of sand, rock, and mineral ores such as 
quartz) . Nevertheless, so far, no specific association has been established between specific 
MEAO exposures and adverse respiratory outcomes, or the onset of serious disease in bothGW1 
and the Iraq and Afghanistan studies (3, 8, 9, 16). The main  limitations in these studies include: 
standardising exposure measures, cross-sectional study designs, retrospective medical review, 
and the self-reported nature of measures in many studies, which make it difficult to reach a 
robust conclusion regarding any potential relationship between deployment exposures and 
adverse respiratory outcomes (3). 
 
Despite the equivocal findings overall, there is evidence that many characteristics of 
deployment may be associated with adverse respiratory outcomes, including exposure to 
various airborne contaminants, burn pits, dust, particulate matter, industrial fires and traumatic 
exposure (10, 13). In addition, evidence suggests tobacco smoking, stress, physical activities 
and other individual susceptibility factors such as age, sex, body mass index (BMI), blood 
pressure, physical fitness, pre-existing conditions and personal characteristics may also increase 
the risk of respiratory symptoms and may enhance susceptibility to environmental exposures 
(11, 17-19). Some of these risk factors are described in detail in chapter 1 of this thesis, 
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including:  physical activity under stressful conditions (11, 19), smoking (3, 10, 11, 13, 17, 18) 
and individual susceptibility factors (10, 12, 151). 
 
The limited available evidence from the GW1 studies indicated that exposure to environmental 
factors such as smoke from oil wells (SMOIL), dust or sand has not adversely affected the long-
term respiratory health of GW1 veterans. The fact that the GW1 results consistently find self-
reported respiratory impacts but little or no evidence of objective declines and no evidence of 
associations with environmental exposures, suggests that factors other than deployment alone or 
environmental exposures are likely to contribute to the observed respiratory symptoms. There is 
also a possibility that the exposures were not intense enough to affect objective respiratory 
function or the self-reported impacts likely reflect somatisation as a result of psychological 
stress or conditions such as PTSD (26-28, 46, 47). However, as the measures were cross-
sectional, and there were no clinically meaningful associations, this doesn‟t answer the question 
of whether there were changes in objective respiratory function, below clinical cut-offs (5-9, 31, 
32, 34-37, 40-42, 60, 155-157). This is a gap in knowledge that this chapter is able to address. 
 
Despite inconsistent GW1 findings studies of the Iraq and Afghanistan conflict since 2001 have 
provided more comprehensive evidence that exposure to airborne particulate matter in the 
deployed environment may explain some of the increased respiratory symptoms and conditions 
documented in military populations.  Several Iraq and Afghanistan conflict studies established 
evidence of environmental exposures and negative effects on respiratory outcomes (11, 12, 20-
24). The key consistent messages that comes from the Iraq and Afghanistan military respiratory 
health studies include decline in respiratory function associated with environmental factors (11, 
18, 20-24, 33). 
 
In addition to ambient airborne hazards, it has been suggested that factors unique to military 
service that may increase the vulnerability of military personnel to respiratory health risk 
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include high levels of psychological stress which may be considered traumatic. These include: 
being exposed to threatening situations, stressful events, vulnerable situations, witnessing 
killing, death and violence, suicide, torture, and other atrocities(5, 53).  
 
Despite evidence of high levels of stress in this population and general links between 
psychological trauma and adverse respiratory outcomes, exposure to psychological trauma has 
been less investigated than environmental exposures, but remains an important factor that may 
also be related to decline in respiratory function (26-28, 46, 47, 53, 76, 107, 108, 111, 113). In 
addition, it has been suggested that chronic stress may alter respiratory response to air pollution 
and may help elucidate pathways for differential susceptibility (76). 
 
The effects of a stressful combat environment on a soldier‟s health are complex and may result 
in a broad spectrum of changes in the immune system, which could in turn increase 
vulnerability to various diseases and respiratory conditions (11).  
 
The fact that a number of studies have found positive associations between psychosocial stress 
and respiratory symptoms (28, 34-36, 47, 53) suggests that, in the context of military service 
and deployment specifically, in addition to the established risk of environmental exposures, the 
psychological stress of deployment should be considered as an important contributing factor. 
 
In addition to psychological traumatic stress, studies have also suggested a connection between  
psychological conditions such as PTSD and respiratory symptoms (14, 32, 60, 62).  
 
Biological mechanisms of PTSD involves changes in the hypothalamic– pituitary–adrenal axis 
and the sympathetic–adrenal–medullary system (63). It has been suggested that these alterations 
lead to a pro-inflammatory state (65-67, 147). As inflammatory processes are involved in 
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airflow limitation, it is plausible that inflammation may be the link between trauma exposure 
and PTSD on the one hand, and airflow limitation on the other (60, 68).  
 
With the current indication of links between trauma exposures, PTSD and adverse respiratory 
outcomes, it is important to investigate these relationships given the prevalence of such 
disorders are high within the military populations(14, 60, 62, 156). 
 
The possibility of associations between sub-threshold PTSD with sub-clinical symptoms is also 
an important factor to consider regarding respiratory function, as the rate of full PTSD is 
expected to be relatively low among deploying populations.  
 
With reference to the available evidence, it appears that deployment environmental and 
psychological exposures may both be associated with adverse respiratory health outcomes. 
More comprehensive prospective studies are needed to further clarify the association between 
environmental exposures, psychological trauma, PTSD and adverse respiratory outcomes in 
military populations (14, 32, 60, 62).  
 
In addition to deployment specific risks, evidence suggests other factors such as physical 
activity (72) increased tobacco use (18, 73), and other individual susceptibility factors (84) may 
increase the risk of respiratory symptoms and enhance susceptibility to environmental and 
trauma exposures in this population. Therefore, when examining environmental and 
psychological factors, it is important to also consider other factors that may influence 







The current study 
The current study used data from the MEAO prospective study and focused on deployment 
related factors that may be associated with respiratory health outcomes among a sample of ADF 
members deployed to the MEAO.  
 
While many previous studies have been prompted by a collection of ill-defined self-reported 
symptoms that were attributed to service in the area of operations but without (as yet) a clear 
causal or diagnostic link having been established (known as First Gulf War Syndrome), (5, 6, 
132), the MEAO prospective study focused on a range of potential health outcomes of direct 
relevance to the nature of the deployment, including those identified by the Institute of 
Medicine (e.g. neurocognitive and neurobehavioral effects, hypertension and chronic 
respiratory effects etc.) (93). Rather than relying solely on subjective assessments, the MEAO 
prospective study collected objective health measures prior to and again after deployment in 
order to identify early markers of the psychological and physical impacts of combat stress and 
the other exposures of interest (3). This provided a unique opportunity to understand the short-
term impacts of deployment-related exposures on the respiratory health of ADF members 
 
The association between deployment-related environmental, combat and other exposures 
(smoking, physical activity, military living conditions), and psychological trauma with adverse 
respiratory outcomes, may be via direct actions (such as deposition of particulate matter) or by 
disturbance of the immune system (by stress/ trauma). While psychological trauma is highly 
prevalent in relation to deployment, its effect on respiratory health outcomes and potential 
mechanisms underlying associations, as well as potential predictors of good or adverse 
respiratory health over time, are not well understood (61, 129, 130). It is important to 
understand that the cumulative impact of deployment exposures and subsequent minor 
symptoms and objective indications, may tip over at some point into clinically significant 
symptoms or probable disorders (131). Identifying indicators of risk in still healthy individuals 
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allows for strategies aimed at ultimately preventing poor health trajectories. Therefore, on the 
basis of the existing research and literature, summarised earlier in this thesis, first it is 
hypothesised that environmental and psychological trauma exposures will independently and 
combined have adverse effects on self-reported respiratory symptoms and objective respiratory 
measures (FEV1/FVC) among ADF members deployed to the MEAO between 2010 and 2012. 
Second, psychological trauma exposure may act as a moderator on the relationship between 
environmental exposure and objective lung function or respiratory symptoms. Furthermore, as 
there is evidence of the link between trauma exposure and psychological symptoms, including 
PTSD (63, 65, 147) and there is emerging evidence of a link between PTSD and self-reported 
respiratory symptoms (29, 60, 61), in addition to examining the effect of environmental and 
psychological trauma exposures, this study also hypothesised that objective respiratory function 
is expected to be lower in the sub-groups with high PCL scores and respiratory symptoms 
compared to sub-groups with low PCL scores and no respiratory symptoms. (The PCL is a 
standardized self-report rating scale for PTSD comprising 17 items that correspond to the key 
symptoms of PTSD; see Chapter 2 section 2.4 self-reported measures for more details). 
 
In order to ascertain whether psychological trauma exposure (i.e. stress on deployment) acts to 
sensitise an individual to greater reactivity to environmental exposures, this study examined 
whether psychological trauma exposure moderated the association between environmental 
exposures and lung function and respiratory symptoms. The examination of both objective and 
self-reported measures enabled this study to address the question of whether these impacts were 
physical or somatic in nature. 
 
Further, this study examined whether any association between PTSD symptoms and respiratory 
symptoms is reflected by objective deficits in respiratory function. In order to establish any 
association, this study first established evidence of association between psychological trauma 
exposures and PCL score within this cohort. Following that, the difference in mean FEV1/FVC 
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in the sub-groups with low and high PCL scores and sub-groups with and without respiratory 
symptoms were tested. 
 
In addition to examining the effects of environmental exposures and psychological trauma 
exposures as possible predictors of change in FEV1/FVC ratio and self-reported respiratory 
symptoms at post-deployment, this study further investigated if there is a difference between the 
sub-groups in terms of level of environmental and psychological trauma exposures. This was 
achieved by  inspecting whether those ADF members with „Abnormal‟, „Decreased‟ 
FEV1/FVC, „High PCL scores‟ and „respiratory symptom‟ have higher mean environmental 
and psychological trauma exposure compared to the „Normal‟, „Increased‟, „Low PCL‟ and „No 
respiratory symptom‟ sub-groups.  
 
4.3 Method  
The following are summary of measures used in this chapter. Detailed methodology, including 
description of sample (Section 2.3), objective and subjective measures (Section 2.4) has been 




A self-reported questionnaire was used to collect pre and post deployment data on Post-
Traumatic Stress Disorder, respiratory symptoms, environmental and psychological trauma 
exposures of ADF members. 
 
•  Post-Traumatic Stress Disorder 
This study used the PCL-C which is a 17-item self-report measure designed to assess the 
symptomatic criteria of PTSD. The 17 questions of the PCL-C are scored from 1 to 5 and are 
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summed to give a total symptom severity score of between 17 and 85, with higher scores 
indicating increased severity (140).  
 
In this chapter, PCL scores were used as both continuous and dichotomous variables. PCL 
scores over 25 were considered high and PCL scores equal or below 25 were considered low. 
 
• Respiratory symptoms 
This study gathered respiratory related data from three sections of the self-report survey: 
“Recent Health Symptoms”, self-reported doctor diagnoses, and the European Respiratory 
Health survey 2-screening questionnaire (40, 142, 143).  
 
The respiratory symptoms/conditions drawn from this questionnaire include: persistent cough; 
shortness of breath; wheezing; unable to take deep breath; fast breathing; coughing; asthma; 
asthma attack; hay fever; tightness in chest; bronchitis; and sinus problems. 
 
Respiratory symptoms were analysed both as a continuous measure (sum number of respiratory 
symptoms i.e. coughing, shortness of, breath, hypersensitivity, tightness in chest, wheezing and 
sinus problems), with a total score of 0-6 as well as dichotomous (yes/no answer for presence or 
absence of any respiratory symptom listed in Table 3.3.3). Individual symptoms were not 
investigated. 
 
• Sum of environmental exposures  
The environmental exposure scale was developed from MEAO Preliminary Study Focus 
Groups and the Kings College London Phase 2 questionnaire. Environmental exposures 
included: local combustion sources (burn pits/fire), dust storm, inhaled fine dust fibres, cigarette 
smoking, diesel exhaust (aviation, marine or automotive fuel), aircraft fumes, toxic industrial 
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chemicals, solvents (e.g. thinners, sealer, paints), living in an area recently sprayed with 
pesticides, and exposure to explosion (40).  The total score calculated by summing the number 
of exposure types endorsed (minimum=0 maximum=10) (43, 148). The sum of exposure types 
was then dichotomised using the median value to categorise exposure levels as low (< 5) or 
high (≥ 5).  
 
• Psychological trauma exposure 
The post-deployment self-report questionnaire contained 26 questions about specific traumatic 
deployment related experiences (3, 145). The 26 items were grouped into nine broad categories 
which were considered to be of a similar nature (Table 4.3.1). These groupings were based on 
previous research on combat exposures by Wilk et al. (2010) and were also used in the MEAO 
census study and prospective study reports (146).  
 
The nine categories of traumatic deployment exposures include: coming under fire, discharging 
own weapon in direct combat at enemy, unable to respond to a threatening situation, vulnerable 
situations or fear of events, in danger of being killed/injured, seeing/handling dead bodies, 
casualties among those close to you, human degradation, and actions resulting in injury or 
death. A total score was calculated by summing the number of exposure types endorsed 
(minimum=0 maximum=9) (144, 147). This was then dichotomised using the median value to 
categorise exposure levels as low (≤ 2) or high (≥ 3). (See Chapter 2, Table 2.4.2 for more 
details regarding categories of traumatic deployment exposures). 
 
• Spirometry  
Spirometry measures were collected during the pre- and post-deployment physical testing of 
ADF members. (135). Three measures for evaluating respiratory health collected via spirometry 
were: Forced Expiratory Volume at one second (FEV1), Forced Vital Capacity (FVC), and 
FEV1/FVC ratio.  
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The FEV1/FVC was used as a continuous measure of lung function. In addition, since the total 
sample analyses may not have adequately captured intragroup variabilities, in addition to 
examining the whole sample, this study utilised a common method used internationally to 
further investigate the objective respiratory shifts within sub-groups(135-137). Therefore, 
dichotomous variables (sub-groups) were created by using the „Global Initiative for Chronic 
Obstructive Lung Disease‟ (GOLD) standard cut off of 70% for FEV1/FVC. Participants were 
then divided into the following 4 sub-groups:  
 
„Normal‟= FEV1/FVC >70% pre- and post-deployment; „Abnormal‟= FEV1/FVC <70% pre- 
and post-deployment; „Increased‟= lung function measures (mean of FEV1/FVC) increased at 
post-deployment; and „Decreased‟ = lung function measures declined at post-deployment (135, 
137).  
 
Data Analysis  
Univariate and multiple linear regression and Poisson regression methods were used to 
investigate the relationship between deployment exposures and FEV1/FVC and self-reported 
respiratory health outcomes post-deployment. Multivariable linear regressions were used for the 
continuous outcome variable „FEV1/FVC‟, and Multivariable Poisson regression was used for 
the outcome variable „respiratory symptoms‟ (Poisson regression is similar to regular multiple 
regression except that the dependent variable is an observed count that follows the Poisson 
distribution). Frequency, Mean ± SEM, significant value at p<0.05, 95% Confidence Interval 
and the estimate for linear regression or the Incidence Rate Ratio (IRR) for Poisson regression 
were reported. Regressions were adjusted for age, cigarette smoking, FEV1/FVC at pre-
deployment or sum of respiratory symptoms at pre-deployment depending on the outcome 




To investigate the possible predictors of change in respiratory health between pre- and post-
deployment, a series of multivariate regressions were performed. Specifically, the effects of 
environmental exposures, psychological trauma exposures, and their interaction, on FEV1/FVC 
ratio and self-reported respiratory symptoms at post-deployment were tested. Multivariate 
analyses were used to find patterns and relationships between several variables simultaneously, 
allowing for prediction of the effect a change in one variable will have on other variables.  
 
To investigate which exposures have more influence on FEV1/FVC and self-reported 
respiratory symptoms, both environmental and psychological trauma exposures were put in the 
same regression model. Significant value at p<0.05, 95% Confidence Interval and the estimate 
for linear regression were reported.  
 
To plot the interaction effect of environmental and psychological trauma exposures for the 
outcomes FEV1/FVC and self-reported respiratory symptoms, linear regressions and 2-way 
interaction unstandardised formula were performed in Excel (Figure 4.4.1 and figure 4.4.2).  
 
In addition to analysis of interaction between the two environmental and psychological trauma 
exposure variables, a correlation test was performed (not shown in table) to evaluate the 
association between the two variables. In addition, significant value at p<0.05 and correlation 
coefficient „r‟ („r‟ indicates the strength of the relationship) were reported (these analyses and 
results were reported in text and not in tables). 
 
Further, this study examined the role of PTSD symptoms (measured by PCL score) in relation 
to respiratory health. To examine the association between PCL score and psychological trauma 




To examine the association between PCL score and FEV1/FVC, a univariate linear regression 
was performed. This test showed whether the FEV1/FVC estimated marginal means were 
increasing or decreasing across levels of respiratory symptoms and PCL scores (Table 4.4.2, 
Figure 4.4.3). The aim of this univariate analysis was not to examine causation or take into 
account the effect of potential confounders, but to simply find patterns in the data.  
 
In addition to establishing evidence of the effects of environmental exposures and psychological 
trauma exposures as possible predictors of change on FEV1/FVC ratio and self-reported 
respiratory symptoms at post-deployment, this study further investigated if there was a 
difference between the sub-groups in terms of levels of environmental and psychological 
trauma exposures. This was achieved by inspecting whether those ADF members with 
„Abnormal‟, „Decreased FEV1/FVC‟, „High PCL scores‟ and „Respiratory symptoms‟ have 
higher mean environmental and psychological trauma exposure compared to „Normal‟, 
„Increased‟, „Low PCL‟ and „No respiratory symptom‟ sub-groups. An independent-samples t-
test was performed to compare the difference in mean environmental and psychological trauma 
exposures between sub-groups. Significant value at p<0.05 was also reported (Table 4.4.3). 
 
The MEAO prospective study which analysed the same sample of ADF members, showed no 
significant association between smoking status or smoking behaviour and change in FEV1/FVC 
(3). Therefore, this study did not repeat what was found previously. In this study, cigarette 
smoking was included as one of the environmental exposures and all regression analyses were 





Following on the analyses from Chapter 3 which suggested that some sub-groups appear to 
have evidence of change in respiratory function, this study further examined factors that may 
influence the extent to which respiratory change is observed. 
 
To investigate the possible predictors of change in respiratory health between pre- and post-
deployment, a series of multivariate regressions were performed. Specifically, the effects of 
environmental exposures, psychological trauma exposures, and their interaction, on FEV1/FVC 
ratio and self-reported respiratory symptoms at post-deployment were tested. 
 
Results in Table 4.4.1 showed that environmental exposures (estimate=-0.02, 95% CI (-0.04, -
0.00), p=0.01) and psychological exposures (estimate=-0.21, 95% CI (-0.41,-0.01), p= 0.04) 
were both negatively associated with lung function (FEV1/FVC) at post-deployment, and the 
interaction between these was significant (interaction p value =0.010). Specifically, as can be 
seen in Figure 4.4.1, when psychological trauma was low, there was no difference in lung 
function of those with „high‟ compared to „low‟ environmental exposures. However, when 
psychological trauma was high, lung function was reduced with increasing environmental 
exposures. 
 
The same pattern of findings was observed for self-reported respiratory symptoms (Table 4.4.1, 
Figure 4.4.2): environmental exposures (IRR= 1.01, 95% CI (1.00, 1.02) p<0.001) were 
positively associated with sum of respiratory symptoms at post-deployment. While 
psychological exposure (IRR=1.00, 95% CI (-0.93, 1.081) p= 0.96) didn‟t have a significant 
independent effect on respiratory symptoms, the interaction between environmental and 
psychological exposures was significant (interaction P value<0.001). As can be seen in Figure 
2, again, under conditions of low psychological trauma, there was no difference in the 
respiratory symptoms of those with „low‟ compared to „high‟ environmental exposures. When 
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psychological trauma was high, higher environmental exposures were associated with increased 
respiratory symptoms.  
 
A correlation test was performed to further establish evidence of correlation between 
environmental and psychological trauma exposures. The result showed that the two variables 
were significantly correlated, however, their correlation was weak (P= 0.00, r=0.19) (not shown 
in table). 
 
xiii Table 4.4.1 Individual and combined effects of environmental and 
psychological trauma exposures on FEV1/FVC measures and sum of respiratory 









Mean ± SEM* 
FEV1/FVC  Environmental exposure -0.02 (-0.04, -0.00) 
a
 46.3 ± 0.01 (198) * 
Psychological trauma 
exposure 
-0.21 (-0.41, -0.01) 
a




-0.02 (-0.04, -0.00) 
a
 48.7 ± 0.01 (198) * 
Sum of respiratory 
symptom  
Environmental exposure 1.01 (1.00, 1.01)
 b











 49.4 ± 0.03 (195) * 
a Multivariable linear regression, b Multivariable Poisson regression, Mean ± S.EM (N), 
*Significant at p<0.05. 
C
 The estimate for linear regression or the Incidence Rate Ratio (IRR) 
for Poisson regression. 95% CI is 95% Confidence Interval. Regressions were adjusted for age, 
cigarette smoking, FEV1/FVC at pre-deployment or sum of respiratory symptoms at pre-




ii Figure 4.4.1 Effect of psychological trauma exposure on the relationship between 
environmental exposure and FEV1/FVC 
 
Linear regression, 2-way interaction unstandardised formula were performed in Excel, 






























* n= 198 
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iii Figure 4.4.2 Effect of psychological trauma exposure on the relationship 
between environmental exposure and respiratory symptoms 
 
Linear regression, 2-way interaction unstandardised formula were performed in Excel, 
significant at *P<0.05 
 
In addition, the regression analyses also indicated that when both environmental and 
psychological trauma exposures were put in the same regression model, environmental 
exposures assuming the strongest predictor (estimate -0.02, 95% CI (-0.03, -0.00), p=0.03) 
eliminated the effect of psychological trauma exposure (estimate -0.20, 95% CI (-0.40, 0.03), 
p=0.10) on FEV1/FVC so that psychological trauma no longer appears to be significant. This 
indicates that environmental exposures have more influence on FEV1/FVC compared to 
psychological trauma exposures. 
 
The following analysis examined the associations between posttraumatic stress symptoms, and 
respiratory health outcomes. This analysis first examined if, in line with international findings, 
there is an association between psychological trauma exposures and PCL scores within the 









































psychological symptoms and adverse respiratory outcomes, this study examined if there is an 
association between high PCL scores with FEV1/FVC, and self-reported respiratory symptoms. 
Using binary logistic regression models, results showed that psychological trauma exposures 
were associated with higher PCL scores (Odds Ratio=3.2, 95% CI: (0.44, 1.87), p<0.001). In 
addition, higher PCL scores were also found to be associated with respiratory symptoms in an 
adjusted model (Odds Ratio=1.30, 95% CI (0.07, 0.45), p<0.001). However, the association 
between high PCL scores and objective lung function (FEV1/FVC) was not significant in an 
adjusted analysis (Odds Ratio=0.98, 95% CI (0.04, 0.00), p=0.14). Therefore, this study further 
investigated if having or not having respiratory symptoms in sub-groups with high PCL would 
make a difference in terms of mean FEV1/FVC. The following series of analyses were 
performed to observe the pattern of relations between objective lung function differences in 
sub-groups with or without respiratory symptoms and „high‟ or „low‟ PCL scores.  
 
A univariate linear regression was performed. This test established whether the FEV1/FVC 
estimated marginal means were increasing or decreasing across levels of respiratory symptoms 
and PCL scores.  
 
The results showed that although the absolute differences in mean FEV1/FVC between high 
and low PCL sub-groups were small and not significant, the slope were almost identical for the 
two sub-groups, suggesting that overall there is no difference between the high and low PCL 
subgroups in terms of the association between respiratory symptoms and lung function. 
However, looking at the overall pattern for both PCL sub-groups, lung function was lower in 
those with higher respiratory symptoms. This suggests that having respiratory symptoms may 
be an important identifying factor for lower FEV1/FVC regardless of having high or low PCL 




xivTable 4.4.2 Objective lung function change in sub-groups with or without 
respiratory symptoms and ‘high’ or ‘low’ PCL scores 
Respiratory symptom at post 
deployment 
PCL score post-deployment Mean ± S.E.M (N) 
No respiratory symptom  Low 80.7 ± 0.3 (88) 
High 80.3 ± 0.7 (17) 
More than 1 respiratory 
symptoms  
Low 79.9 ± 0.4 (46) 
High 79.3 ± 0.5 (46) 
Data are means FEV1/FVC ± S.E.M (n = number of ADF participants in sub-groups);*P<0.05. 
 
ivFigure 4.4.3 FEV1/FVC change in sub-groups with or without respiratory 
symptoms and high or low PCL scores 
 
FEV1/FVC % estimated marginal means across levels of respiratory symptoms and PCL scores 
P<0.05*.  
 
Table 4.4.1, and Figures 4.4.1 and 4.4.2, have demonstrated the effects of environmental 
exposures and psychological trauma exposures as possible predictors of change on FEV1/FVC 
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ratio and self-reported respiratory symptoms at post-deployment. In relation to these findings, 
the purpose of the following analyses was to further understand if there is a difference between 
the sub-groups in terms of level of environmental and psychological trauma exposures, and 
further, whether those ADF members with „Abnormal‟ or „Decreased‟ lung function, high 
respiratory symptoms or „High PCL‟ have higher mean environmental and psychological 
trauma exposures compared with the „Normal‟, „Increased‟,  „No respiratory symptoms‟ and 
„Low PCL‟ sub-groups.  
 
The results showed that the overall mean of environmental and psychological trauma exposures 
were somewhat higher in „Abnormal‟, „Decreased‟, „High PCL‟, and „symptomatic‟ sub-groups 
compared to the „Normal‟, „Increased‟, „Low PCL‟ and „No respiratory symptom‟ sub-groups 
respectively, however, this difference was only significant for the high compared to low PCL 
groups.  
 
xvTable 4.4.3 Difference between the sub-groups in terms of environmental and 
psychological trauma exposure at post deployment 
 Environmental exposures Psychological trauma exposures 
Sub-groups 
a
 Mean ± S.E.M 
     b 
difference 
a 
Mean ± S.E.M 
b 
difference 
Normal 46.1 ± 1.9 (190) 
4.3± 9.6 
      2.4 ± 0.1 (185) 
1.3 ± 0.8 
Abnormal 50.5 ± 12.2 (8)       3.7 ± 0.9 (8) 
Increased  49.7 ± 2.7 (78) 
-1.5 ± 3.5 
      2.3 ± 0.2 (78) 
-0.2 ± 0.3 
Decreased  51.3 ± 2.3 (98)       2.5 ± 0.2 (95) 
Low PCL  48.8 ± 1.8 (134) 
-8.6 ± 4.0* 
      2.1 ± 0.2 (131) 
  -1.1 ± 0.3** 
High PCL  57.5 ± 3.9 (43)       3.3 ± 0.3 (41) 
No symptoms  44.5 ± 2.4 (118) 
-6.3 ± 3.8 ^ 
     2.5 ± 0.2 (116) 
       0.0 ± 0.3 
Symptomatic 50.9 ±    2.9 (77)      2.4 ± 0.2 (74)  
a 
Data are mean ± SEM, n = number of ADF participants in sub-groups at post deployment. 
b
 




4.5 Discussion  
Following on from the findings of Chapter 3 which suggested that deployment may increase the 
risk of adverse respiratory outcomes among a subset of ADF members deployed to the MEAO, 
this chapter further examined the hypotheses that environmental and psychological trauma 
exposures independently and combined are associated with adverse respiratory outcomes 
observed among ADF members deployed to the MEAO. In addition, the role of psychological 
trauma exposure as a moderator on the relationship between environmental exposure and 
respiratory function and symptoms was also examined.  
 
Similar to previous international and Australian findings regarding the association between 
environmental factors experienced on deployment in the Middle East, and adverse respiratory 
function (11, 21, 36, 37, 39), this study identified a similar pattern for psychological trauma as 
an independent factor. Findings also showed that the effect of environmental exposures on both 
objective lung function and self-reported respiratory symptoms was influenced by the level of 
psychological trauma exposure. To the author‟s knowledge, this finding is novel as no previous 
prospective military study has demonstrated the effect of psychological stress as a moderator of 
association between deployment environmental factors and adverse respiratory outcomes 
among military members.   
 
The results indicate that environmental and psychological trauma exposures independently and 
combined have an inversely proportional association with objective lung function whereby 
when environmental or psychological trauma exposures increased, lung function decreased. 
Environmental exposures and the interaction between environmental exposures and 
psychological trauma were also significantly associated with self-reported respiratory 
symptoms at post-deployment. As expected, increased environmental exposures were 
associated with increased respiratory symptoms. Further, psychological exposure appears to 
interact with environmental exposures to influence respiratory symptom outcomes, such that the 
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association between environmental exposures and respiratory symptoms was stronger when 
accompanied by higher levels of psychological trauma exposure. These findings suggest that in 
the case of self-reported symptoms, exposure to psychological trauma alone was not associated 
with respiratory outcomes. Rather, it is possible that psychological trauma exposure influences 
how ADF members experience environmental exposures, thereby resulting in effects on 
perceived respiratory health. 
 
There is extensive evidence for association between psychological trauma and mental disorders 
such as PTSD with prominent respiratory symptoms (60, 124, 152). This raises questions 
regarding the effect that psychological symptoms may have on the respiratory function of ADF 
members and the underlying mechanisms involved (60, 124, 158). Within the ADF population, 
the incidence of mental disorders has been estimated at 22%, with 8.3% of ADF members 
meeting criteria for PTSD (131). PTSD is characterised by changes in the hypothalamic–
pituitary–adrenal axis and the sympathetic–adrenal–medullary system. It is thought that these 
alterations can lead to a pro-inflammatory state which may result in structural and functional 
changes in the respiratory system (60, 65-68, 147). In one US study, PTSD-positive male 
combat veterans had an increased risk of reporting chronic pulmonary diseases compared to 
those who were PTSD-negative (158), and in another US study, female veterans were at a 1.6 
times  higher risk of self-reported asthma than those without PTSD (144).  
 
In the current study, high PCL scores were found to be associated with respiratory symptoms. 
However, the association between high PCL scores and objective lung function was not 
significant. In addition, further investigation of the pattern of relations between objective lung 
function changes in sub-groups with „high‟ or „low‟ PCL scores with or without respiratory 
symptoms did not identify any significant relationship. This suggests that having a high PCL 
score is unlikely to influence objective lung function in this predominantly young and healthy 
cohort of the ADF, rather, it may manifest in physiological symptoms such as respiratory 
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symptoms. Contrary to our findings, Spitzer et al (2011) demonstrated that military personnel 
with decreased objective parameters of lung function were more likely to exhibit PTSD 
symptoms as well as respiratory symptoms or vice versa. The authors suggested that 
inflammation may be the link between trauma exposure and both PTSD and airflow limitations 
(60, 68). However, the difference between this German study and the current Australian study is 
the nature of the participants. The study by Spitzer et al. (2011) recruited 20-79-year-olds from 
a general population in West Pomerania, while the ADF sample was mostly comprised of 
healthy young men 16-54 years of age. Therefore, it was expected to see minimal changes to 
their objective respiratory function at post-deployment. Further comprehensive investigation of 
the ADF cohort is required to investigate the role of inflammation in those with high and low 
PCL scores and the association with adverse respiratory function. 
 
Another finding of this study is that those with elevated post-traumatic stress symptoms 
reported more environmental and psychological trauma exposures, consistent with the 
possibility of a link between these exposures and increased respiratory symptoms. There is a 
commonly proposed mechanism for this association: both environmental and psychological 
trauma exposures may effect respiratory function via changes in the immune system. These 
associations may be via direct actions that initiate local and systemic inflammation by 
stimulation of epithelial cells and alveolar macrophages by particulate matter, leading to 
respiratory symptoms. Another possible pathway may involve excessive pro-inflammatory 
responses to acute psychological stress that may result in airway damage and consequently 
structural and functional pulmonary changes (19, 48-51, 53, 60, 68, 100, 101, 107, 108, 111, 
113). Therefore, presumably, higher levels of stress during deployment may, in part, explain the 
small decrease in objective lung function and increased rate of respiratory symptoms reported 
among ADF members (53, 106, 108). However, testing this mechanism was beyond the scope 




The results from this study together with the international findings indicate that while 
deployment appears to be associated with adverse respiratory outcomes, this cannot be 
exclusively attributed to environmental exposures. Other deployment factors such as 
psychological trauma exposure in the combat environment should also be considered. Overall, 
the documented associations in this study were small, and deployment-related respiratory 
conditions have been shown to be subtle. This was expected, as abnormalities in lung function 
are often present in the sub-syndromal form among an otherwise healthy population (152, 154). 
Therefore, careful evaluation is required over time to determine the long-term impacts of 
deployment on syndromal respiratory diseases, as has previously been described for ADF 
members with self-reported psychological distress (154).  
 
While the associations between stress-related mental disorders such as PTSD and altered 
immune responses is not causative, low level inflammation and altered immune responses 
provide plausible mechanisms by which psychological trauma exposure may be associated with 
respiratory symptoms (53, 60, 124, 144, 152, 158). Further analyses, of this prospective study 
dataset, are needed to clarify the role of inflammatory mediators in relation to psychological 
trauma exposures among those ADF with prominent respiratory symptoms.  
 
The findings of this study are of importance to the ADF, providing evidence that deployment 
exposures and subtle adverse respiratory outcomes should be a focus of clinical intervention 
and assessment of individuals at risk, post deployment, in order to reduce future respiratory 
burden. 
 
One limitation in this study includes self-reporting for respiratory symptoms potentially leading 
to misdiagnosis of the symptoms or under-reporting due to reluctance to report diseases 
regarding career consequences. The self-report questionnaire recorded up to 4 months after 
deployment which made it open to recall bias, particularly when data are collected well after 
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symptoms/conditions have occurred (54, 106). The above-mentioned limitations may result in 
lower reported rates of respiratory symptoms, environmental and psychological exposures and 
may minimise associations between exposures and FEV1/FVC and self-reported respiratory and 
PTSD symptoms. 
 
Another limitation of this study was using a default Listwise deletion for analyses in SPSS 
which did not include cases that have missing values on the variables under analysis. This led to 
loss of data due to the exclusion of subjects from the analysis if they were missing data for any 
variable in that analysis.  
 
 Some participant‟s data were not included in the final analyses due to non-reproducible 
recordings, coughing or shortness of breath. The resultant small numbers of participants in sub-
groups did not provide sufficient power to detect statistically significant differences.  
 
This study is the first to provide detailed investigation of the effects of individual and combined 
environmental, psychological trauma and other deployment factors on the respiratory health of 
Middle East deployed ADF members. In addition to international studies suggesting that 
environmental exposures may be associated with reports of respiratory symptoms, this study 
also included psychological trauma exposures.  
 
4.6 Conclusion  
The findings from this chapter and those from recent studies suggest that environmental 
exposures are a risk factor for adverse respiratory outcomes within the military population. 
Exposure to psychological trauma has also been shown to impose additional effects that seem to 
be synergistic with environmental exposures. The findings from this study support the 
hypothesis that environmental and psychological trauma exposures independently and 
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combined have adverse effects on self-reported respiratory symptoms and objective respiratory 
measures in a cohort of MEAO deployed ADF members. This study has also shown that apart 
from the direct effect of trauma exposure on adverse respiratory outcomes, psychological 
trauma may increase the impact of environmental exposures leading to a negative shift in both 
objective and subjective respiratory outcomes.   
 
Since this study found an association between higher PCL scores and respiratory symptoms and 
not objective lung function, there is a possibility that psychological distress in the deployment 
environment may manifest in respiratory symptoms, explaining the association between 
apparent somatisation and psychological exposures. While the results showed some statistically 
significant effects, these were not necessarily large, and this is mainly assumed to be related to 
the general good health of ADF members and the small sample size within the sub-groups. 
These results are similar to the GW1 findings reporting on somatic manifestation of distress 
without actual significant objective impact (This has been discussed in more detail in chapter 
1). 
 
Low level inflammation and altered immune responses provide plausible mechanisms by which 
psychological trauma exposure may be associated with adverse respiratory outcomes .Further 
analyses of this prospective study are needed to clarify the role of inflammatory mediators in 










5.1 Summary  
In light of findings from the existing literature discussed in previous chapters of this thesis, the 
overall objective of this thesis was to understand how deployment may impact on respiratory 
health outcomes in military populations. The aims  of this study were to first investigate if, 
similar to the reported international literature, there was an increase in subjective respiratory 
symptoms (self-reported respiratory symptom measured by questionnaire) of ADF members 
from pre- to post-deployment to the MEAO between 2010 and 2012 and whether these were 
accompanied with changes in objective function (FEV1/FVC measured by spirometry). The 
second aim was to examine the predictors of adverse respiratory outcomes among this cohort in 
the context of combat environmental and psychological trauma exposures. 
 
To investigate the aims, a systematic review of the literature was undertaken to inform the 
current thesis analysis approach and key factors of interest. Next, this study examined how 
respiratory health changed from pre- to post-deployment in a subset sample of ADF members 
deployed to the MEAO from 2010 to 2012. Building on the findings previously reported by 
Davy et al. (2012), this study then examined the role of exposures more specifically, including a 
focus on environmental exposures and the contribution of psychological factors (trauma 
exposures and PTSD symptoms) to the respiratory health of ADF members.  
 
A major contribution of this study was to identify if psychological trauma exposures are 
associated with negative respiratory health outcomes, in the short-term, following deployment 
to the MEAO. To the author‟s knowledge, this is the first Australian prospective study to 
investigate the effect of psychological trauma exposures on respiratory health outcomes and 
whether psychological responses to deployment exposures moderate associations between 




By investigating how respiratory health changed from pre- to post deployment in a subset 
sample of contemporary ADF members deployed to the MEAO from 2010 to 2012, and by 
examining the role of exposures, including a focus on environmental exposures and the 
contribution of psychological factors to respiratory health of ADF members, this thesis 
provided a deeper insight into how the deployment may impact respiratory health outcomes in 
military populations. 
 
While the majority of individuals were still within the normal range of objective respiratory 
function (i.e. their FEV1/FVC measures were greater than 70% according to the GOLD 
standard cut off for Normal respiratory function (135, 136)), this study established evidence of 
small negative changes in respiratory function in both subjective and objective respiratory 
measures from pre- to post-deployment among a subset sample of contemporary ADF members 
deployed to the MEAO between 2010 and 2012. In addition, environmental and psychological 
trauma exposures were independently associated with adverse respiratory outcomes on both 
objective and self-report measures. Importantly, there was also a significant interaction, with 
associations between environmental exposures and both objective and self-reported respiratory 
measures; stronger under conditions of high compared to low psychological trauma exposure.  
 
The subtle negative changes in respiratory function were expected among this healthy 
population. Even though these changes were statistically significant, they were small and 
probably clinically unimportant. In order to determine if the associations between these small 
changes in respiratory function and deployment exposures are meaningful, careful, ongoing 
objective and subjective monitoring of this population is required to determine the long-term 
impacts of deployment on syndromal respiratory conditions. 
 
Section 5.1.1 of this chapter will discuss the findings of this study regarding changes in 
respiratory function among ADF personnel deployed to the MEAO from pre- to post-
104 
 
deployment between 2010 and 2012 and section 5.1.2 will discuss the impacts of deployment 
exposures on adverse respiratory outcomes. 
 
5.1.1 Changes in respiratory function among ADF personnel deployed to the 
MEAO from pre- to post-deployment between 2010 and 2012 
International and Australian GW1 as well as Iraq and Afghanistan conflict (since 2001) studies 
have documented an increase in the incidence of reported respiratory symptoms among military 
members during and following deployment to the Middle East (5, 7-12, 25, 44, 45). An 
important concern for military members is that these symptoms may be suggestive of early 
onset of potentially serious diseases, such as asthma, bronchitis and COPD (10, 13-15, 60). 
However, there is a paucity of prospective studies regarding the level of respiratory distress and 
evidence regarding potential factors leading to adverse respiratory outcomes in military 
members post-deployment to the Middle East. 
 
Chapter 3 of this thesis investigated if, in congruence with the reported international literature, 
there was an observable decline in the objective respiratory function and subjective respiratory 
function of ADF members from pre- to post-deployment.  
 
Building on previous studies, the current study found significant changes in both the objective 
and subjective respiratory function of contemporary ADF members deployed to the MEAO.  
 
Examination of the „Normal‟ and „Abnormal‟ sub-groups showed that while there are health 
restrictions in place for ADF enrolment (i.e. the ADF has historically precluded asthmatics from 
particular services or service roles), this study found that 4% met the global initiative for airway 
obstruction (FEV1/FVC <70%) at pre-deployment. This number increased to 4.5% at post-
deployment. Deployment of ADF members with sub-optimal respiratory function may be the 
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result of less stringent recruitment procedures, compared to the UK and US military recruitment 
process (34, 149). 
 
Further analysis of the „Abnormal‟ subgroups showed that from the total 9 (4.5%) „Abnormal‟ 
cases identified at post-deployment, 4 (2%) had „Abnormal‟ respiratory function results at both 
pre- and post-deployment, while 5 (2.5%) were new cases of „Abnormal‟ respiratory function at 
post-deployment. Although these changes are small, the increase in new cases of abnormal 
respiratory function could be an indication of possible deployment risk factors influencing 
adverse respiratory outcome. These sub-threshold respiratory abnormalities and symptoms do 
not usually result in a reduction in ability to pass military fitness testing. However, early 
identification of respiratory distress in military members may prove useful in determining 
strategies for prevention of adverse respiratory outcomes and aids earlier intervention, including 
recruitment guidelines, such as those followed by the US and UK. 
 
Although the overall increase in sum of self-reported respiratory symptoms among ADF 
members was not significant, further analysis of the number of respiratory symptoms within this 
cohort showed that the proportion of ADF members who reported 3 and 4 respiratory symptoms 
had significantly increased from pre- to-post deployment. This is in line with increased 
reporting of respiratory symptoms in both the GW1 and the Iraq and Afghanistan conflict (5-9, 
31, 151, 152).  
 
Previous military studies, i.e. GW1 studies, were generally limited by a lack of prospective 
design, meaning that it was not possible to determine the timing of onset of symptoms. 
However, the MEAO prospective study allowed determination of whether respiratory 
symptoms do in fact precede or follow deployment. The current study examined the 
development of respiratory symptoms at post-deployment in those who were symptom-free 
prior to their deployment.  
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The analysis addressed which respiratory function sub-groups had a significant increase in 
incidence of newly reported respiratory symptoms at post-deployment as well as whether or not 
new respiratory symptoms at post-deployment reflect clinical diagnosis guidelines using the 
GOLD standard cut off of 70% for FEV1/FVC. The result showed a significant increase in 
incidence of newly reported respiratory symptoms within the sub-group with decreased 
objective respiratory function at post-deployment. This is further supported by the significant 
association observed between overall increase in respiratory symptoms and decrease in 
objective respiratory function.  
 
In the other sub-groups „Normal‟, „Abnormal‟, and „Increased‟, respiratory function also 
showed an increase in incidence of newly reported symptoms. Although these increases were 
not significant, it is notable that even though the sub-group with „Normal‟ objective respiratory 
function met the criteria for being clinically healthy, some participants in this sub-group were 
symptomatic. The presence of respiratory symptoms within the „Normal‟ respiratory function 
group could suggest that symptoms per se might not necessarily be a reflection of clinically 
abnormal diagnosis. Instead it may be the result of decrease in objective respiratory function. 
This has been demonstrated in the current study as the results have shown a significant (p=0.02) 
increase in incidence of newly reported respiratory symptoms within the sub-group with 
decreased objective respiratory function at post-deployment.  
 
In addition to establishing evidence of change in objective and subjective measures of 
respiratory function, this study also found that respiratory function as measured by the 
FEV1/FVC ratio and sum of self-reported respiratory symptoms, between pre-and post-
deployment, was not influenced by age, sex, service, prior deployment or current smoking 
status. This suggests that an increased risk of adverse respiratory outcomes may involve more 
specific exposures during deployment, such as environmental particulate matter or the 
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psychological stress of deployment, additional to the characteristics of ADF members or 
deployment alone.  
 
Given the healthy state of military members at recruitment, existing research suggests that 
exposures such as environmental (particulate matter, metal particles, burn pit, air pollution), 
combat stress, and other exposures (physical activity, military living conditions and smoking) 
might be related to impairments in respiratory function among military members (11, 20, 25, 
28, 57, 60, 152). 
 
As suggested by other studies, alterations in the autonomic and/or immune systems (124, 127, 
128), possibly following environmental and psychological exposures or a psychological 
condition such as PTSD, may be possible underlying mechanisms involved in adverse 
respiratory outcomes observed in this study (27, 124, 127, 128).  
 
The possibility of somatisation and self-reported symptoms reflecting mental distress rather 
than any actual physical impairment also remains (9). There are suggestions that asymptomatic 
and undiagnosed conditions may be underestimated. Aggravation of these sub-threshold and 
mild pre-existing conditions by deployment risk factors such as environmental and 
psychological exposures may result in worsening of conditions and eventually clinically 
diagnosable disease or condition. Therefore, deployment could possibly be exacerbating, rather 
than causing the condition (106, 153). Nevertheless, to make robust statements regarding 
linkage between deployment exposures, psychological conditions, and immune changes with 
adverse respiratory outcomes, further physiological and psychological investigations of the 
ADF members and various exposures in this cohort are required.  
 
The finding of the current study regarding increased respiratory symptom reporting, supports 
the findings of previous cross-sectional studies (3, 5-7, 9, 21, 31, 40, 45, 60). Despite similar 
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findings between the different studies reporting high incidence of adverse respiratory function 
(3, 5-7, 9, 21, 31, 40, 45, 60), it is not possible to determine whether the higher rates of self-
reported respiratory symptoms and reduced respiratory function were due to a higher 
occurrence of new respiratory conditions, somatisation, higher baseline prevalence, or 
reporting, selection, or confounding bias.  
 
Many of the conclusions of other epidemiological studies of military respiratory health have 
been based solely on self-reported findings of questionnaire surveys. The use of spirometry tests 
in our study has provided objective data which provides more valid and reliable results. In 
addition, given the strengths of a prospective study with known base-line information, including 
descriptive, self-reported symptoms and objective data, this study demonstrates that there are 
some significant subtle decreases in both objectively assessed and self-reported respiratory 
function and symptoms following deployment. Bearing in mind that deployment-related 
respiratory symptoms and conditions were expected to be subtle and that abnormalities in 
respiratory function may have presented in a sub-syndromal form among otherwise healthy 
populations. In order to determine how meaningful these small changes and patterns are, careful 
evaluation of this cohort is required over time to determine the long-term impacts of 
deployment on syndromal respiratory conditions. 
 
This study established limited evidence of change in respiratory function via both subjective 
and objective respiratory measures from pre- to post-deployment among a subset sample of 
MEAO deployed ADF members between 2010 and 2012. Although the overall analyses of this 
cohort as a whole showed little decline in both objective and subjective respiratory function 
post-deployment, further investigation of „Normal‟ and „Abnormal‟ respiratory function sub-
groups showed significant changes in both objective and subjective respiratory function. 
Psychological trauma exposures or conditions such as PTSD may be the influencing factors on 
respiratory function via changes in the autonomic and immune systems (as discussed in the 
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introduction to this thesis). Furthermore, the possibility of somatisation reflecting mental 
distress rather than any actual respiratory impairment also remains. 
 
Early identification of potential underlying differences in affected and non-affected ADF 
members may prove useful in determining strategies for prevention of adverse respiratory 
outcomes and aid earlier intervention, including recruitment guidelines, such as those followed 
by the US and UK. These results, together with investigation of possible risk factors, may 
contribute significantly to long term respiratory health outcomes of the deployed ADF 
population. For this reason, Chapter 4 of this thesis aimed to examine predictors of adverse 
respiratory health in the context of combat environmental and psychological trauma exposures 
among the same cohort of Middle East deployed ADF members. 
 
5.1.2 The impacts of deployment exposures on adverse respiratory outcomes of 
ADF members deployed to the MEAO between 2010 and 2012 
Previous studies indicated that deployment has adverse psychological and physiological effects 
on ADF members which can last for significant periods post-deployment, such as PTSD, 
asthma, chronic bronchitis and shortness of breath (3, 40, 71, 131, 133, 134, 152, 154, 159). The 
significance of examining health concerns is emphasized by consistent findings from post-
deployment studies of personnel deployed in support of the GW1 which showed increased 
reporting of all somatic symptoms, including respiratory symptoms, by GW1 veterans 
compared with non-GW1 comparison groups (5-8).  
 
As yet, in both the GW1 and the Iraq and Afghanistan conflicts, no specific association has 
been established between particular MEAO exposures and adverse respiratory outcomes, or the 
onset of serious disease, despite extensive epidemiological research (5, 12, 16, 17). Because of 
the limitations in standardising exposure measures, cross-sectional study designs, retrospective 
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medical review and the self-reported nature of measures in many studies, it is difficult to reach 
strong conclusions regarding any potential relationship between deployment exposures and 
adverse respiratory outcomes. However, despite equivocal findings, the current literature 
suggests that increases in adverse respiratory outcomes among military members following 
deployment to the MEAO may be associated with exposure to environmental factors (10-12, 
20-24). In regards to adverse respiratory outcomes, exposure to psychological trauma has been 
less investigated than environmental exposures, but remains an important factor that may 
contribute to impairment in respiratory function (26-28, 46, 47). There is also a common 
proposed mechanism for this association: both environmental and psychological trauma 
exposures may affect respiratory function via changes in the immune system.  
While environmental exposure has a local inflammatory effect, directly on the lung, 
psychological exposures induce a systemic inflammatory response that can affect the 
respiratory system systemically.  
 
Although examining immunological changes regarding adverse respiratory outcomes and 
possible links with deployment exposures was beyond the scope of the current study, this was 
discussed both in the background section of Chapter 1, and the discussion in Chapter 4 as there 
is the possibility that immune changes influence respiratory outcomes via effects of 
environmental and psychological exposures.   
 
Following on from the findings of Chapter 3, which suggested that deployment may increase 
the risk of adverse respiratory outcomes among a subset of ADF members deployed to the 
MEAO, Chapter 4 further examined the hypotheses that environmental and psychological 
trauma exposures independently and combined are associated with adverse respiratory 
outcomes observed among ADF members deployed to the MEAO. In addition, the role of 
psychological trauma exposure as a moderator on the relationship between environmental 
exposure and FEV1/FVC or respiratory symptoms was also examined. 
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Similar to previous international and Australian findings regarding the association between 
environmental factors experienced on deployment in the Middle East, and adverse respiratory 
function, (11, 36, 37, 39) this study identified psychological trauma as an independent factor. 
Findings also showed that the effect of environmental exposures on both objective lung 
function and self-reported respiratory symptoms was influenced by the level of psychological 
trauma exposure. To the author‟s knowledge, this finding is novel as no previous prospective 
military study has demonstrated the effect of psychological stress as a moderator of association 
between deployment environmental factors and adverse respiratory outcomes among military 
members.  
 
The results showed that environmental and psychological trauma exposures independently and 
combined have an inversely proportional association with FEV1/FVC i.e. when environmental 
or psychological trauma exposures increased, the FEV1/FVC decreased. Environmental 
exposure and the interaction between environmental exposures and psychological trauma were 
also significantly associated with self-reported respiratory symptoms at post-deployment. 
Similar to the findings of previous studies (11, 36, 37, 39), it was expected to see an association 
between increased environmental exposures with increased respiratory symptoms at post-
deployment. In addition, psychological exposure appeared to interact with environmental 
exposures and influenced respiratory symptom outcomes, such that the association between 
environmental exposures and respiratory symptoms was stronger when accompanied by higher 
levels of psychological trauma exposure. The findings suggest that, in the case of self-reported 
symptoms, exposure to psychological trauma alone was not associated with respiratory 
outcomes. Rather, it is possible that psychological trauma exposure influences how ADF 





Further, there is also extensive evidence for association between psychological trauma and 
mental disorders such as PTSD with prominent respiratory symptoms (60, 124, 152). This 
raises questions regarding the effect that psychological symptoms may have on the respiratory 
function of ADF members and the underlying mechanisms involved (60, 124, 152).  
 
Within the ADF population the incidence of mental disorders has been estimated at 22%, with 
8.3% of ADF members meeting criteria for PTSD (131). PTSD is characterised by changes in 
the hypothalamic–pituitary–adrenal axis and the sympathetic–adrenal–medullary system. It is 
thought that these alterations lead to a pro-inflammatory state which may result in structural and 
functional changes in the respiratory system (60, 65-68, 147). In one US study, PTSD-positive 
male combat veterans had  increased reporting of chronic pulmonary diseases compared to 
those who were PTSD-negative (158), and in another US study, female veterans were at 1.6-
fold higher self-reported asthma than those without PTSD (144).  
 
In the current study, high PCL scores (symptom severity score for PTSD) were found to be 
associated with respiratory symptoms. However, the association between high PCL scores and 
objective lung function (FEV1/FVC) was not significant. Further, investigation of the pattern of 
relations between objective lung function changes in sub-groups with „high‟ or „low‟ PCL 
scores with or without respiratory symptoms did not identify any significant relationship. This 
suggests that having a high PCL score is unlikely to influence objective lung function in this 
predominantly young and healthy cohort of ADF, rather, it may manifest in physiological 
symptoms including respiratory symptoms. Given the high rate of PTSD within the military 
population, identifying PTSD-affected individuals with prominent respiratory symptoms but 
with no objective decline in respiratory function may be a cost-effective way to reduce future 
respiratory burden by addressing the psychological root of this issue. In addition, this could be 




Another finding of this study was that those with elevated posttraumatic stress symptoms 
reported more environmental and psychological trauma exposures, consistent with the 
possibility of a link between these exposures, PTSD symptoms, and increased respiratory 
symptoms. A commonly proposed mechanism for these associations is a change in the immune 
system (this has been discussed in detail in Chapter 1 and 4 of this thesis). High intensity or 
repeated exposures to environmental factors may lead to chronic respiratory conditions, such as 
chronic bronchitis or COPD. Another possible pathway may involve excessive pro-
inflammatory responses to acute psychological stress that may result in airway damage and 
consequently structural and functional pulmonary changes (19, 48-51, 53, 60, 100, 101, 107, 
111, 159). In such a way, psychological stressors may make the respiratory system more 
vulnerable to other stressors or exposures. Therefore, higher levels of stress during deployment 
may, in part, explain the decrease in FEV1/FVC and increased rate of respiratory symptoms 
reported among ADF members. However, testing this mechanism was beyond the scope of the 
current study. This understanding might be gained by comprehensive investigation of the levels 
of deployment exposures, objective measures of respiratory outcomes and circulating 
inflammatory markers at pre-, during, and post-deployment. 
 
Overall, the documented associations in this study were small and deployment-related 
respiratory conditions have been shown to be subtle. This was expected, as abnormalities in 
lung function are often present in the sub-syndromal form among an otherwise healthy 
population (152, 154). Therefore, careful evaluation is required over time to determine the long-
term impacts of deployment on syndromal respiratory diseases, as has previously been 
described for ADF members with self-reported psychological distress (154). 
 
The findings from this study support the hypothesis that environmental and psychological 
trauma exposures independently and combined have adverse effects on self-reported respiratory 
symptoms and objective respiratory measures in a cohort of MEAO deployed ADF members. 
114 
 
This study has also shown that, apart from the direct effect of trauma exposure on adverse 
respiratory outcomes, psychological trauma may increase the impact of environmental 
exposures leading to a negative shift in both objective and subjective respiratory outcomes. This 
may explain why previous military findings did not find associations between environmental 
exposures (i.e. smoke from oil wells (SMOIL) which were set alight by the Iraqi troops in 
Kuwait) and objective respiratory decline, despite significant increase in respiratory symptoms 
(7, 31). Therefore, while deployment appears to be associated with adverse respiratory 
outcomes, this cannot be exclusively attributed to environmental exposures. Other deployment 
factors, such as psychological trauma exposure in the combat environment, should also be 
considered. 
 
While the associations between stress-related mental disorders such as PTSD and altered 
immune responses is not causative, low level inflammation and altered immune responses 
provide plausible mechanisms by which psychological trauma exposure may be associated with 
respiratory symptoms (53, 60, 124, 144, 152, 158). Further analyses of this prospective study 
are needed to clarify the role of inflammatory mediators in relation to psychological trauma 
exposures among those ADF with prominent respiratory symptoms. This would be an important 
future study to provide further objective evidence that deployment exposures may affect 
respiratory outcomes via changes in the immune system. This may inform future preventative 
measures, such as objective screening of military members to identify inflammatory markers 
associated with risk for psychological exposure/conditions and adverse respiratory outcomes 
leading to a decline in future respiratory burden within military population. 
 
5.2 Strengths and limitations 
The main strengths of this study include the prospective design and recruitment from a wide 
cross-section of units preparing to deploy rather than treatment-seeking populations. While 
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using this prospective design minimised selection bias, given that the current sample 
represented only a proportion of ADF members deployed to the Middle East over the study 
period, with some demographic differences seen between the sample and population (e.g. 
number of males and females), the results may not be representative. This is an inherent 
limitation of studying deploying personnel, where the short notice and intensive training 
associated with deployment precluded the research team from approaching many potential 
participants(134). In addition, the inclusion of important factors in analyses of respiratory health 
outcomes of ADF members, such as BMI and physical activities in stressful situations were 
beyond the scope of this study. This may have led to exclusion of possible confounding factors. 
 
The findings presented in this study are limited due to the fact that only 60-70% of pre-
deployment participants completed the pre- and post-deployment data collection, and it is 
possible that those who only completed pre-deployment or who did not respond at either time 
point, differed in health or deployment experiences from those who did not participate (3). 
 
Although the scope of this thesis did not allow for the in-depth analyses warranted by such an 
extensive and valuable dataset, to the author‟s knowledge this is the first Australian study which 
has attempted to examine whether psychological responses to deployment exposures moderate 
the relationship between environmental exposures and respiratory health outcomes. 
International studies have mainly focused on environmental and psychological trauma 
exposures in the deployed environment as independent predictors. This study is the first study 
to provide investigation of effects of individual and combined environmental and psychological 
trauma exposures on respiratory health of Middle East deployed ADF members. 
 
Previous studies have largely relied on self-reported data or cross-sectional studies, which have 
several limitations in terms of their reliability and validity. In addition to self-reported 
respiratory data, this prospective study utilised data from objective spirometry tests pre- and 
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post-deployment. Objective measures are generally used to increase precision and to validate 
the self-report measures (160). This has increased the comprehensiveness and objectivity of our 
assessment over the limited previous research on this subject. 
 
While in conjunction with a respiratory questionnaire, spirometry testing provides a powerful 
diagnostic tool with adequate sensitivity and specificity, the self-report questionnaire data 
presented in this study were based on subjective assessments made by the ADF participants. 
This could be limitation in this study, as self-reporting for respiratory symptoms may have led 
to misdiagnosing of the symptoms or under-reporting due to participants being reluctant to 
report diseases regarding career consequences. In addition, the self-report questionnaire 
recorded up to 4 months after deployment which makes it open to recall bias, particularly when 
data are collected well after symptoms/conditions have occurred (106). The above-mentioned 
limitations may result in lower reported rates of respiratory symptoms, environmental and 
psychological exposures, and may minimise associations between exposures and FEV1/FVC, 
self-reported respiratory and PTSD symptoms. 
 
Previous studies of military populations are either limited to non-deployed or comparing 
deployed to non-deployed military personnel. This prospective study followed the same group 
of deployed ADF members from pre-deployment to post-deployment, which allowed for the 
clarity of the temporal sequence as well as calculation of incidence. This is important because 
baseline health status is determined before exposure or condition events occur.  
 
Despite the strength of this prospective design, another limitation of this study was missing data 
associated with poor spirometry, leading to the exclusion of many participants with completed 
data pre- and post-deployment. Although exclusion is justified in some cases due to non-
reproducible recordings, coughing or shortness of breath, this led to almost half of the 
respondents‟ data not being included in the statistical analyses. The resultant small numbers of 
117 
 
participants in sub-groups do not provide sufficient power to detect statistically significant 
differences.  
 
5.3 Implication  
The results provided a good indication of the types of respiratory shifts, i.e. increase in reported 
respiratory symptoms and decrease in FEV1/FVC ratio, which may occur pre- to post-
deployment among ADF personnel deployed to the MEAO, especially given the consistency 
which is in concurrence with some international studies. Therefore, the findings can be 
informative in terms of what should be done next regarding further studies into preventative 
measures. 
 
For deployed personnel who have been exposed to environmental factors such as particulate 
matter and stressful events during deployment, the recruitment of respiratory symptoms is likely 
to have important implications for the risk of future respiratory disorder. Therefore, it is 
important to understand that the minor increase in respiratory symptoms and decrease in 
objective indications, may tip over at some point into clinically significant symptoms or 
probable disorders (151, 152).  
 
While the analysis of underlying mechanisms including inflammatory mechanisms may have 
proved more informative in looking at respiratory function in this particular cohort, it was 
beyond the scope of this thesis. Nevertheless, the limited findings of this study are of 
importance to the ADF, providing evidence that deployment exposures and subtle adverse 
respiratory outcomes may be indicative of psychological conditions or respiratory distress not 
yet clinically identified. Therefore, in order to prevent future respiratory burden, comprehensive 
subjective and objective assessment of individuals at risk, post-deployment, should be a focus 
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of military intervention. Identifying indicators of risk in still healthy individuals allows for 
mitigation strategies aimed at preventing poor health trajectories. 
 
The value of ADF members is substantial to the Australian government and communities, as 
well as other countries protected by these highly trained individuals. Therefore, any steps that 
can maximise the duration of their service life without addition of adverse health outcomes 
should be a critical priority. 
 
Adverse respiratory outcomes in military personnel, linked with deployment exposures, would 
highlight the need for a risk management approach to deployment environment. Risk 
management strategies could focus on reducing exposures, ensuring recovery, and increasing 
resilience to these risk contributors to minimise adverse respiratory outcomes in vulnerable 
military personnel. 
 
5.4 Recommendations and Future Research  
Preventative measures can be taken to avoid the decline of respiratory functions to minimise the 
increase or emergence of symptoms post-deployment. One recommendation would be to 
identify adverse respiratory outcomes by adding specific respiratory questionnaires, such as the 
one used in this study, together with a complete spirometry at pre- and post-deployment. This 
will aid in identifying individuals at risk of developing adverse respiratory outcomes over time. 
In addition, the data obtained could be used for further cohort studies to determine the 
trajectories of respiratory symptoms among deployed ADF members with and without combat 
exposures.  
 
The results of this and previous studies highlighted the need for increased monitoring and 
support services to be provided for individuals in roles involving exposure to psychological 
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trauma, such as those in combat roles. Therefore, in addition to the support services at post-
deployment, the next recommendation is to better prepare Defence personnel at pre-deployment 
against psychological and environmental exposures, shown to have a negative respiratory 
effect. This can be achieved through an increase in training and awareness of environmental 
risk factors and further psychological screening and awareness seminars pre-deployment.  
In relation to our findings, all the shifts in respiratory function were small and may not have any 
clinical significance. Nevertheless, future comprehensive prospective studies with a focus on 
deployment exposures and respiratory health, including complete objective spirometry and 
immunological tests, could build on the findings of the current study. The findings from the 
future comprehensive studies may lead to implementing a structural framework into the 
conducting of objective and subjective respiratory testing at pre-deployment which would be a 
cost-effective exercise for the military. Those at risk would be identified and closely monitored 
during deployment for symptoms to ensure adequate measures are taken in line with 
occupational health and safety guidelines. These pre-deployment tests can also be an effective 
preventative measure when looking at re-deployment.  
 
An interesting future study could include a comparison of ADF members who did not show any 
shift in respiratory symptoms and lung function (the majority) to those who showed a shift (the 
minority). Similar to the US and UK recruitment restrictions, this information could be used as 
a preventative measure in the form of changes to recruitment procedures in the ADF, as 
currently the Australian recruitment rules are less stringent (34). 
 
The ultimate goal of the Australian Department of Defence is to look after the health and 
wellbeing of its members. The high standard of health and well-being for ADF members pre-
deployment is a standard that must be maintained to the highest level possible during and post-
deployment as it is crucial for these individuals who defend not only Australia, but also 
contribute to the security and stability of South East Asia and the Indo-Pacific region. The 
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findings of this study will be presented in the Australian Military Medicine Association 
conference and will be made available to all Defence personnel via internal Defence and 
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ID:
For the purposes of this study, deployment to the Middle East Area of Operations
includes:
- Deployment to Iraq or areas supporting operations in Iraq;
- Deployment to Afghanistan or areas supporting operations in Afghanistan.
For more information please refer to the instructions on the following page. If you are
still uncertain regarding your eligibility to participate in this study, please contact the
study team on 1800 232 904 or email cmvh@adelaide.org.au
Middle East Area of Operations (MEAO)
Prospective Health Study
Pre Deployment Questionnaire
Part 1: Brief Deployment History
Part 2: Pre Deployment Health Questionnaire
Part 3: Personality and Resilience Insert
Teleform Predeployment Survey_JB_20110415-v5.pdf
36541
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Instructions to complete this questionnaire:
This questionnaire asks about your physical and mental health.
All information you provide in this questionnaire will be
de-identified and will not be linked to other data we have
collected about your health without your consent.
Please complete all sections by following the instructions at the
beginning of each question. Please shade circles, rather than
ticking or crossing them, and write clearly and in capital letters.
If you make a mistake and wish to change your answer, simply
cross out your mistake and choose the answer that is right for
you.
Please use blue or black pen, not pencil.
Some questions may seem repetitive, but this is necessary due
to the questions being grouped into scales.
If you have any questions, please call us on 1800 232 904.
ID:
36541
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SUPPORT
If you require support in regards to anything in this questionnaire, please refer to the contacts
provided below:
ALL HOURS SUPPORT LINE (a confidential telephone triage support service for ADF members and their
families)
1800 628 036; outside Australia +61 2 9425 3878
LIFELINE
13 11 14
VETERANS AND VETERANS' FAMILY COUNSELLING SERVICE
1800 011 046
VETERANS' AFFAIRS NETWORK (VAN)
1300 551 918; non-metro 1800 555 254
DEPARTMENT OF VETERANS' AFFAIRS
13 32 54
NATIONAL OFFICE FOR THE MILITARY COMPENSATION AND REHABILITATION SERVICE
1300 550 461
For questions, problems or concerns, or to have your name removed from the mailing list please
contact:
THE STUDY TEAM: The Centre for Military and Veterans' Health
Freecall 1800 232 904; cmvh@adelaide.edu.au
FIRST CHIEF INVESTIGATOR: Professor Annette Dobson, University of Queensland
(07) 3365 5346; a.dobson@uq.edu.au
If you prefer to speak to an independent officer of the Universities or Defence Force not involved in the
study, you may contact an ethics officer on the numbers listed below:
THE AUSTRALIAN DEFENCE HUMAN RESEARCH ETHICS COMMITTEE
Executive Secretary: (02) 6266 3837; ADHREC@defence.gov.au
THE UNIVERSITY OF ADELAIDE RESEARCH BRANCH
Secretary, Human Research Ethics Committee: (08) 8303 6028
THE DEPARTMENT OF VETERANS' AFFAIRS HUMAN RESEARCH ETHICS COMMITTEE
HREC Coordinator: (02) 6289 6204; ethics.committee@dva.gov.au
ID:
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Yes No
1.1 Have you been on an ADF operational deployment? (war-like, peacekeeping, peace-monitoring or humanitarian
support)





















- please skip to question 1.7





Instructions: Please indicate which of the following major operations you have been deployed on (please complete
as much of this information as you can).
1.2 Deployments to MEAO
ID:
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1.3 Did you feel pressure from your unit to volunteer for
this deployment?
Yes, formal chain of command
Yes, mates within Unit
No
Not applicable
No, I was treated the same as the members of the host Unit
Yes, I was treated better than the members of the host Unit
Yes, I was treated worse than the members of the host Unit
1.4 When you deployed, did you deploy with your
parent unit?
Yes
No, but I deployed with some members from my Unit
No, I didn't know anyone I deployed with
Not applicable, did not have a parent unit
Thinking about your most recent deployment to the MEAO:
Brief Deployment History - MEAO
a) Did you feel you were treated any differently than members of the host unit?
If NO:









































Brief Deployment History - Other Deployments























Brief Deployment History - Other Deployments
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1998





1.6 What other Operations have you been deployed on (war like, peacekeeping, peace-monitoring or humanitarian
support), including UN missions (e.g. OP Palate, OP Riverbank), Humanitarian Missions (e.g. OP Pakistan Assist,
OP Sumatra Assist), secondments to foreign militaries (e.g. OP Enduring Freedom, OP Herrick), and border
protection (e.g. Op Resolute)? If you have depolyed on more than 10 other Operations, please enter your 10 longest.
ID:
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Brief Deployment History
COUNTRY
(If you do not
remember or do not
wish to report this
please write NA)
COMPANY NAME
(If you do not remember or













1.7 Have you worked in the Middle East in a role outside of the ADF (e.g. as a security contractor
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Married and living together
Married with unaccompanied spouse
Living with partner (ADF recognised)
Living with partner (not ADF recognised)
In a long term relationship but not living together
Section One: Background Details
1.2 Are you male or female?
1.3 What is your date of birth? (dd/mm/yyyy)
Male Female
1.6 How satisfied are you with your marriage / relationship? Extremely satisfied
Satisfied




1.1 What is today's date? (dd/mm/yyyy)
1.7 Have you or your spouse / partner ever seriously suggested the
idea of divorce or permanent separation within the LAST YEAR?
Yes No Not applicable
(i.e. married partner currently lives elsewhere)
1.4 Are you currently in a significant intimate relationship?
1.4a Are you:
Never married
Previously married but now divorced
Previously married but now separated
Other, please specify:
1.4b Are you:
- go to question 1.4b
- go to question 1.4aYes
No
(i.e. married partner currently lives elsewhere)
1.5 Were you in a significant intimate relationship ONE YEAR AGO?
Married and living together
Married with unaccompanied spouse
Living with partner (ADF recognised)
Living with partner (not ADF recognised)
In a long term relationship but not living together
1.5a Were you:
Never married
Previously married but now divorced
Previously married but now separated
Other, please specify:
1.5b Were you:
- go to question 1.5b
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Section One: Background Details
1.9 Which category best describes the highest educational
qualification you have completed? Choose one.
Primary school
Secondary school up to grade 10
Secondary school grades 11-12




1.10 How many hours per week are you in paid employment, when you are not on deployment? hours
1.11 To the nearest year, how long have / had you served with the Australian Defence Force: (if more than 0, but less
than 1 year, please enter 1)
a) As a regular?
b) As a reservist?
1.12 What is your CURRENT rank or what
WAS your rank when you left the
military?
Senior Commissioned Officer (CMDR / LTCOL / WGCDR and above)
Commissioned Officer (LCDR / MAJ / SQNLDR and below)
Senior Non-Commissioned Officer (PO / SGT and above)
Junior Non-Commissioned Officer (LS / CPL and below)
Other ranks (AB / SMN / PTE / LAC / AC or equivalent)
1.13 In the past THREE YEARS, roughly how many months in total have you been away on
Operational deployment? (if more than 0, but less than 1 month, please enter 1)
months
years or Not applicable
years or Not applicable
1.8 Overall, what impact have your military commitments (now, or in the past if you have left the military) had on your:









If you are still a member of the regular Australian Defence Force, please go to Section Two.
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Section One: Background Details
1.16 What is your current employment status? Paid employment full-time
Paid employment part-time / casual




Not working due to ill-health / TPI
Unemployed
Other, please specify:
1.17 Since you separated from the ADF, have you had a period of
unemployment greater than 3 months?
If YES, was this period of unemployment primarily due to health problems?
If YES, please specify type:
Yes No Not applicable
Yes No
1.14 What year did you discharge from the Regular Australian
Defence Force?
or
Not applicable, I am a Reservist
1.15 Did you discharge to the Reserves
or out of the ADF completely?
Reserves Out of ADF Not applicable, I have always been a reservist
1.18 What is your main source of income now? Choose one. Wage or salary
Own business or share in a partnership
Age Service pension
Invalidity Service Pension
Compensation benefit under the VEA
Compensation benefit under the SRCA
Compensation benefit under the MRCA
Other government pension / allowance / benefit
Child allowance
Superannuation / annuity
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Section Two: Recent Health Symptoms
We would like to know about your health in the past month. Please indicate whether or not you have suffered any of





2.4 Irritability / outbursts of anger
2.5. Unable to breathe deeply enough
2.6 Faster breathing than normal
2.7 Feeling short of breath at rest
2.8 Wheezing
2.9 Sleeping difficulties
2.10 Feeling jumpy / easily startled
2.11 Feeling unrefreshed after sleep
2.12 Fatigue
2.13 Double vision
2.14 Intolerance to alcohol
2.15 Itchy or painful eyes
2.16 Rash or skin irritation
2.17 Skin infections e.g. boils
2.18 Skin ulcers
2.19 Shaking
2.20 Tingling in fingers and arms
2.21 Tingling in legs and toes
2.22 Numbness in fingers / toes
2.23 Feeling distant or cut off from others
2.24 Constipation
2.25 Flatulence or burping
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
In the past month have you suffered from: NO YES
ID:
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Section Two: Recent Health Symptoms




2.32 Lump in throat
2.33 Sore throat
2.34 Forgetfulness
2.35 Dizziness, fainting or blackouts
2.37 Feeling disorientated
2.38 Loss of concentration
2.39 Difficulty finding the right word
2.40 Pain on passing urine
2.41 Passing urine more often
2.42 Burning sensation in the sex organs
2.43 Loss of interest in sex
2.44 Problems with sexual functioning
2.45 Increased sensitivity to noise
2.46 Increased sensitivity to light
2.47 Increased sensitivity to smells or odours
2.48 Ringing in the ears
2.49 Avoiding doing things or situations
2.50 Pain, without swelling or redness, in several joints
2.51 Joint stiffness
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe2.52 Feeling that your bowel movement is not finished
2.36 Seizures or convulsions
2.30 Pain in the face, jaw, in front of the ear, or in the ear
2.29 Dry mouth
2.26 Stomach cramps No Mild Moderate Severe
ID:
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Section Two: Recent Health Symptoms
In the past month have you suffered from: NO YES




No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
2.60 Tender or painful swelling of lymph glands in neck,
armpit or groin
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe2.67 Unintended weight loss greater than 4kg
2.66 Unintended weight gain greater than 4kg
2.65 Stomach bloating
2.56 Difficulty speaking
2.57 Low back pain
2.58 Night sweats which soak the bed sheets
2.59 Feeling feverish
2.54 General muscle aches or pains
2.55 Loss of balance or coordination
No Mild Moderate Severe
No Mild Moderate Severe
2.53 Changeable bowel function (mixture of diarrhoea /
constipation)
No Mild Moderate Severe
ID:
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Section Two: Recent Health Symptoms
Memory problems or lapses
Balance problems or dizziness
Sensitivity to bright light
Irritability
Headaches
2.68 During your lifetime, did you experience any of the following events?
2.69 How many times in total have you experienced each of the following symptoms immediately after any of the
events listed above?
2.70 Did any of the following problems begin or get worse after any of the events listed above?
If NO to all events in 2.68: please skip to question 3.1. Otherwise, continue.
Loss of consciousness / "knocked out"
Being dazed, confused, or "seeing stars"








Blast or Explosion IED (improvised explosive device)
Vehicular accident / crash (any vehicle, including aircraft)














Memory problems or lapses
Balance problems or dizziness
Sensitivity to bright light
Irritability
Headaches
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Section Three: Your Health Now
3.1 In general, how would you say your health is? Excellent Very good Good Fair Poor
Moderate activities, such as moving a table,
pushing a vacuum cleaner, bowling, or
playing golf?
Climbing several flights of stairs?
Yes, limited a lot Yes, limited a little No, not limited at all
3.2 The following questions are about activities you might do during a typical day. Does your health now limit you in
these activities? If so, how much?
Yes, limited a lot Yes, limited a little No, not limited at all
3.5 During the past 4 weeks, how much did pain interfere with your normal work (including both work outside the
home and housework)?
Not at all A little bit Moderately Quite a bit Extremely
Accomplished less than you would like
Did work or other activities less carefully than usual
3.3 During the past 4 weeks, how much of the time have you had any of the following problems with your work or
other regular daily activities as a result of your physical health?
Accomplished less than you would like
Were limited in the kind of work or other activities
3.4 During the past 4 weeks, how much of the time have you had any of the following problems with your work or
other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious)?
Have you felt downhearted and depressed?
Have you felt calm and peaceful?
















3.6 These questions are about how you feel and how things have been with you during the past 4 weeks. For each
question, please give the one answer that comes closest to the way you have been feeling. How much of the time
during the past 4 weeks...
3.7 During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with
your social activities (like visiting friends, relatives etc.)?
All of the time Most of the time Some of the time A little of the time None of the time
This next set of questions ask for your views about your health. This information will help you to keep track of how you
feel and how well you are able to do your usual activities.
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3.10 Eyesight (with glasses or contact lenses, if you wear them)?
3.12 Memory?
3.13 Teeth and gums?






Section Three: Your Health Now
In general, how would you rate your:
3.8 Overall health?
3.16 In the past four (4) weeks, about how often did you
feel so nervous that nothing could calm you down?
3.17 In the past four (4) weeks, about how often did you
feel hopeless?
3.18 In the past four (4) weeks, about how often did you
feel restless or fidgety?
3.14 In the past four (4) weeks, about how often did you
feel tired for no good reason?













3.20 In the past four (4) weeks, about how often did you
feel depressed?
3.21 In the past four (4) weeks, about how often did you
feel that everything was an effort?
3.22 In the past four (4) weeks, about how often did you
feel so sad that nothing could cheer you up?
3.19 In the past four (4) weeks, about how often did you
feel so restless that you could not sit still?
3.23 In the past four (4) weeks, about how often did you
feel worthless?
The following questions inquire about how you have been feeling over the last four (4) weeks. Please read each
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a) I am able to adapt to change














3.28 Please rate the following statements based on how you have felt in the past 30 days using the scale below.
Section Three: Your Health Now
3.25 [Aside from those days], in the past four (4) weeks, HOW MANY DAYS were you able to work
or study or manage your day to day activities, but had to CUT DOWN on what you did because
of these feelings?
3.26 In the past four (4) weeks, how many times have you seen a doctor or any other health
professional about these feelings?
The next few questions are about how these feelings may have affected you in the past four (4) weeks. You need not
answer these questions if you answered 'None of the time' to all of the previous ten questions about your feelings.
3.24 In the past four (4) weeks, how many days were you TOTALLY UNABLE to work, study or
manage your day to day activities because of these feelings?




None of the time A little of the time Some of the time Most of the time All of the time
ID:
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Section Three: Your Health Now
YES NO
3.31 Bowel disorder e.g. diarrhoea, constipation, bleeding
3.32 Eye or vision problems e.g. glaucoma
3.29 High blood pressure
3.30 Migraines
We would like to know if you have ever been diagnosed by a medical doctor and treated in the last 12 months for any
of the following medical problems or conditions.
3.35 Any other significant infections, please specify type:





3.37 Back or neck problems
3.38 Joint problems
3.44 Dermatitis
3.45 Any other skin problem, please specify type:
3.42 Hay fever
3.43 Ear infection
3.48 Anxiety, stress or depression
3.49 Post traumatic stress disorder
3.46 Skin cancer e.g. squamous cell or basal cell skin cancers
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Section Three: Your Health Now
3.50 Other psychiatric or psychological condition needing treatment or counselling, please
specify type:
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Section Four: Lifestyle Behaviours
NO YES
c. Pipes
d. Smokeless tobacco (e.g. chew, dip, snuff)
a. Cigarettes
b. Cigars
4.1 In the past year, have you used any of the following tobacco products?
4.2 In your lifetime, have you smoked at least 100 cigarettes (5 packs)?
No
Yes
- please skip to question 4.9
4.4 How many years have you, or did you, smoke an average of at least 3 cigarettes per day
(or one pack per week)?
4.5 When smoking, how many packs per day did you, or do you, smoke?
4.3 At what age did you start smoking? years old
years
Less than half a pack per day
Half to 1 pack per day
1 to 2 packs per day
More than 2 packs per day
4.6 Have you ever tried to quit smoking? Yes, and succeeded
Yes, but not successfully
No
4.7 If you have ever deployed, was your smoking pattern different while on deployment?
I have never deployed
I did not smoke on deployment
I smoked less than usual while on deployment
I smoked the same amount on deployment as when not deployed
I smoked more than usual while on deployment
I began / restarted smoking on deployment
4.8 If your smoking pattern changed during your deployment, what was the main reason?
- continue to next question
ID:
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Section Four: Lifestyle Behaviours
Monthly or 2 to 4 times 2 to 3 times 4 or more
Never Less a month a week times a week4.9. How often do you have a drink containing
alcohol?
4.10 How many 'standard' drinks (see above)
containing alcohol do you have on a typical day
when you are drinking?
4.11 How often do you have six or more drinks on one
occasion?
4.12 How often during the last 12 months have you found











4.13 How often during the last 12 months have you
failed to do what was normally expected from you
because of drinking?
In answering the following questions, please remember that a standard drink contains 10g of pure alcohol
1 or 2 3 or 4 5 or 6 7 to 9 10 or more N/A
ID:
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Section Four: Lifestyle Behaviours
4.21 On an average day, how many 250 - 375ml beverages containing caffeine do you drink (such as caffeine
containing energy drinks, coffee, tea, coca-cola)?
None 1-2 per day 3-5 per day 6-10 per day 11 or more per day
4.17 Have you or someone else been injured as a
result of your drinking?
4.18 Has a relative, a friend, a doctor or other health
professional been concerned about your
drinking or suggested you cut down?
4.15 How often during the last 12 months have you had
a feeling of guilt or remorse after drinking?
4.16 How often during the last 12 months have you been
unable to remember what happened the night
before because you had been drinking?
4.14 How often during the last 12 months have you
needed a drink in the morning to get yourself going












No but not in the last during the last
12 months 12 months
Yes, Yes,
No but not in the last during the last
12 months 12 months
4.19 Do you presently have a problem with drinking?
4.20 In the next 3 months, how difficult would you
find it to cut down or stop drinking?
Probably
No not Unsure Possibly Definitely
Neither
Very Fairly difficult Fairly Very
easy easy nor easy difficult difficult N/A
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Section Four: Lifestyle Behaviours
4.22 Do you currently take any of the following supplements?
c) Weight loss supplements
a) Body building supplements (such as amino acids, weight gain products, creatine, etc.)
b) Energy supplements (such as energy drinks, pills, or energy enhancing herbs)
Never Less than once a month Monthly Weekly Daily or almost daily
Never Less than once a month Monthly Weekly Daily or almost daily
Never Less than once a month Monthly Weekly Daily or almost daily
If YES, what was the name (generic or brand name) of the supplement that you used?
If YES, what was the name (generic or brand name) of the supplement that you used?
If YES, what was the name (generic or brand name) of the supplement that you used?
In the last 12 months...
4.23 Have you bet more than you could really afford to lose?
4.24 Have you needed to gamble with larger amounts of money to




4.25 When you gambled, did you go back another day to try to win
back the money you lost?
4.26 Have you borrowed money or sold anything to get money to
gamble?
4.27 Have you felt that you might have a problem with gambling?
4.28 Has gambling caused you any health problems, including
stress or anxiety?
4.29 Have people criticized your betting or told you that you had a
gambling problem, regardless of whether or not you thought it
was true?
4.30 Has your gambling caused any financial problems for you or
your household?
4.31 Have you felt guilty about the way you gamble or what
happens when you gamble?
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Section Five: Life Experiences
5.2 Repeated, disturbing dreams of a stressful
experience from the past?
5.1 Repeated, disturbing memories, thoughts or
images of a stressful experience from the past?
5.4 Feeling very upset when something reminded you
of a stressful experience from the past?
5.3 Suddenly acting or feeling as if a stressful
experience from the past were happening again
(as if you were reliving it)?
5.10 Feeling distant or cut off from other people?
5.9 Loss of interest in activities that you used to enjoy?
5.6 Avoiding thinking about or talking about a stressful
experience from the past or avoiding having
feelings related to it?
5.5 Having physical reactions (e.g. heart pounding,
trouble breathing, sweating) when something
reminded you of a stressful experience from the
past?
5.8 Trouble remembering important parts of a stressful
experience from the past?
5.7 Avoiding activities or situations because they
reminded you of a stressful experience from the
past?
5.13 Trouble falling or staying asleep?
5.12 Feeling as if your future somehow will be cut
short?
5.11 Feeling emotionally numb or being unable to
have loving feelings for those close to you?
5.14 Feeling irritable or having angry outbursts?
5.15 Having difficulty concentrating?
5.17 Feeling jumpy or easily startled?
5.16 Being "superalert" or watchful or on guard?
Below is a list of problems and complaints that people sometimes have in response to stressful life experiences. Please
read each one carefully, then shade the circle to the right to indicate how much you have been bothered by that problem
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Section Five: Life Experiences
5.20 If NO, did this occur during another overseas deployment?
5.19 Did this occur while deployed to the MEAO? Yes No
Yes No
If yes, what was that event?
5.21 Is there any other event that has caused you to have similar reactions? No
Yes - while deployed
Yes - while NOT deployed
Year of event
Year
















5.17a Having strong negative beliefs about yourself,
other people, or the world (for example, having
thoughts such as: I am bad, there is something
seriously wrong with me, no one can be trusted,
the world is completely dangerous)?
5.17b Blaming yourself or someone else severely for the
stressful experience or what happened after it?
5.17d Taking too many risks or doing things that cause
you harm?
5.17c Having strong negative feelings such as fear,
horror, anger, guilt, or shame?
Below is a list of problems and complaints that people sometimes have in response to stressful life experiences. Please
read each one carefully, then shade the circle to the right to indicate how much you have been bothered by that problem
in the past month.
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5.24 How often over the last month did you threaten someone with physical violence?
5.23 How often over the last month did you get into a fight with someone and hit the person?
Never One time Two times Three or four times Five or more times
Section Five: Life Experiences
Never One time Two times Three or four times Five or more times
a) I found myself getting angry at people or situations












c) When I got angry, I stayed angry
d) When I got angry at someone, I wanted to hit them
e) My anger interfered with my ability to get my work,
study or other productive activity done
f) My anger prevented me from getting along with
people as well as I'd have liked to
i) My anger had a bad effect on my health
g) I became angry at myself when I did not perform
as well or achieve what I wanted
h) I became angry at myself when I did not handle
social situations as well as I wanted
5.22 Thinking over the past 4 weeks, shade the circle that best describes the amount of time you felt that way.
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Section Five: Life Experiences
5.35 In the last 4 weeks, have you had an anxiety attack - suddenly feeling fear or panic?
If NO: please skip to question 5.50
YESNO
The next group of questions are about anxiety.
5.36 Has this ever happened before?
5.37 Do some of these attacks come suddenly out of the blue - that is, in situations where
you don't expect to be nervous or uncomfortable?
5.38 Do these attacks bother you a lot or are you worried about having another attack?
5.25 Little interest or pleasure in doing things













5.27 Trouble falling or staying asleep, or sleeping too much
5.28 Feeling tired or having little energy
5.29 Poor appetite or overeating
5.30 Feeling bad about yourself, or that you are a failure, or have
let yourself or your family down
5.31 Trouble concentrating on things, such as reading the
newspaper or watching television
5.32 Moving or speaking so slowly that other people could have
noticed? Or the opposite - being so fidgety or restless that you
have been moving around a lot more than usual
5.33 Thoughts that you would be better off dead or of hurting
yourself in some way
5.34 If you checked off any of these problems, how difficult have these problems made it for you to do your work, take
care of things at home, or get along with other people?
Not difficult at all Somewhat difficult Very difficult Extremely difficult
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Section Five: Life Experiences
5.50 Feeling nervous, anxious, on edge, or worrying a lot about different things
If NOT AT ALL: please skip to question 5.57







5.51 Feeling restless so that it is hard to sit still
5.52 Getting tired very easily
5.53 Muscle tension, aches, or soreness
NOT AT
ALL
5.54 Trouble falling asleep or staying asleep
5.55 Trouble concentrating on things, such as reading a book or watching TV
5.56 Becoming easily annoyed or irritable
5.39 Were you short of breath?
5.40 Did your heart race, pound, or skip?
Think about your last bad anxiety attack.
YESNO
5.41 Did you have chest pain or pressure?
5.42 Did you sweat?
5.43 Did you feel as if you were choking?
5.44 Did you have hot flushes or chills?
5.45 Did you have nausea or an upset stomach, or the feeling that you were going to have
diarrhoea?
5.46 Did you feel dizzy, unsteady, or faint?
5.47 Did you have tingling or numbness in parts of your body?
5.48 Did you tremble or shake?
5.49 Were you afraid you were dying?
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5.57 In the last 12 months, have you ever felt that life was not worth living?
5.58 In the last 12 months, have you ever felt so low that you thought about committing suicide?
No Yes
No Yes
5.59 In the last 12 months, have you made a suicide plan?
5.60 In the last 12 months, have you attempted suicide?
No Yes
No Yes
Please shade the circles that best describe your experience.
Section Five: Life Experiences
If you require support in relation to any issues you have identified in this survey, we encourage you to
refer to the contacts provided on Page 3.
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Section Six: Your Respiratory Health
6.1 Have you had wheezing or whistling in your chest at any time in the last 12 months?
YESNO
The following questions ask you about any respiratory symptoms you may have experienced in the past 12 months.
If YES:
a. Have you been at all breathless when the wheezing noise was present?
b. Have you had this wheezing or whistling when you did not have a cold?
6.2 Have you woken up with a feeling of tightness in your chest at any time in the last 12
months?
6.3 Have you been woken by an attack of shortness of breath at any time in the last 12
months?
6.4 Have you been woken by an attack of coughing at any time in the last 12 months?
6.5 Have you had an attack of asthma in the last 12 months?
6.6 Are you currently taking any medicine for asthma (including inhalers, aerosols, or
tablets)?
6.7 Do you have any nasal allergies including hay fever?
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Section Seven: Your Reproductive History
7.3 Have you ever been pregnant or fathered a pregnancy (including miscarriages, ectopics or terminations)?
Yes
No - please skip to Section Eight
If YES:
7.4 Please answer the following questions for each of your pregnancies (if you have had more than 4 pregnancies,
please phone the study team on 1800 232 904). For pregnancies involving twins, triplets or more, use a separate
column for each baby.






Live birth but baby died













20 or more but less
than 37
37 or more (inc. full term)
7.1 Have you and your partner (current or previous) ever had problems with infertility (tried to get pregnant for more
than 12 consecutive months without success)?
Never tried to get pregnant
No problem with infertility
Yes
- please skip to question 7.3
- please skip to Section Eight
If YES:





d d m m y y d d m m y y d d m m y y d d m m y y
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8.1 Have contact with an ex-service
organisation?















Please answer the following questions regarding your recreation and social activities.
8.3 Have contact with friends or relatives?
8.4 Attend social activities such as
watching sport, eating meals or
watching movies?
8.5 Play sport (e.g. golf, fishing, exercise)?
8.6 Set aside time to do a hobby (e.g.
wood work, craft, music)?
8.7 Set aside time to relax (e.g. watch
TV, read, listen to music)?
Section Eight: Recreation and Social Activities
EVERY
DAY
8.8 Do voluntary work?
8.9 Do you commemorate significant military-related occasions such as attend ANZAC Day
services, participate in marches or attend dawn services?
8.10 Do you know of other service veterans living near you?
Yes No
Yes No
8.11 Are any of your close relatives (parents, siblings) military veterans? Yes No
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Section Nine: Evaluation Questions
If YES: please give details in the space provided
here.
9.1 Are there other important health concerns we have not asked you about? Yes No
If YES: please give details in the space provided
here.
9.2 Do you have any additional comments you would like to add? Yes No
You are 2/3 of the way through. Keep going!
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Section One: Personality
1.3 Dependable, self-disciplined
1.4 Anxious, easily upset
1.5 Open to new experiences, complex
1.1 Extraverted, enthusiastic
1.2 Critical, quarrelsome
Here are a number of personality traits that may or may not apply to you. For each statement, shade the circle that
indicates the extent to which you agree or disagree with that statement.
1.7 Sympathetic, warm
1.8 Disorganised, careless
1.9 Calm, emotionally stable
1.6 Reserved, quiet
1.10 Conventional, uncreative
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Section Two: Social Support
2.4 How often do they criticise you?
2.5 How often do friends create tensions or arguments with you?
2.6 How often do family make you feel cared for?
2.1 How often do friends make you feel cared for?
2.2 How often do they express interest in how you are doing?
OFTEN SOMETIMES RARELY NEVER
The next group of questions are about your relationships with people.
2.9 How often do family criticise you?
2.10 How often do they create tensions or arguments with you?
2.7 How often do family express interest in how you are doing?
Section Three and Four: Negative Life Events
3. Overall, I had a happy childhood.
Strongly disagree Disagree Neither agree nor disagree Agree Strongly agree
4. I have needed professional help to deal with emotional problems in the past.
Not at all To a small extent To a moderate extent To a large extent Totally
For each of these next questions, shade the circle that best describes your response.
OFTEN SOMETIMES RARELY NEVER
2.3 How often do friends make too many demands on you?
2.8 How often do they make too many demands on you?
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Section Five: Symptom Interpretation
Listed below are conditions you may or may not have ever experienced. For each condition, please shade the circle
next to each reason or group of reasons that corresponds to how much that might explain your condition. Please
check every item for each question. Also, answer whether you have had the condition in the last 3 months by
shading the 'Yes' or 'No' circle as appropriate.
5.4 If I noticed my mouth was dry, I would probably think that is
because:
Yes NoHave you had a dry mouth in the last 3 months?
There is something wrong with my salivary glands
I need to drink more liquids









5.3 If I got dizzy all of a sudden, I would probably think it is
because:
Yes NoHave you felt dizzy in the last 3 months?
I must be under alot of stress
I am not eating enough or I got up too quickly









5.2. If I was sweating a lot, I would probably think that it is because:
Yes NoHave you noticed yourself sweating a lot in the last 3 months?
The room is too warm, I'm overdressed or working too hard
I'm anxious or nervous









5.1 If I had a prolonged headache, I would probably think that it is
because:
Yes NoHave you had a prolonged headache in the last 3 months?
A loud noise, bright light or something else has irritated me
There is something wrong with my muscles, nerves or brain
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Section Five: Symptom Interpretation
5.5 If I felt my heart pounding in my chest, I would probably think
that this is because:
Yes NoHave you noticed your heart pounding in the last 3 months?
There must be something wrong with my heart
I must be really excited or afraid









5.6 If I felt fatigued, I would probably think that it is because:
Yes NoHave you felt fatigued in the last 3 months?
I'm anaemic or my blood is weak
I've been over exerting myself or not exercising enough









5.7 If I noticed my hand trembling, I would probably think that it is
because:
Yes NoHave you noticed your hands trembling in the last 3 months?
I've tired the muscle in my hand
I'm very nervous









5.8 If I had trouble sleeping, I would probably think that it is because:
Yes NoHave you had trouble sleeping in the last 3 months?
I'm worrying too much or I must be nervous about something
I'm not tired or I had too much coffee
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Section Five: Symptom Interpretation
5.9 If my stomach was upset, I would probably think that it is
because:
Yes NoHave you had an upset stomach in the last 3 months?
I've had something to eat that did not agree with me
I have the flu or stomach irritation









5.10 If I lost my appetite, I would probably think that it is because:
Yes NoHave you lost your appetite in the last 3 months?
I have some stomach or intestinal problem
I'm worrying so much that food just doesn't taste good anymore










5.11 If I had a hard time catching my breath, I would probably think
that it is because:
Yes NoHave you had a hard time catching your breath in the last 3 months?
I'm over excited or anxious
The room is stuffy or there is too much pollution in the air









5.12 If I noticed numbness or tingling in my hands or feet, I would
probably think that it is because:
Yes No
Have you had numbness or tingling in your hands or feet in the last
3 months?
I am cold or my hand or foot went to sleep
There is something wrong with my nerves or blood circulation
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Section Five: Symptom Interpretation
5.13 If I was constipated or irregular, I would probably think that it is
because:
Yes NoHave you been constipated in the last 3 months?
There is something wrong with my bowels or intestine
Nervous tension is keeping me from being regular
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6.3 Fire, flood, or other natural disaster












6.7 Serious physical attack or assault
6.8 Threatened / harassed without weapon
No Yes
6.9 Threatened with weapon / held captive / kidnapped





6.12 Witnessed domestic violence
No Yes
No Yes
6.13 Finding dead body
6.14 Witnessed someone suicide or attempt suicide
No Yes
6.15 Child abuse - physical




6.17 Any other stressful event, please specify: No Yes
6.18 Did you ever suffer a great shock because one of these
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Section Seven: Alexithymia
7.3 I have physical sensations that even doctors
don't understand.
7.4 I am able to describe my feelings easily.
7.5 I prefer to analyse problems rather than just
describe them.
7.1 I am often confused about what emotion I am
feeling.














7.7 I am often puzzled by sensations in my body.
7.8 I prefer to just let things happen rather than to
understand why they turned out that way.
7.9 I have feelings that I can't quite identify.
7.6 When I am upset, I don't know if I am sad,
frightened, or angry.
7.10 Being in touch with emotions is essential.
7.13 I don't know what's going on inside me.
7.14 I often don't know why I am angry.
7.15 I prefer talking to people about their daily
activities rather than their feelings.
7.11 I find it hard to describe how I feel about
people.
7.12 People tell me to describe my feelings more.
7.17 It is difficult for me to reveal my innermost
feelings, even to close friends.
7.18 I can feel close to someone, even in
moments of silence.
7.19 I find examination of my feelings useful in
solving personal problems.
7.16 I prefer to watch "light" entertainment shows
rather than psychological dramas.
7.20 Looking for hidden meanings in movies or
plays distracts from their enjoyment.
Using the scale provided as a guide, indicate how much you agree or disagree with each of the following statements
by shading the corresponding circle. Give only one answer for each statement.
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Teleform Postdeployment Survey_JB_20110829-v6.pdf
For the purposes of this study, deployment to the Middle East Area of Operations
includes:
- Deployment to Iraq or areas supporting operations in Iraq;
- Deployment to Afghanistan or areas supporting operations in Afghanistan.
For more information please refer to the instructions on the following page. If you
are still uncertain regarding your eligibility to participate in this study, please contact
the study team on 1800 232 904 or email cmvh@adelaide.org.au
Middle East Area of Operations (MEAO)
Prospective Health Study
Post Deployment Questionnaire
Part 1: Post Deployment Health Questionnaire
Part 2: Deployment Experiences Questionnaire
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Instructions to complete this questionnaire:
This questionnaire asks about your physical and mental health.
All information you provide in this questionnaire will be
de-identified and will not be linked to other data we have
collected about your health without your consent.
Please complete all sections by following the instructions at the
beginning of each question. Please shade circles, rather than
ticking or crossing them, and write clearly and in capital letters.
If you make a mistake and wish to change your answer, simply
cross out your mistake and choose the answer that is right for
you.
Please use blue or black pen, not pencil.
Some questions may seem repetitive, but this is necessary due
to the questions being grouped into scales.
If you have any questions, please call us on 1800 232 904.
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SUPPORT
If you require support in regards to anything in this questionnaire, please refer to the contacts
provided below:
ALL HOURS SUPPORT LINE (a confidential telephone triage support service for ADF members and their
families)
1800 628 036; outside Australia +61 2 9425 3878
LIFELINE
13 11 14
VETERANS AND VETERANS' FAMILY COUNSELLING SERVICE
1800 011 046
VETERANS' AFFAIRS NETWORK (VAN)
1300 551 918; non-metro 1800 555 254
DEPARTMENT OF VETERANS' AFFAIRS
13 32 54
NATIONAL OFFICE FOR THE MILITARY COMPENSATION AND REHABILITATION SERVICE
1300 550 461
For questions, problems or concerns, or to have your name removed from the mailing list please
contact:
THE STUDY TEAM: The Centre for Military and Veterans' Health
Freecall 1800 232 904; cmvh@adelaide.edu.au
FIRST CHIEF INVESTIGATOR: Professor Annette Dobson, University of Queensland
(07) 3365 5346; a.dobson@uq.edu.au
If you prefer to speak to an independent officer of the Universities or Defence Force not involved in the
study, you may contact an ethics officer on the numbers listed below:
THE AUSTRALIAN DEFENCE HUMAN RESEARCH ETHICS COMMITTEE
Executive Secretary: (02) 6266 3837; ADHREC@defence.gov.au
THE UNIVERSITY OF ADELAIDE RESEARCH BRANCH
Secretary, Human Research Ethics Committee: (08) 8303 6028
THE DEPARTMENT OF VETERANS' AFFAIRS HUMAN RESEARCH ETHICS COMMITTEE
HREC Coordinator: (02) 6289 6204; ethics.committee@dva.gov.au
ID:
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Section One: Background Details
1.2 Are you male or female?
1.3 What is your date of birth? (dd/mm/yyyy)
Male Female
1.6 How satisfied are you with your current marriage / relationship? Extremely satisfied
Satisfied




1.7 Have you or your spouse / partner seriously suggested the idea of
divorce or permanent separation since the beginning of your last
deployment to the MEAO?
Yes No Not applicable
1.1 What is today's date? (dd/mm/yyyy)
Married and living together
Married with unaccompanied spouse
Living with partner (ADF recognised)
Living with partner (not ADF recognised)
In a long term relationship but not living together
(i.e. married partner currently lives elsewhere)
1.4 Are you currently in a significant intimate relationship?
1.4a Are you:
Never married - go to question 1.8
Previously married but now divorced - go to question 1.8
Previously married but now separated - go to question 1.8
Other, please specify: - go to question 1.8
1.4b Are you:
- go to question 1.4b
- go to question 1.4aYes
No
(i.e. married partner currently lives elsewhere)
1.5 Were you in a significant intimate relationship before the beginning of your
last deployment to the MEAO?
Married and living together
Married with unaccompanied spouse
Living with partner (ADF recognised)
Living with partner (not ADF recognised)
In a long term relationship but not living together
1.5a Were you:
Never married - go to question 1.8
Previously married but now divorced - go to question 1.8
Previously married but now separated - go to question 1.8
Other, please specify: - go to question 1.8
1.5b Were you:
- go to question 1.5b
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Section One: Background Details
1.9 Which category best describes the highest educational
qualification you have completed? Choose one.
Primary school
Secondary school up to grade 10
Secondary school grades 11-12




1.10 How many hours per week do you usually work, when you are not on deployment? hours
1.11 To the nearest year, how long have you served with the Australian Defence Force: (if more than 0, but less than 1
year, please enter 1)
a) As a regular?
b) As a reservist?
1.12 What is your CURRENT rank or what
WAS your rank when you left the
military?
Senior Commissioned Officer (CMDR / LTCOL / WGCDR and above)
Commissioned Officer (LCDR / MAJ / SQNLDR and below)
Senior Non-Commissioned Officer (PO / SGT and above)
Junior Non-Commissioned Officer (LS / CPL and below)
Other ranks (AB / SMN / PTE / LAC / AC or equivalent)
1.13 In the past THREE YEARS, roughly how many months in total have you been away on
Operational deployment? (if more than 0, but less than 1 month, please enter 1)
months
If you are still a member of the regular Australian Defence Force, please go to Section Two.
If you are a Reservist or have discharged from the regular Australian Defence Force, please complete the
following questions.
years or Not applicable
years or Not applicable
1.8 Overall, what impact have your military commitments (now, or in the past if you have left the military) had on your:
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Section One: Background Details
1.16 What is your current employment status? Paid employment full-time
Paid employment part-time / casual




Not working due to ill-health / TPI
Unemployed
Other, please specify:
1.17 Since you separated from the ADF, have you had a period of
unemployment greater than 3 months?
If YES, was this period of unemployment primarily due to health problems?
If YES, please specify type:
Yes No Not applicable
Yes No
1.18 What is your main source of income now? Choose one. Wage or salary
Own business or share in a partnership
Age Service pension
Invalidity Service Pension
Compensation benefit under the VEA
Compensation benefit under the SRCA
Compensation benefit under the MRCA
Other government pension / allowance / benefit
Child allowance
Superannuation / annuity
Dividends / interest / income from investments
Other, please specify:
1.14 What year did you discharge from the Regular Australian Defence Force?
or
Not applicable, I am a Reservist
1.15 Did you discharge to the Reserves
or out of the ADF completely? Reserves Out of ADF Not applicable, I have always been a reservist
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Section Two: Recent Health Symptoms
We would like to know about your health in the past month. Please indicate whether or not you have suffered any of





2.4 Irritability / outbursts of anger
2.5. Unable to breathe deeply enough
2.6 Faster breathing than normal
2.7 Feeling short of breath at rest
2.8 Wheezing
2.9 Sleeping difficulties
2.10 Feeling jumpy / easily startled
2.11 Feeling unrefreshed after sleep
2.12 Fatigue
2.13 Double vision
2.14 Intolerance to alcohol
2.15 Itchy or painful eyes
2.16 Rash or skin irritation
2.17 Skin infections e.g. boils
2.18 Skin ulcers
2.19 Shaking
2.20 Tingling in fingers and arms
2.21 Tingling in legs and toes
2.22 Numbness in fingers / toes
2.23 Feeling distant or cut off from others
2.24 Constipation
2.25 Flatulence or burping
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
In the past month have you suffered from: NO YES
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Section Two: Recent Health Symptoms




2.32 Lump in throat
2.33 Sore throat
2.34 Forgetfulness
2.35 Dizziness, fainting or blackouts
2.37 Feeling disorientated
2.38 Loss of concentration
2.39 Difficulty finding the right word
2.40 Pain on passing urine
2.41 Passing urine more often
2.42 Burning sensation in the sex organs
2.43 Loss of interest in sex
2.44 Problems with sexual functioning
2.45 Increased sensitivity to noise
2.46 Increased sensitivity to light
2.47 Increased sensitivity to smells or odours
2.48 Ringing in the ears
2.49 Avoiding doing things or situations
2.50 Pain, without swelling or redness, in several joints
2.51 Joint stiffness
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe2.52 Feeling that your bowel movement is not finished
2.36 Seizures or convulsions
2.30 Pain in the face, jaw, in front of the ear, or in the ear
2.29 Dry mouth
2.26 Stomach cramps No Mild Moderate Severe
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Section Two: Recent Health Symptoms
In the past month have you suffered from: NO YES




No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
2.60 Tender or painful swelling of lymph glands in neck,
armpit or groin
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe
No Mild Moderate Severe2.67 Unintended weight loss greater than 4kg
2.66 Unintended weight gain greater than 4kg
2.65 Stomach bloating
2.56 Difficulty speaking
2.57 Low back pain
2.58 Night sweats which soak the bed sheets
2.59 Feeling feverish
2.54 General muscle aches or pains
2.55 Loss of balance or coordination
No Mild Moderate Severe
No Mild Moderate Severe
2.53 Changeable bowel function (mixture of diarrhoea /
constipation)
No Mild Moderate Severe
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Section Two: Recent Health Symptoms
Memory problems or lapses
Balance problems or dizziness
Sensitivity to bright light
Irritability
Headaches
2.68 Since the beginning of your last deployment, have you experienced any of the following events?
2.69 How many times in total have you experienced each of the following symptoms immediately after any of the
events listed above?
2.70 Did any of the following problems begin or get worse after any of the events listed above?
If NO to all events in 2.68: please skip to question 3.1. Otherwise, continue.
Loss of consciousness / "knocked out"
Being dazed, confused, or "seeing stars"








Blast or Explosion IED (improvised explosive device)
Vehicular accident / crash (any vehicle, including aircraft)














Memory problems or lapses
Balance problems or dizziness
Sensitivity to bright light
Irritability
Headaches
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Section Three: Your Health Now
3.1 In general, how would you say your health is? Excellent Very good Good Fair Poor
Moderate activities, such as moving a table,
pushing a vacuum cleaner, bowling, or
playing golf?
Climbing several flights of stairs?
Yes, limited a lot Yes, limited a little No, not limited at all
3.2 The following questions are about activities you might do during a typical day. Does your health now limit you in
these activities? If so, how much?
Yes, limited a lot Yes, limited a little No, not limited at all
3.5 During the past 4 weeks, how much did pain interfere with your normal work (including both work outside the
home and housework)?
Not at all A little bit Moderately Quite a bit Extremely
Accomplished less than you would like
Did work or other activities less carefully than usual
3.3 During the past 4 weeks, how much of the time have you had any of the following problems with your work or
other regular daily activities as a result of your physical health?
Accomplished less than you would like
Were limited in the kind of work or other activities
3.4 During the past 4 weeks, how much of the time have you had any of the following problems with your work or
other regular daily activities as a result of any emotional problems (such as feeling depressed or anxious)?
Have you felt downhearted and depressed?
Have you felt calm and peaceful?
















3.6 These questions are about how you feel and how things have been with you during the past 4 weeks. For each
question, please give the one answer that comes closest to the way you have been feeling. How much of the time
during the past 4 weeks...
3.7 During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with
your social activities (like visiting friends, relatives etc.)?
All of the time Most of the time Some of the time A little of the time None of the time
This next set of questions ask for your views about your health. This information will help you to keep track of how you
feel and how well you are able to do your usual activities.
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3.10 Eyesight (with glasses or contact lenses, if you wear them)?
3.12 Memory?
3.13 Teeth and gums?






Section Three: Your Health Now
In general, how would you rate your:
3.8 Overall health?
3.16 In the past four (4) weeks, about how often did you
feel so nervous that nothing could calm you down?
3.17 In the past four (4) weeks, about how often did you
feel hopeless?
3.18 In the past four (4) weeks, about how often did you
feel restless or fidgety?
3.14 In the past four (4) weeks, about how often did you
feel tired for no good reason?













3.20 In the past four (4) weeks, about how often did you
feel depressed?
3.21 In the past four (4) weeks, about how often did you
feel that everything was an effort?
3.22 In the past four (4) weeks, about how often did you
feel so sad that nothing could cheer you up?
3.19 In the past four (4) weeks, about how often did you
feel so restless that you could not sit still?
3.23 In the past four (4) weeks, about how often did you
feel worthless?
The following questions inquire about how you have been feeling over the last four (4) weeks. Please read each
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a) I am able to adapt to change














3.28 Please rate the following statements based on how you have felt in the past 30 days using the scale below.
Section Three: Your Health Now
3.25 [Aside from those days], in the past four (4) weeks, HOW MANY DAYS were you able to work
or study or manage your day to day activities, but had to CUT DOWN on what you did
because of these feelings?
3.26 In the past four (4) weeks, how many times have you seen a doctor or any other health
professional about these feelings?
The next few questions are about how these feelings may have affected you in the past four (4) weeks. You need not
answer these questions if you answered 'None of the time' to all of the previous ten questions about your feelings.
3.24 In the past four (4) weeks, how many days were you TOTALLY UNABLE to work, study or
manage your day to day activities because of these feelings?




None of the time A little of the time Some of the time Most of the time All of the time
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Section Three: Your Health Now
YES NO
3.31 Bowel disorder e.g. diarrhoea, constipation, bleeding
3.32 Eye or vision problems e.g. glaucoma
3.29 High blood pressure
3.30 Migraines
Since returning from your last MEAO deployment, has a medical doctor diagnosed you with, or treated you for any of
the following medical problems or conditions?
3.35 Any other significant infections, please specify type:





3.37 Back or neck problems
3.38 Joint problems
3.44 Dermatitis
3.45 Any other skin problem, please specify type:
3.42 Hay fever
3.43 Ear infection
3.48 Anxiety, stress or depression
3.49 Post traumatic stress disorder
3.46 Skin cancer e.g. squamous cell or basal cell skin cancers
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Section Three: Your Health Now
3.50 Other psychiatric or psychological condition needing treatment or counselling, please
specify type:
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Section Four: Lifestyle Behaviours
NO YES
c. Pipes
d. Smokeless tobacco (e.g. chew, dip, snuff)
a. Cigarettes
b. Cigars
4.1 Since the beginning of your last deployment to the MEAO, have you used any of the following tobacco products?
4.2 In your lifetime, have you smoked at least 100 cigarettes (5 packs)?
No
Yes
- please skip to question 4.9
4.4 How many years have you, or did you, smoke an average of at least 3 cigarettes per day
(or one pack per week)?
4.5 When smoking, how many packs (25 cigarettes) per day did you, or do
you, smoke?
4.3 At what age did you start smoking? years old
years
Less than half a pack per day
Half to 1 pack per day
1 to 2 packs per day
More than 2 packs per day
4.6 Have you ever tried to quit smoking? Yes, and succeeded
Yes, but not successfully
No
4.7 Was your smoking pattern different while on your last deployment to the MEAO?
I did not smoke on deployment
I smoked less than usual while on deployment
I smoked the same amount on deployment as when not deployed
I smoked more than usual while on deployment
I began / restarted smoking on deployment
4.8 If your smoking pattern changed during your deployment, what was the main reason?
- continue to next question
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Section Four: Lifestyle Behaviours
Monthly or 2 to 4 times 2 to 3 times 4 or more
Never Less a month a week times a week4.9. How often do you have a drink containing
alcohol?
4.10 How many 'standard' drinks (see above)
containing alcohol do you have on a typical day
when you are drinking?
4.11 How often do you have six or more drinks on one
occasion?
4.12 How often since the beginning of your last
deployment have you found that you were not able










4.13 How often since the beginning of your last
deployment have you failed to do what was normally
expected from you because of drinking?
In answering the following questions, please remember that a standard drink contains 10g of pure alcohol
1 or 2 3 or 4 5 or 6 7 to 9 10 or more N/A
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Section Four: Lifestyle Behaviours
4.21 On an average day, how many 250 - 375ml beverages containing caffeine do you drink (such as caffeine
containing energy drinks, coffee, tea, coca-cola)?
None 1-2 per day 3-5 per day 6-10 per day 11 or more per day
4.17 Have you or someone else been injured as a
result of your drinking?
4.18 Has a relative, a friend, a doctor or other health
professional been concerned about your
drinking or suggested you cut down?
4.15 How often since the beginning of your last
deployment have you had a feeling of guilt or
remorse after drinking?
4.16 How often since the beginning of your last
deployment have you been unable to remember
what happened the night before because you had
been drinking?
4.14 How often since the beginning of your last
deployment have you needed a drink in the












Yes, but not since the Yes, since the
No beginning of my last beginning of my last
deployment deployment
4.19 Do you presently have a problem with drinking?
4.20 In the next 3 months, how difficult would you
find it to cut down or stop drinking?
Probably
No not Unsure Possibly Definitely
Neither
Very Fairly difficult Fairly Very
easy easy nor easy difficult difficult N/A
Yes, but not since the Yes, since the
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Section Four: Lifestyle Behaviours
4.22 Do you currently take any of the following supplements?
c) Weight loss supplements
a) Body building supplements (such as amino acids, weight gain products, creatine, etc.)
b) Energy supplements (such as energy drinks, pills, or energy enhancing herbs)
Never Less than once a month Monthly Weekly Daily or almost daily
Never Less than once a month Monthly Weekly Daily or almost daily
Never Less than once a month Monthly Weekly Daily or almost daily
If YES, what was the name (generic or brand name) of the supplement(s) that you used?
If YES, what was the name (generic or brand name) of the supplement(s) that you used?
If YES, what was the name (generic or brand name) of the supplement(s) that you used?
Since the beginning of your last deployment...
4.23 Have you bet more than you could really afford to lose?
4.24 Have you needed to gamble with larger amounts of money to




4.25 When you gambled, did you go back another day to try to win
back the money you lost?
4.26 Have you borrowed money or sold anything to get money to
gamble?
4.27 Have you felt that you might have a problem with gambling?
4.28 Has gambling caused you any health problems, including
stress or anxiety?
4.29 Have people criticized your betting or told you that you had a
gambling problem, regardless of whether or not you thought it
was true?
4.30 Has your gambling caused any financial problems for you or
your household?
4.31 Have you felt guilty about the way you gamble or what
happens when you gamble?
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Section Five: Life Experiences
5.2 Repeated, disturbing dreams of a stressful
experience from the past?
5.1 Repeated, disturbing memories, thoughts or
images of a stressful experience from the past?
5.4 Feeling very upset when something reminded you
of a stressful experience from the past?
5.3 Suddenly acting or feeling as if a stressful
experience from the past were happening again
(as if you were reliving it)?
5.10 Feeling distant or cut off from other people?
5.9 Loss of interest in activities that you used to enjoy?
5.6 Avoiding thinking about or talking about a stressful
experience from the past or avoiding having
feelings related to it?
5.5 Having physical reactions (e.g. heart pounding,
trouble breathing, sweating) when something
reminded you of a stressful experience from the
past?
5.8 Trouble remembering important parts of a stressful
experience from the past?
5.7 Avoiding activities or situations because they
reminded you of a stressful experience from the
past?
5.13 Trouble falling or staying asleep?
5.12 Feeling as if your future somehow will be cut
short?
5.11 Feeling emotionally numb or being unable to
have loving feelings for those close to you?
5.14 Feeling irritable or having angry outbursts?
5.15 Having difficulty concentrating?
5.17 Feeling jumpy or easily startled?
5.16 Being "superalert" or watchful or on guard?
Below is a list of problems and complaints that people sometimes have in response to stressful life experiences. Please
read each one carefully, then shade the circle to the right to indicate how much you have been bothered by that
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Section Five: Life Experiences
5.20 Did any of these occur during another overseas deployment?
5.19 Did any of these occur while on your deployment to the MEAO? Yes No
Yes No
If yes, what was that event?
5.21 Is there any other event that has caused you to have similar reactions? No
Yes - while deployed
Yes - while NOT deployed
Year of event
Year
















Below is a list of problems and complaints that people sometimes have in response to stressful life experiences. Please
read each one carefully, then shade the circle to the right to indicate how much you have been bothered by that problem
in the past month.
5.17d Taking too many risks or doing things that cause
you harm?
5.17c Having strong negative feelings such as fear,
horror, anger, guilt, or shame?
5.17b Blaming yourself or someone else severely for the
stressful experience or what happened after it?
5.17a Having strong negative beliefs about yourself,
other people, or the world (for example, having
thoughts such as: I am bad, there is something
seriously wrong with me, no one can be trusted,
the world is completely dangerous)?
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5.24 How often over the last month did you threaten someone with physical violence?
5.23 How often over the last month did you get into a fight with someone and hit the person?
Never One time Two times Three or four times Five or more times
Section Five: Life Experiences
Never One time Two times Three or four times Five or more times
a) I found myself getting angry at people or situations












c) When I got angry, I stayed angry
d) When I got angry at someone, I wanted to hit them
e) My anger interfered with my ability to get my work,
study or other productive activity done
f) My anger prevented me from getting along with
people as well as I'd have liked to
i) My anger had a bad effect on my health
g) I became angry at myself when I did not perform
as well or achieve what I wanted
h) I became angry at myself when I did not handle
social situations as well as I wanted
5.22 Thinking over the past 4 weeks, shade the circle that best describes the amount of time you felt that way.
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Section Five: Life Experiences
5.35 In the last 4 weeks, have you had an anxiety attack - suddenly feeling fear or panic?
If NO: please skip to question 5.50
YESNO
The next group of questions are about anxiety.
5.36 Has this ever happened before?
5.37 Do some of these attacks come suddenly out of the blue - that is, in situations where
you don't expect to be nervous or uncomfortable?
5.38 Do these attacks bother you a lot or are you worried about having another attack?
5.25 Little interest or pleasure in doing things













5.27 Trouble falling or staying asleep, or sleeping too much
5.28 Feeling tired or having little energy
5.29 Poor appetite or overeating
5.30 Feeling bad about yourself, or that you are a failure, or have
let yourself or your family down
5.31 Trouble concentrating on things, such as reading the
newspaper or watching television
5.32 Moving or speaking so slowly that other people could have
noticed? Or the opposite - being so fidgety or restless that you
have been moving around a lot more than usual
5.33 Thoughts that you would be better off dead or of hurting
yourself in some way
5.34 If you checked off any of these problems, how difficult have these problems made it for you to do your work, take
care of things at home, or get along with other people?
Not difficult at all Somewhat difficult Very difficult Extremely difficult
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Section Five: Life Experiences
5.50 Feeling nervous, anxious, on edge, or worrying a lot about different things
If NOT AT ALL: please skip to question 5.57







5.51 Feeling restless so that it is hard to sit still
5.52 Getting tired very easily
5.53 Muscle tension, aches, or soreness
NOT AT
ALL
5.54 Trouble falling asleep or staying asleep
5.55 Trouble concentrating on things, such as reading a book or watching TV
5.56 Becoming easily annoyed or irritable
5.39 Were you short of breath?
5.40 Did your heart race, pound, or skip?
Think about your last bad anxiety attack.
YESNO
5.41 Did you have chest pain or pressure?
5.42 Did you sweat?
5.43 Did you feel as if you were choking?
5.44 Did you have hot flushes or chills?
5.45 Did you have nausea or an upset stomach, or the feeling that you were going to have
diarrhoea?
5.46 Did you feel dizzy, unsteady, or faint?
5.47 Did you have tingling or numbness in parts of your body?
5.48 Did you tremble or shake?
5.49 Were you afraid you were dying?
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5.71 It would stop me from being deployed again.
5.72 It is difficult to schedule an appointment.
5.57 Since the beginning of your last deployment, have you ever felt that life was not worth living?




5.59 Since the beginning of your last deployment, have you made a suicide plan?
5.60 Since the beginning of your last deployment, have you attempted suicide?
No Yes
No Yes
Please shade the circles that best describe your experience.
Section Five: Life Experiences
If you require support in relation to any issues you have identified in this survey, we encourage you to
refer to the contacts provided on Page 3
Using the scale provided, rate each of the possible reasons that might affect your decision to receive mental health
counselling or services if you ever had a problem:
5.63 It would harm my career.
5.62 It would be too embarrassing.
5.65 My unit leadership might treat me differently.
5.64 Members of my unit might have less
confidence in me.





5.67 I would be seen as weak.
5.61 Have you sought help for a stress, emotional, mental health or family problem in the last 12
months?
No Yes
5.68 I don't trust mental health professionals.
5.69 I don't know where to get help.
5.70 I do not have confidence in military health,
administrative, or social services.
5.73 There would be difficulty getting time off
work for treatment.
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Section Six: Your Respiratory Health
6.1 Have you had wheezing or whistling in your chest at any time since the beginning of
your last deployment?
YESNO
The following questions ask you about any respiratory symptoms you may have experienced since the beginning of
your last deployment.
If YES:
a. Have you been at all breathless when the wheezing noise was present?
b. Have you had this wheezing or whistling when you did not have a cold?
6.2 Have you woken up with a feeling of tightness in your chest at any time since the
beginning of your last deployment?
6.3 Have you been woken by an attack of shortness of breath at any time since the
beginning of your last deployment?
6.4 Have you been woken by an attack of coughing at any time since the beginning of your
last deployment?
6.5 Have you had an attack of asthma since the beginning of your last deployment?
6.6 Are you currently taking any medicine for asthma (including inhalers, aerosols, or
tablets)?
6.7 Do you have any nasal allergies including hay fever?
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7.1 Have contact with an ex-service
organisation?













Please answer the folowing questions regarding your recreation and social activities. How often do you…
7.3 Have contact with friends or relatives?
7.4 Attend social activities such as
watching sport, eating meals or
watching movies?
7.5 Play sport (e.g. golf, fishing, exercise)?
7.6 Set aside time to do a hobby (e.g.
wood work, craft, music)?
7.7 Set aside time to relax (e.g. watch
TV, read, listen to music)?
Section Seven: Recreation and Social Activities
EVERY
DAY
7.8 Do voluntary work?
7.9 Do you commemorate significant military-related occasions such as attend ANZAC Day
services, participate in marches or attend dawn services?
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Section Eight: Evaluation Questions
If YES: please give details in the space provided
here.
8.1 Are there other important health concerns we have not asked you about? Yes No
If YES: please give details in the space provided
here.
8.2 Do you have any additional comments you would like to add? Yes No
You are 2/3 of the way through. Keep going!
ID:
Draft




Please answer these questions in relation to your LAST
deployment to the Middle East Area of Operations.
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Section One: Deployment Details
1.1 On your MOST RECENT deployment to the MEAO, were




Other areas in Afghanistan
Other areas supporting Afghanistan
Iraq
Other areas supporting Iraq
Attachment to foreign militaries or UN
1.4 Were you required to work mixed duty cycles (ie. day -
night - day shifts)?
Often Sometimes Rarely Never
1.5 Were you permanently on night shifts during your last deployment to the MEAO?
Combat (e.g. Infantry, Artillery, etc.)
Medical (e.g. RMO, Environmental or Preventive Health, Nurses, Medics)
Security
EOD (Bomb Disposal, IED Technician)





Welfare (e.g. Chaplain, Psychologist)
Trades (e.g. Fitter, Mechanic)
Air Crew - Rotary Wing
Air Crew - Fixed Wing
Flight Operations Cell
Oil Platform Protection
Maritime Operations - Between Deck












1.3 During your last deployment to the MEAO, what were your MAIN duties? (please shade all that apply)
1.2 How many weeks lead time were you given prior to your last deployment to the MEAO?
(if more than 0, but less than 1 week, please enter 1) weeks
1.6 About how many hours per day, on average, were you considered 'on duty'? hours
Yes No
1.7 How many days per month did you not work on your last deployment to the
MEAO? (if more than 0, but less than 1 day, please enter 1) days per month
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Section One: Deployment Details
1.8 What was your rank during your last
deployment to the MEAO?
Senior Commissioned Officer (CMDR / LTCOL / WGCDR and above)
Commissioned Officer (LCDR / MAJ / SQNLDR and below)
Senior Non-Commissioned Officer (PO / SGT and above)
Junior Non-Commissioned Officer (LS / CPL and below)
Other ranks (AB / SMN / PTE / LAC / AC or equivalent)
1.9 Please indicate your service status during your last deployment to the MEAO.
Reservist on full time service Full time member Other, please specify:
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Section Two: Chemical and Environmental Exposures
2.3 Were you exposed to an environment where you inhaled fine
dust or fibres (e.g. driving vehicles, near operating aircraft,
damaged building)?
2.4 Were you exposed to others' cigarette smoke in an enclosed
recreational or work environment?
2.5 Were you exposed to diesel exhaust?
2.1 Were you exposed to smoke from fires / smoke from waste
incineration / oil fire smoke?







During your last deployment to the MEAO, how often…?
2.7 Were you exposed to aircraft fumes?
2.8 Were you exposed to toxic industrial chemicals?
2.9 Were you exposed to solvents (e.g. thinners, sealer, paints)?
2.6 Were you exposed to aviation, marine or automotive fuels?
2.10 Did you live in an area recently sprayed or fogged with
chemicals?
2.15 Were you bitten by flies, sand flies, fleas, mosquitoes or
other insects that required medical attention?
2.13 Were you close to loud noises and did not have hearing
protection (e.g. explosions, weapon fire)?
2.17 Did you come into contact with body fluids or blood?
2.18 Did you receive a blood transfusion?
2.20 Did you eat local food?
2.19 Did you drink from local taps or wells?
2.11 Did you dip your cams to prevent insect bites?
2.12 Did you take medication to prevent or suppress malaria
(e.g. Doxycycline, Primaquine)?
2.14 Were you exposed to noise for extended periods of time
without hearing protection (e.g. machinery, aircraft
operations)?
2.21 Did the food available have a negative effect on your
performance?
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Section Two: Chemical and Environmental Exposures
2.31 Did you use an NBC suit (not for training purposes)?
2.32 Did you use a respirator (not for training purposes)?
2.33 Did you clear / search buildings?
2.28 Did you enter or come in close proximity to recently
destroyed vehicles?






During your last deployment to the MEAO, how often…?
2.36 Did you come under guided or directed mortar / artillery fire
or missile attack?
2.37 Did you experience in-direct fire (e.g. rocket attack)?
2.39 Did you experience an IED / EOD that detonated?
2.35 Did you come under small arms or anti-aircraft fire?
2.41 Did you experience a landmine strike?
2.42 Did you encounter small arms fire from an unknown enemy
combatant (e.g. sniper, civilian with weapon)?
2.43 Did you discharge your weapon in direct combat?
2.27 Did you have contact with depleted uranium shell casings?
2.25 Were you close to sources of non-ionising radiation (e.g.
radar or microwave, or EOD countermeasures)?
2.26 Did you have contact with any chemical or biological
weapons?
2.24 Did you get sunburnt?
2.29 Did you enter or come in close proximity to recently
destroyed structures (e.g. buildings, bunkers, etc.)?
2.38 Did you seriously fear you would encounter an IED?
2.40 Did you experience a suicide bombing?
2.34 Did you clear / search caves?
2.23 Did you have contact with the local population?
2.22 Did you swim or bath in local lakes, rivers or the sea?
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Section Two: Chemical and Environmental Exposures
2.55 Were you witness to human degradation and misery on a
large scale?
e.g. refugee camps, starvation
2.56 Did you hear of a loved one who had been injured or killed?
2.57 Were you present when a loved one was injured or killed?
2.53 Were you present when a close friend or co-worker was
injured or killed?
e.g. combat, MVA, disaster situation
2.54 Did you fear that you had been exposed to a contagious
disease, toxic agent or injury?





During your last deployment to the MEAO, how often…?
2.59 Do you believe your actions or inaction resulted in someone
being killed?
e.g. in combat or as a result of rules of engagement or UN
restrictions not allowing you to act
2.58 Do you believe your action or inaction resulted in someone
being seriously injured?
e.g. in combat or as a result of rules of engagement or UN
restrictions not allowing you to act
2.52 Did you hear of a close friend or co-worker who had been
injured or killed?
e.g. combat, MVA, disaster situation
2.49 Were you in danger of being injured?
e.g. combat, MVA, assault, hostage situation
2.50 Did you handle dead bodies?
e.g. combat, civilian casualties
2.51 Did you see dead bodies?
e.g. combat, civilian casualties
2.48 Were you in danger of being killed?
e.g. combat, motor vehicle accident (MVA), assault, hostage
situation
2.47 Were you concerned about yourself or others (including
allies) having an unauthorised discharge of a weapon?
2.46 Did you participate in support convoys (eg. re-supply, VIP
escort)?
2.45 Did you go on combat patrols or missions?
2.44 Did you experience a threatening situation where you were
unable to respond due to the rules of engagement?
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2.61 Are there any additional experiences you would like to tell us about? Please comment.
2.60 During your last deployment to the MEAO, for how long were you outside your base in
a hostile area in total?
Not at all
Up to one week
Up to one month
More than a month
Section Two: Chemical and Environmental Exposures
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Section Three: Your Work on Deployment
3.1 Did you feel that the work asked of you in theatre generally matched your trade experiences and ability?
3.2 Thinking of one very difficult experience on this deployment, do you feel that:
Yes
No, work was generally above my trade experience and ability
No, work was generally beneath my trade experience and ability
Yes No
b) You did what was expected of you?
a) Your colleagues did what was expected of them?
Yes No
3.5 I had all the supplies and equipment needed
to get my job done
3.3 I experienced pain or injury from using the
equipment provided to me














3.6 If you agree with any of the above 3 questions, please give examples:
The following statements relate to the equipment you were provided with while on your last deployment to the MEAO.
Please indicate the degree to which you either agree or disagree with each statement.
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Section Three: Your Work on Deployment
c) My superiors were interested in what I did or
thought
d) I felt well informed about what was going on in
my Unit
a) I felt a sense of comradeship (or closeness)
between myself and other people in my Unit
b) There was someone I could go to in my Unit if I








3.8 How much do you agree or disagree with the following statements?




d) Take part in Hearts and Minds campaigns, e.g.
interacted with the community?
e) Work with DFAT* / NGO** or Aid organisations*** to
assist the locals?
a) Work with the National Police / Army (e.g. patrols)?













3.7 The following questions ask about your work during your last deployment to the MEAO. Please answer how often
you performed these duties during your deployment, and if you did perform the duty, whether you think this
benefited the local community.
YES NO
* DFAT = Department of Foreign Affairs and Trade
** NGO = Non-Government Organisation
*** Aid Organisation = e.g. Red Cross
c) Train local Police / Army?
e) I had good communication with other Australian
forces / Australian H.Q. from my Unit
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Section Four: Your Health on Deployment
4.1 How many times did you attend sick parade during your LAST deployment to the MEAO?
a) Injury from a motor vehicle accident
b) Injury sustained in combat






c) Musculoskeletal injury sustained in your job / role (not combat related)
d) Musculoskeletal injury sustained during training
e) Musculoskeletal injury sustained during recreation or sport
NO
f) Head injury / concussion
g) Heat stress / exhaustion / dehydration
h) Effects of cold or exposure
i) Respiratory illness (e.g. cold / flu)
j) Dental problems
k) Skin rashes / irritations
m) Other, please specify:
If YES, how long were you unconscious?
l) Diarrhoea and/or vomiting
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Section Four: Your Health on Deployment
4.10 During your last deployment to the MEAO, on an average day, how many 250 - 375ml beverages containing
caffeine did you drink (such as caffeine containing energy drinks, coffee, tea, coca-cola)?
4.2 Did the symptoms of diarrhoea and/or
vomiting prevent you from carrying out
your duties?
If you had diarrhoea or vomiting during your last deployment to the MEAO:
Yes No Not Applicable, I did not have diarrhoea or vomiting
4.3 Did you need intravenous fluids (a drip) as
a result of diarrhoea and/or vomiting?
Yes No Not Applicable, I did not have diarrhoea or vomiting
None 1-2 per day 3-5 per day 6-10 per day 11 or more per day
4.4 Did the symptoms of diarrhoea or vomiting
resolve when you exited the MEAO?
Yes No Not Applicable, I did not have diarrhoea or vomiting
4.5 How well did you sleep?
In regard to your sleep and rest while on your last deployment to the MEAO:
Very poorly Poorly Neither good nor poorly Good Very good
4.6 How satisfied were you with your sleep?
4.7 Did you have difficulties with sleeping?
Very dissatisfied Dissatisfied Neither satisfied nor dissatisfied Satisfied Very satisfied
Not at all A little A moderate amount Very much An extreme amount
4.8 How much did any sleep problems worry you?
Not at all A little A moderate amount Very much An extreme amount
4.9 Did you take any medication to help you sleep? No Yes, once or twice Yes, regularly
ID:
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Section Four: Your Health on Deployment
c) Weight loss supplements
a) Body building supplements (such as amino acids, weight gain products, creatine, etc.)
b) Energy supplements (such as energy drinks, pills, or energy enhancing herbs)
Never Less than once a month Monthly Weekly Daily or almost daily
4.11 During your last deployment to the MEAO, did you take any of the following supplements?
Never Less than once a month Monthly Weekly Daily or almost daily
Never Less than once a month Monthly Weekly Daily or almost daily
If YES, what was the name (generic or brand name) of the supplement that you used?
If YES, what was the name (generic or brand name) of the supplement that you used?
If YES, what was the name (generic or brand name) of the supplement that you used?
4.12 Compared to your health BEFORE your last deployment to the MEAO, how would you rate your health in general
NOW?
Much better now Somewhat better now About the same Somewhat worse now Much worse now
4.13 To what extent do you agree with the following statement?
The change in my health is because of my last deployment to the MEAO.
Strongly Agree Agree Neither Agree nor Disagree Not applicable Disagree Strongly Disagree
ID:
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Section Five: Other Deployment Experiences
a) I received enough personal support from my family
b) I had serious financial problems
5.1 During your last deployment to the MEAO, did you have any major personal problems at home? (e.g. financial
problems, family problems, etc). Please shade ONE circle for each statement.
NOT
APPLICABLEDISAGREE
c) My partner / spouse left me
d) There were problems with my children
e) I was concerned I might lose my civilian job
AGREE
f) I faced other major problems at home whilst deployed
5.2 Did the military provide any reassurance / support to your spouse /
partner whilst you were deployed? (e.g. phone calls or visits, arranging
'get togethers' with other service families, newsletters, etc.)
Yes, it was sufficient
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Section Six: Post Deployment Experiences
6.1 Why did you exit from theatre? (Please shade ONE circle only)
End of Deployment
CASEVACed through combat related injury
CASEVACed through non-combat related injury
Compassionate leave
Problems at home
Routine change of role / appointment / posting
To attend professional courses
Other, please specify:
6.2 Did you receive a Return to Australia Psychological Screen brief? Yes No
6.4 After leaving the theatre of operation, did you have a short period of time somewhere away from the operation
area for you to relax before returning to your home base?
Yes No - please skip to question 6.6
a) For how many days?
6.5 If YES:
b) Was the majority of this time…? Structured (a daily programme of activities, e.g. fitness)
Unstructured (no planned activities)
c) Did you find this period of time useful? Yes No
d) What were the good points?
e) What were the bad points?
6.3 Do you believe this process was useful? (please shade ONE circle only)
If YES:
Not at all useful Not particularly useful Neither useful nor un-useful Somewhat useful Extremely useful
ID:
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6.6 After returning to your usual home base, were you required to spend some time in or around your home Unit
before being allowed to go on Post Operational Leave?
Yes
No
Not applicable, did not go on Post Operational Leave
- please skip to question 6.8
a) For how many days were you required at your home Unit?
6.7 If YES:
b) Was the majority of this time…? Structured (a daily programme of activities e.g. fitness / administration)
Unstructured (no planned activities)
c) Did you find this period of time useful? Yes No
d) What were the good points?
e) What were the bad points?
- please skip to question 6.8
6.8 How long was it before you could relax properly on return to Australia?
Immediately 1 Week 2 Weeks 3-4 Weeks 4-8 Weeks 9 or more weeks Have not
6.9 How long before you stopped scanning the environment for risk?
Immediately 1 Week 2 Weeks 3-4 Weeks 4-8 Weeks 9 or more weeks Have not
6.10 Overall, do you think the Australian public were supportive of the mission to the MEAO
during your MOST RECENT deployment?
Yes No
6.11 Since returning home from your last deployment, has anyone had a go at you, or given you
a hard time because you went to the MEAO?
Yes No
Section Six: Post Deployment Experiences
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a) I was well supported by the military
b) I found it difficult to adjust to being back home
6.12 To what extent do you agree or disagree with the following statements?
NOT
APPLICABLEDISAGREE
c) People didn't understand what I had been through
d) I did not want to talk about my experiences with my family / friends
e) I found it difficult to resume my normal social activities
AGREE
f) I had serious financial problems
In the weeks after I came home...
g) I argued more with my spouse / partner
h) I have been let down by people who I thought would stand by me
i) I had other major problems on return from deployment
a) Loss of seniority, promotion opportunity, or responsibility
b) Medical classification (MEC) downgraded
Yes No
6.13 Were any of the following a problem?
Yes No
6.14 Overall, have your experiences on YOUR LAST DEPLOYMENT TO THE MEAO made you more or less likely to
continue your military career?
Very Likely No difference Less likely Already Discharged
Section Six: Post Deployment Experiences
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If YES: 6.16 In the weeks after you returned from your deployment:
Please answer the following questions if you DEPLOYED AS A RESERVIST.
Otherwise, please go to Section Seven.
6.17 Were you in civilian employment at the time of your call-up for deployment?
Yes No Already in full time regular service or equivalent
6.18 Post-deployment, did you return to the same job you held before your deployment?
Yes
No, resigned at time of call-up / mobilisation
No, contract of employment ended just before / during deployment
No, employer kept job open for me but I chose not to return
No, employer did not keep job open for me, but I wanted to return
No, employer did not keep job open for me, and I didn't want to return
No, other reason, please specify:
6.15 Were you married or in a significant relationship when you last
deployed to the MEAO?
Yes No - go to question 6.17
a) How well did your partner meet your needs?
b) How good was your relationship compared to most?
1 2 3 4 5
c) How often did you wish you hadn't married or lived
together?
d) To what extent did your marriage or relationship meet your
original expectations?
e) Which best described the degree of happiness, all things considered, in your relationship at the time?
1 2 3 4 5
1 2 3 4 5









a) Loss of seniority, promotion opportunity, or responsibility in civilian job
b) Loss of income during call-up
6.19 Were any of the following a problem?
NOT
APPLICABLENO
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Section Seven: Final Questions
If YES: please give details in the space provided
here.
7.1 Are there other important military experiences or exposures we have not asked you about? Yes No
As a check of our coverage in this questionnaire, please answer these final questions.
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Introduction
During the last decade, over 2�5 million United 
States (US) and coalition troops have deployed 
to Iraq and Afghanistan�1-3 In addition to combat 
injuries, late health effects of operational service 
are well recognised 4, particularly psychological 
and physical effects of deployment exposures� 
There is also increasing evidence suggesting a 
higher prevalence of respiratory conditions among 
international military personnel deployed to the 
Middle East Area of Operations (MEAO)�5-7 Although 
no specific risk factors other than deployment 
have been definitively linked to these respiratory 
health outcomes, there are many characteristics 
of deployment that may raise the risk of adverse 
respiratory health effects, including exposure to 
various airborne contaminants, burn pits, dust, 
particulate matter, industrial fires and traumatic 
exposure�5, 6 In addition, evidence suggests tobacco 
smoking, physical activities and other individual 
susceptibility factors such as age, sex, body mass 
index (BMI), blood pressure, physical fitness, pre-
existing conditions and personal characteristics 
may also increase the risk of respiratory symptoms 
and may enhance susceptibility to environmental 
exposures�8-11
Although many studies have reported increases in 
respiratory conditions and symptoms among military 
personnel, existing knowledge regarding underlying 
aetiology is yet to be fully clarified� Therefore, a 
systematic review of research into the impacts 
of deployment on respiratory function among 
contemporary military Veterans of deployments to the 
MEAO was undertaken� The aim of this review was 
to examine the evidence regarding specific exposures 
and risk factors in the deployment environment 
that could be associated with respiratory symptoms 
and illnesses among military Veterans, and to 
ascertain whether there are unique risk factors and 
manifestations of respiratory health among deployed 
personnel� In this review, we summarise the existing 
published research related to the respiratory 
health of military personnel deployed to Iraq and 
Afghanistan, and examine evidence regarding 
associations between various deployment and other 
factors, and respiratory health� To provide context 
for the review, we first describe key respiratory 
health outcomes and potential exposures relevant 
to the military and deployed environment, and how 
these could be associated with respiratory health of 
MEAO deployed Service members� Following this, the 
available evidence regarding the association between 
Systematic Review of The Impact 
of Deployment on Respiratory 
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International and Australian 
Veterans’
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Abstract
Current international literature suggests a higher prevalence of respiratory conditions in military personnel 
during and following deployment to the Middle East for reasons that are not well understood� Therefore, a 
systematic review of research into the impacts of deployment on respiratory function among international and 
Australian contemporary military Veterans was undertaken�
The findings from this review suggest that deployment-related environmental, psychological trauma exposures 
and other military factors such as physical activity, increased tobacco use and individual susceptibility markers 
could contribute to respiratory conditions and other health effects not yet identified�
Key words: respiratory conditions, Middle East, military veterans, deployment, risk factors, exposure
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Key findings of articles, country of origin, 
measurement, population and sample size are 
presented in Appendix 1� Where possible a military 
comparison group was preferred; however, broader 
criteria were used to provide the most comprehensive 
overview of available published research� Due to the 
limited research in this area, studies of lower levels of 
evidence addressing issues of interest were retained, 
although findings were interpreted with caution and 
used as supporting rather than primary evidence 
sources� A total of 172 papers were evaluated by the 
lead author, with ~50% n=87) also evaluated by the 
second author� Following this process, a total of 85 
papers were included in this review (see Figure 1)�
Figure 1: Studies obtained from initial database searches
Results
Preliminary assessment of studies identified the 
following key areas where the impact of deployment 
on these respiratory outcomes could be examined�
• Environmental and/or chemical exposures 
including; particulate matter (including metal 
particles), burn pits and air pollution
• Trauma and combat exposures including; blast, 
trauma/stress
• Other exposures/factors including; physical 
activity, smoking and individual susceptibility 
factors�
Papers were grouped accordingly� An assessment 
of the available evidence was summarised for each 
outcome, and conclusions regarding the state of 
evidence in the area as a whole presented, including 
an overview of notable gaps� Key study information 
and findings, organised by topic, are summarised in 
Appendix 1�
military deployment risk factors and respiratory 
health will be reviewed�
Methods
A systematic literature search of library databases 
was undertaken in May 2016, including, Embase, 
PubMed and Scopus� Emtree and MeSH Indexing 
languages were used in Embase and PubMed 
databases respectively (there is no indexing language 
available for Scopus)� The following keywords were 
searched in titles, abstracts and texts: respiratory, 
respiratory tract diseases, lung disease, acute lung 
injuries, lung function test, respiratory function, 
veterans, veteran’s health, military, military 
personnel, defence, deployment, armed conflicts, 
Afghan campaign 2001, Operation Enduring 
Freedom (OEF), Iraq wars 2003-2011,Operation 
Iraqi Freedom (OIF), air pollutants, environmental 
exposure, inhalational exposure, air environmental 
pollutant, combat disorder, trauma and stressor 
related disorder, and tobacco smoking�
To broaden the search, the reference lists of all 
included studies were examined to identify any other 
potentially relevant papers (pearling)� Results were 
limited to studies published in English from the year 
1997 to 2016�
Exclusion criteria from the initial search included:
• Editorials or correspondence
• Items that were not journal articles, reviews, 
clinical trials, government publications or 
observational studies
• Languages other than English
• Published prior to 1997
• Items not published in peer-reviewed journals
• Included ages less than 18
• Items that did not involve military, veterans or 
servicemen
• Items that did not report respiratory problems�
Included studies were assessed on their design and 
level of evidence according to the Australian National 
Health and Medical Research Council (NHMRC) 
hierarchy of evidence�12 Inclusion criteria were 
further refined to focus on:
• Deployed Service members or Veterans of military 
forces
• The impact of deployment exposures and 
associations with respiratory health�
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pearling) 
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Respiratory health outcomes in deployed 
military populations
International studies have documented an increased 
incidence of respiratory disorders in military personnel 
who served in the Middle East compared with non-
deployed populations�5-7 Overall, studies have 
reported increased rates of non-specific respiratory 
symptoms, asthma and constrictive bronchiolitis 
in deployed military personnel, with evidence that 
exposures while on deployment contribute to this 
via direct actions and by disturbance of the immune 
system�
In a study of the causes underlying respiratory 
symptoms in military personnel returning from duty 
in Iraq and Afghanistan by Morris et al� (2013), 42% 
of US Veterans reported non-specific respiratory 
symptoms, although most did not reach the threshold 
for a specific clinical diagnosis�13 The majority of 
patients who did receive a specific diagnosis had 
evidence of asthma or nonspecific airway hyper-
reactivity� This may have reflected aggravation of 
pre-existing disease13 or hyper-activation of the 
immune system�14 Smith et al� (2009) also reported 
that deployment was associated with respiratory 
symptoms in both US Army and Marine Corps 
personnel, independent of smoking status and 
deployment length was positively associated with 
increased symptom reporting in Army personnel� 
This study concluded that specific exposures rather 
than deployment in general are determinants of post-
deployment respiratory illness�6 Further recent US 
studies have also implicated inhalational exposures 
during deployment as predictors of constrictive 
bronchiolitis and new-onset asthma in Veterans�15, 16
In this review, we describe the most prevalent 
respiratory health outcomes reported among 
military personnel including asthma, constrictive 
bronchiolitis (CB), chronic obstructive pulmonary 
disease (COPD), respiratory infection and acute 
eosinophilic pneumonia (AEP)�
Asthma
Asthma, a form of reversible bronchospasm, is 
usually connected to allergic reaction or other 
forms of airway hypersensitivity� Given the nature 
of deployment exposures, deployed populations may 
be at risk of increased inflammation, which in turn 
can impact on respiratory function�17 Since 2004, US 
military candidates diagnosed with asthma after the 
age of 13 have been excluded from military enlistment 
unless exempted via medical waiver�16 Entry to the 
Australian Defence Force (ADF) for people with 
asthma similarly changed post 2007� Currently 
candidates with mild asthma may be considered 
for entry to the ADF subject to certain criteria, 
including normal spirometry and negative bronchial 
provocation testing�18 However, rates of asthma 
among serving military personnel are generally low, 
in comparison to the general population� Despite 
low asthma rates at intake into the military, asthma 
diagnoses have increased in the US military since 
the beginning of the Iraq Afghanistan war�6, 19 The 
US Department of Defense reported that 13% of US 
Army Medical visits in Iraq were for new-onset acute 
respiratory illness�16
Recently, an increasing number of studies have 
reported consistent positive associations between 
psychosocial stress and asthma6, 13, 16, 20 suggesting 
that, in the context of military service and deployment 
specifically, both environmental exposures and 
also the psychological stress of deployment should 
be considered as important contributing factors� 
In relation to deployment specifically, several 
studies provide evidence of an association between 
deployment and new-onset asthma and other 
respiratory symptoms�6, 16, 19 A retrospective review 
of medical diagnoses by Szema et al� (2010) of more 
than 6 000 US military personnel deployed and 
subsequently discharged from military active duty, 
reported that deployment to Iraq was associated 
with a higher risk of having a new International 
Classification of Diseases-9 (ICD-9) diagnosis 
of asthma post deployment�16 Similar findings 
were documented in occupationally exposed first 
responders to the World Trade Center disaster�21-23
In a case control study, Abraham et al� (2012) 
reported an increase in post-deployment respiratory 
symptoms and medical encounters for obstructive 
pulmonary diseases, relative to pre-deployment 
rates, in the absence of an association with 
cumulative deployment duration or total number of 
deployments, indicating that it may be more specific 
exposures having an impact rather than deployment 
alone�24 However, in contrast, DelVecchio et al� (2015) 
evaluated 400 US Army personnel with a clinical 
diagnosis of asthma and found that there was no 
significant relationship between rates of diagnosis 
or severity based on history of deployment�25 The 
findings from this retrospective study may indicate 
that deployment-related lung conditions are subtle 
and require careful evaluation over time to determine 
the long-term impacts of deployment on the 
development of respiratory disease� Furthermore, 
this study did not focus on deployment-related 
environmental exposures, which may explain why 
no association was found�
Despite screening processes in many international 
militaries, pre-existing disease may also play a role 
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in the development of respiratory symptoms� In a 
prospective study Morris et al� (2007) examined 
airway hyper-reactivity in asymptomatic US military 
personnel�19 Asymptomatic airway obstruction had a 
prevalence of 14% in young military personnel with 
evidence of worsening obstruction during exercise� 
This suggests that rates of asymptomatic asthma may 
be higher than previously recognised� Results of a 
cross-sectional study by Roop et al� (2007) suggested 
that asthmatics with good baseline symptom 
control are similar to non-asthmatics in their risk 
of developing worsening respiratory symptoms or 
functional limitations during deployment�26
Overall some studies show increased rates of asthma, 
which may or may not be related to deployment� There 
are also suggestions that asymptomatic asthma may 
be underestimated, therefore deployment could 
possibly be exacerbating, rather than causing the 
condition� However, in the absence of mandated 
pre-enlistment lung function testing, it is difficult to 
determine the true prevalence of asthma or hyper-
reactive airways in the enlistment population�
Constrictive bronchiolitis (CB)
Constrictive bronchiolitis (CB) is a recognised form 
of non-reversible obstructive lung disease in which 
bronchioles are compressed and narrowed by 
fibrosis and/or inflammation� In a descriptive case 
series by King et al� (2011), 49 soldiers that returned 
from the Middle East with unexplained respiratory 
symptoms underwent lung biopsy�15 Thirty-eight of 
these soldiers subsequently received diagnosis of 
CB, an otherwise uncommon diagnosis� The majority 
of biopsy samples showed polarisable material 
consistent with the inhalation of particulate matter, 
even though most of the soldiers were lifelong non-
smokers� In addition, thickening of the arteriolar 
wall or occlusion in adjacent arterioles was observed, 
which may have been the result of toxic inhalation�
Chronic obstructive pulmonary disease 
(COPD)
A small number of participants in a prospective 
study of Australian military personnel deployed to 
the MEAO were found to meet the global initiative for 
COPD criteria� A slight but statistically significant 
change to lung function between pre-and post-
deployment was also observed among this group, 
specifically between small decreases in the lung 
function and reported exposure to different chemical 
and/or environmental exposures�1 In a retrospective 
review by Matthews et al� (2014), military personnel 
diagnosed with COPD were investigated� Despite 
evidence of increased respiratory symptoms in 
deployed military personnel, this study reported that 
the impact of deployment on increased diagnosis or 
severity of COPD appears minimal�27
Infection
Respiratory infections are the leading cause of 
outpatient treatment during deployment and account 
for 25–30% of infectious disease hospitalisations in 
US Army personnel�28, 29 Soltis et al� (2009) found 
that 39% of soldiers have had at least one respiratory 
infection while on deployment�30 The deployment 
environment may facilitate transmission of respiratory 
infections, thereby accounting for higher incidence 
rates than comparable civilian populations� Service 
members may be exposed to high level of stress, 
contagious novel pathogens, harsh environmental 
conditions31 as well as overcrowding and inadequate 
hand-washing facilities�32 Respiratory bacteria 
and viruses are transmitted person-to-person via 
respiratory droplets, and typically result in acute 
self-limiting infections�33 However, highly virulent 
and transmissible strains of pathogens can lead to 
morbidity and mortality�34
Combat training programs are demanding, involving 
not only prolonged periods of physical activity but 
also exposure to psychological stressors, sleep 
deprivation, shifts in daily rhythm, and exposure to 
thermal extremes and high-altitude environments� 
The effects of such challenges on a soldier’s health are 
complex, resulting in a broad spectrum of changes 
in the immune system, which may predispose to 
various diseases, predominantly of the respiratory 
tract�8 Although recent attention has been directed 
towards acute morbidities as a result of respiratory 
infections, the adverse long-term effects of respiratory 
infections are not well understood, specifically in 
military populations� Given the potentially high rates 
of respiratory infection in deployed personnel, this is 
an important area for further research�
Acute Eosinophilic pneumonia (AEP)
Acute eosinophilic pneumonia (AEP) is an 
uncommon, idiopathic lung disease� The diagnosis 
is typically based upon clinical testing that include 
bronchoalveolar lavage, blood test or smear and chest 
radiograph� Lung biopsy is rarely necessary� AEP 
is characterised by general respiratory symptoms, 
alveolar and or blood eosinophilia, and peripheral 
pulmonary infiltrates on chest imaging�35 In most 
cases the acute illness lasts less than four weeks� 
Dry cough, dyspnoea and fever are present in almost 
every patient� Associated symptoms and signs can 
include malaise, myalgia, night sweats, chills and 
chest pain�35 Some studies suggest that AEP is an 
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post deployment� These include type, severity and 
duration of exposure to environmental hazards, 
such as desert dust storms, proximity and duration 
of exposure to burn pits or fires, and frequency of 
exposure to air pollution�5
Air pollution
Air sampling studies, conducted by US researchers 
suggest that multiple sources of air pollution including 
smoke from oil well fires, sand and dust storms, and 
not exclusively burn pit emissions, contribute to poor 
air quality in the deployed environment�46, 48 These 
findings are supported by independent work from 
investigators outside of the US;47-49 however, there is 
no data available from longitudinal research studies 
with objective pulmonary assessments comparing 
lung function between those deployed to the Middle 
East and non-deployed personnel� A review article by 
Falvo et al� (2015) summarised current knowledge 
about the impact of service and environmental 
exposures on respiratory health of military Service 
members deployed to Iraq and Afghanistan�21 The 
report reviewed 19 studies published from 2001 to 
2014� While studies of environmental exposures, 
in particular airborne pollutants, have shown an 
association with an increased burden of acute 
respiratory symptoms, studies reporting chronic 
respiratory diseases do not provide conclusive results, 
mainly because of the non-representative sample of 
the study populations� Data associating airborne 
hazard exposures to respiratory disease are similarly 
inconclusive� Therefore, there is insufficient evidence 
to support any association between air pollution in 
the deployed environment and respiratory health of 
military personnel�21
Particulate matter (PM)
US data suggests that deployment to both Iraq 
and Afghanistan may pose additional risk factors 
to respiratory health because of the high levels of 
airborne PM and geologic dusts inherent in those 
regions�50 A majority (94%) of US Service personnel 
deployed to OIF and OEF reported exposure to high 
levels of airborne PM from a range of sources that 
may have exceeded environmental, occupational 
and military exposure guidelines,43, 51 indicating 
that these pose a real risk to health� McAndrew et 
al� (2012) reported that among MEAO deployed 
personnel, the most prevalent exposures were air 
pollution (94%), vaccines (86%) and petrochemicals 
(81%)�43 Exposures and concern about exposures 
were both related to greater somatic symptom 
burden, and concern about exposure was highly 
correlated with symptom burden�
acute hypersensitivity reaction to an unknown 
inhaled antigen in an otherwise healthy individual�36 
Eighteen cases of AEP (including two fatalities) were 
reported among over 180 000 military personnel 
deployed in or near Iraq between March 2003 and 
March 2004� All AEP patients were smokers with 
78% recently beginning to smoke during deployment 
and all but one patient had significant exposure to 
fine airborne sand or dust; no other common source 
exposure could be identified� The study concluded 
that ‘recent exposure to tobacco may prime the lung 
in some way such that a second exposure or injury, 
eg, in the form of dust, triggers a cascade of events 
that culminates in AEP’�5, 37 AEP was also reported in 
at least one firefighter following the collapse of the 
World Trade Center towers in 2001�38
As outlined above, current literature, including case 
reports and retrospective cohort studies, suggest a 
potentially higher prevalence of respiratory symptoms 
and respiratory illnesses including asthma,5, 16, 26 
CB,15 COPD,1, 39 and AEP37 among deployed military 
personnel� Specific deployment-related exposures 
such as environmental (particulate matter, metal 
particles, burn pit, air pollution), combat (blast, 
stress) and other exposures (smoking, physical 
activity, military living conditions) may relate to 
these impairments in respiratory function5, 10, 11, 15, 37, 
40-44 and are discussed below�
Environmental and/or chemical exposures
Military personnel who have served in Iraq and 
Afghanistan have expressed concern about 
possible long-term health effects associated with 
environmental exposures during deployment, 
including toxic industrial chemicals, local combustion 
sources and poor air quality�5, 41, 42, 45-47 US Veterans 
seeking treatment at Department Veterans Affairs 
(DVA) clinics after deployment, have reported a high 
prevalence of environmental exposure and exposure 
concerns, although whether this concern translates 
to actual adverse respiratory health outcomes is 
unclear�
In line with these concerns, researchers have 
hypothesised that there may be a relationship 
between deployment exposures and respiratory 
symptoms�21, 43, 46, 47 Korzeniewski et al� (2013) 
reported that the prevalence of respiratory diseases 
was closely related to environmental factors on 
deployment, such as exposure to sand and dust 
storms, extreme temperature changes and poor 
public health measures�7 A medical research working 
group formed to consider lung disease in US soldiers 
returning from Iraq and Afghanistan identified a 
number of potential risks for developing lung disease 
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medical encounter rates among personnel deployed 
to burn pit locations were compared directly to those 
among personnel deployed to locations without 
burn pits� No significant differences in respiratory 
outcomes between these groups were found�
Furthermore, findings from Smith et al� (2012) do 
not support an elevated risk for respiratory outcomes 
among personnel deployed within proximity of 
documented burn pits in Iraq�45 Comparing burn 
pit exposed and non-exposed groups, this study 
observed similar proportions of newly reported CB 
and emphysema (1�5% vs 1�6% respectively), newly 
reported asthma (1�7% vs 1�6%), and respiratory 
symptoms in 2007 (21�3% vs 20�6%)� Similarly, 
a study by Baird et al� (2012) reported that while 
potential exposure to sulphur plant fires was 
positively associated with self-reported health 
concerns and symptoms, it was not associated 
with an increase in clinical encounters for chronic 
respiratory health conditions�44 Powell et al� (2012) 
found no increase in chronic multi-symptom illness 
(CMI) symptom reporting in military personnel 
deployed to three selected bases with documented 
burn pits compared with other deployment sites�53 
However, limitations in standardising exposures 
may have biased these results�
Toxicological, epidemiological and clinical data 
are limited and prevent reliable evaluation of 
the prevalence or severity of adverse effects of 
inhalational exposures to PM or burn pit combustion 
products in military personnel deployed to Iraq 
and Afghanistan� The current clinical evidence on 
the effect of deployment on respiratory health is 
primarily retrospective and does not provide clarity 
regarding specific causative factors or the effect on 
the deployed population as a whole�21 Taken together, 
these findings suggest that environmental exposures 
including burn pits and air pollution may be 
associated with subjective physical health symptom 
reporting, but there is no evidence of increased rates 
of objective respiratory health outcomes�
Regardless of the source, it seems likely that higher 
levels of air pollution are common in many deployment 
areas and could contribute to future pulmonary and 
other health effects not yet identified�48 Together, 
these findings indicate that while deployment appears 
to be associated with adverse respiratory outcomes, 
this cannot be reliably attributed to environmental 
exposures� Other deployment exposures that should 
also be considered include trauma, particularly blast 
trauma and psychosocial stress associated with a 
combat environment�
Metal particles
Another exposure of relevance to the deployed 
environment is metal PM� Biopsied lung tissue from 
selected deployed US soldiers with unexplained 
respiratory symptoms and history of inhalational 
exposure, identified the presence of metals including 
iron, titanium and crystalline material� This 
deployment’s inhalational exposure was thought to 
be the cause of unexplained exertional dyspnoea and 
diffuse CB conditions in these soldiers�15 Exertional 
dyspnoea is excessive shortness of breath and mainly 
reflects poor ventilation or oxygen deficiency in 
circulating blood� CB is a rare, small airway fibrotic 
respiratory disease� The cause of this condition is still 
unknown, although it is thought that environmental 
factors and genetic susceptibility could be major 
contributors to the development of the disease�52 King 
et al� (2011) found that in 38 of 49 previously healthy 
soldiers with unexplained exertional dyspnoea and 
diminished exercise tolerance after deployment, 
an analysis of biopsy samples showed diffuse CB, 
possibly associated with inhalational exposure�15
Burn pit
A further identified exposure for respiratory insult, 
again common in the MEAO, is open-air burning of 
rubbish and other waste� Although the extent of the 
chemicals released in burn pits is unknown, ambient 
air sampling performed in selected Middle East 
regions has revealed that smoke from burn pits is a 
major source of air pollution�42 Some air pollutants 
such as dioxins, carbon monoxide, volatile organic 
compounds from burning of trash, vehicle/generator 
exhaust, oil well fires, gases from industrial facilities, 
and contaminants from dust containing silica, 
asbestos, lead, aluminium and manganese are well 
recognised carcinogens� Other agents may irritate 
the respiratory system causing acute cough or 
shortness of breath, hypersensitivity pneumonitis, 
irritant induced asthma and CB, especially when 
exposures are repetitive or exceed recommended 
concentrations�45
Evidence to support long-term adverse effects of 
exposure to burn pits is controversial� Although 
some studies have found that deployment may be 
associated with a subsequent risk of developing 
respiratory conditions� Abraham et al� (2014) 
suggests that elevated medical encounter rates 
(visits to medical centres for respiratory outcomes 
including general respiratory system and other chest 
symptoms, asthma, COPD, bronchitis, emphysema, 
bronchiectasis and extrinsic allergic alveolitis) were 
not uniquely associated with burn pits�42 In this study, 
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Trauma/stress
In addition to the frequent and proximate exposures 
to ambient airborne hazards, factors unique to 
military service that may make military personnel 
more vulnerable to greater respiratory health risk 
include high levels of psychological stress�21 Vocal 
cord dysfunction (VCD) refers to abnormal closing of 
the vocal cords when inhaling or exhaling� It is often 
misdiagnosed as asthma in the clinical setting and 
has been reported in military personnel�50 A study 
of exertional dyspnoea in US military personnel 
demonstrated that 12% of patients evaluated had 
evidence of VCD, most of which was exercise related� 
Morris et al� suggested that the development of 
VCD in the deployed environment might be related 
to nonspecific upper airway irritation, underlying 
psychiatric conditions and/or significant stress 
attributed to the combat environment�50
There is also growing evidence for an association 
between exposure to traumatic stress, including 
childhood maltreatment or combat experience 
and pulmonary diseases such as asthma, CB and 
COPD�60-63 This relationship was also demonstrated 
in adult research populations exposed to the 11 
September 2001 World Trade Center terrorist attack� 
More specifically, moderate associations between 
probable post-traumatic stress disorder and 
respiratory symptoms have been observed in first 
responders to the World Trade Center disaster�22, 23, 
60, 64
A cross-sectional study conducted by Spitzer et 
al� (2011), analysed the associations between lung 
function, trauma exposure and post-traumatic 
stress disorder (PTSD) in 1 772 adults from the 
general population using standardised questions 
and spirometry test�60 Those with a diagnosis of PTSD 
had a significantly greater risk of having asthma 
symptoms than those without PTSD� However, 
those with a history of psychological trauma, but 
no diagnosis of PTSD, did not have an elevated risk, 
suggesting the association is specific to disorder 
status rather than symptomatology or trauma 
exposure� Analyses indicated that subjects with 
diagnosed PTSD had a significantly increased risk 
for airflow limitation independent of its definition�
One possible mechanism underpinning the 
association between stress and reduced respiratory 
function could be increased levels of systemic 
inflammatory markers�20, 65-68 Excessive pro-
inflammatory responses may cause airway damage 
and consequently structural and functional 
pulmonary changes�31 Hypothetically, higher levels 
of stress during deployment among personnel may, 
Combat exposures
Blast
In addition to air pollution and smoke from burn 
pits, military Veterans who have served in Iraq 
and Afghanistan may have been exposed to other 
significant respiratory stressors, such as aerosolised 
metals and chemicals from improvised explosive 
devices (IEDs), or to traumatic respiratory insult 
such as blast overpressure or shock waves to the 
lung�54
Concern about the effects from embedded metal 
fragments from IEDs used in the Middle East conflicts 
has been raised among Service members� As a result, 
the US DVA established a special registry in 2008 for 
medical surveillance and management of Veterans 
with retained metal�51 Some of the embedded metal 
contaminants, including aluminium, arsenic, cobalt, 
chromium and nickel, may have immunogenic 
respiratory health effects� In a recent report from the 
Toxic Embedded Fragment Surveillance Centre, of 
89 urine samples tested, 47% exceeded the reference 
value for aluminium and 31% for tungsten�55
Recently, publication of an unusual case report of 
chronic beryllium disease (CBD) was described in a 
41-year-old Israeli soldier who suffered mortar shell 
injury with retained shrapnel in the chest wall� This 
report raised the possibility of shrapnel- induced CBD 
from long-term exposure to the surface of retained 
aluminium shrapnel fragments in the body�56
It has been proposed that Service members 
who sustained subclinical blast injury may be 
susceptible to long-term sequelae� Apart from 
direct consequences of blast injuries such as blast 
pressure wave, fragments of debris or injuries 
due to acceleration or deceleration, there are also 
less obvious injuries caused by a blast including 
psychological trauma, burns and toxic-substance 
exposure from inhalation of hot contaminated 
air�57,58 Such injuries can have unpredictable long-
term outcomes including permanent fibrosis of the 
bronchial mucosa�59
Despite the high plausibility of long-term adverse 
effects following acute pulmonary blast injury, there 
is an absence of data on the long-term outcomes� 
Furthermore, the possibility of other long-term 
pulmonary consequences of blast exposure, such 
as the effect of explosion-related dust exposure, 
and other exposures such as smoking, has not been 
adequately examined� Overall there is limited data 
to support a conclusion regarding an association 
between exposure to blast and long-term respiratory 
outcomes�57
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reported respiratory illnesses during deployment; 
suggesting that factors other than tobacco use 
were likely to contribute to the observed respiratory 
symptoms and morbidity�
Findings from a prospective study of Australian 
military personnel deployed to the MEAO showed that 
those respondents who began or resumed smoking 
while on deployment were also likely to have more 
co-morbidities compared to those who did not smoke 
on deployment�1 Similarly, those who smoked more 
than usual were likely to have more co-morbidities 
compared to those who did not smoke�1 However, 
the relative impact of different exposures and other 
non-smoking related risk were not examined in this 
population�
Since the 1960s, the rate of tobacco smoking has 
declined in the US including in the military�71 
However, the rate of tobacco smoking among active 
duty military personnel remains higher (32%) 
compared to the general population (~20%)�71 Within 
the US military population, the prevalence of smoking 
is approximately 40% higher among Veterans and 
50% higher among deployed military personnel 
compared with their non-deployed counterparts�71 
In a cross-sectional study by Sanders et al� (2005), 
it was reported that 47�6% of US military personnel 
deployed to Iraq and Afghanistan began or resumed 
smoking while deployed and ~40% smoked half a 
pack of cigarettes or more per day�31 High rates of 
tobacco smoking are not restricted to US military 
personnel but are also increased 40%–60% among 
coalition militaries�72
While specific factors contributing to smoking rates 
have not been ascertained, the significant smoking 
uptake observed in a number of studies is thought 
to relate to deployment stress particularly among 
those with prolonged deployments, or combat 
exposures�73 Combat exposure, military stressors 
and PTSD have all been identified also as predictors 
for cigarette smoking�74, 75 As discussed above, 
these psychological risk factors and mental health 
disorders have also been associated with respiratory 
symptoms, abnormal lung function and diseases 
such as asthma�20, 76 Although tobacco smoke 
may differ in many respects from the ambient air 
pollution in deployed settings, the contribution of 
tobacco smoke exposure to military personnel’s 
cumulative exposures to airborne hazards while on 
deployment cannot be underestimated, given the 
prevalence and intensity of tobacco use in stressful 
combat situations�21 The potential for smoking to 
interact with and/or exacerbate other environmental 
or stress exposures is of importance to examine�
in part, explain the increased rate of respiratory 
symptoms reported in recent studies� There is 
increasing evidence of associations between stress 
related mental disorders such as PTSD and altered 
immune responses, and elevated circulating 
inflammation� The direction of this association 
is not conclusive, however� Regardless, low level 
inflammation and altered immune response provide 
plausible mechanisms by which trauma exposure 
may be associated with respiratory symptoms�20, 60, 
65-68
Other exposure factors
In addition to deployment specific risks, evidence 
suggests other military factors such as physical 
activity, increased tobacco use and other individual 
susceptibility factors may increase the risk of 
respiratory symptoms and enhance susceptibility 
to environmental and trauma exposures in this 
population�
Physical activity
Researchers have suggested that physical activity 
performed in stressful environments alters 
immune function�17 Light physical activity or 
moderate environmental stress stimulate immune 
responses, but exhausting physical activity or severe 
environmental stress can have immune suppressant 
effects, manifested by a temporary increase in 
susceptibility to respiratory infections�9 Multiple 
physical and psychological stressors, such as those 
encountered on deployment, may induce alterations 
in immune parameters (as discussed above) and/
or neurological and endocrine responses; these 
common exertion-induced pathways could result in 
respiratory tract syndromes�8
Smoking
Cigarette smoking has been associated with 
morbidity and mortality in a number of studies�5-7, 
21, 31, 69, 70 Pathological mechanisms of smoking and 
its adverse health effects generally overlap with 
environmental air pollution� Smoking has also been 
related to increased susceptibility to respiratory 
insult from airborne hazards�70 Interestingly, there 
is no clear evidence of direct effects of smoking 
on respiratory outcomes in deployed military 
populations� For example, Sanders et al� found that 
approximately 70% of US military personnel deployed 
to Iraq and Afghanistan reported at least 1 episode 
of an acute respiratory illness and 15% reported 
3 or more incidents of respiratory illnesses during 
their deployment�31 There was, however, no observed 
relationship between cigarette smoking and self-
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health� Cross-sectional studies are carried out at 
one period and do not indicate the series of events, 
therefore it is difficult to determine the relationship 
between exposure and outcome as it lacks the time 
element�
Previous studies have largely relied on self-report 
data to measure the impact of exposures on 
respiratory health� This type of measurement is open 
to recall bias, particularly when data is collected well 
after exposures have occurred�31, 26 Medical record 
reviews are predominantly retrospective7, 16, 39 and 
therefore also subject to potential biases (reflected in 
documentation and health care seeking)�
Discussion
Long-term psychological and physical health effects 
following deployment are of concern to Veterans, 
healthcare providers and the community� While some 
international literature suggests a higher prevalence 
of respiratory conditions in military personnel during 
and following deployment to the Middle East, findings 
are equivocal and the exact reasons underpinning 
any elevated respiratory health consequences 
are not well understood� Some inconsistencies in 
findings could be due to difficulties retrospectively 
standardising for exposure; reliance on self-reported 
symptoms or conditions, or inconsistent application 
of ICD codes, making it difficult to say with certainty 
which conditions are increasing in incidence or 
prevalence� Furthermore, many studies have 
focused on limited exposure and outcome variables� 
The potential interaction of these factors, and their 
effects on multiple respiratory outcomes, has not 
been thoroughly considered�
Current evidence (mainly from US studies) indicates 
that deployment-related environmental (PM, burn 
pit, air pollution, metal particles), combat (blast, 
stress) and other exposures (smoking, physical 
activity, military living conditions), and psychological 
trauma more generally, may be associated with 
several respiratory conditions in military personnel, 
such as asthma,5, 16, 26 CB,15 COPD,1, 39 sinusitis,40 
and AEP37� These associations may be via direct 
actions and by disturbance of the immune system� 
Psychological stress, while highly prevalent in 
relation to deployment, is a less investigated risk 
factor for respiratory health outcomes and its 
contribution to respiratory health outcomes and 
potential mechanisms underlying associations, as 
well as potential predictors of good or poor health 
over time, are not well understood�61, 68, 79-85
Taken together, further prospective and cross-
sectional analyses are needed to clarify relationships 
Individual susceptibility factors
Studies regarding the association between respiratory 
health conditions and individual factors (age, sex, 
BMI, blood pressure, physical fitness, pre-existing 
conditions and personal characteristics) in general 
the population and deployed military personnel 
generally focus on single respiratory outcomes and 
are usually assessed using different methods�
In a cross-sectional study, data collected from a 
European Community Respiratory Health survey of 
16 countries were examined� The aim of this study 
was to estimate the age and sex-specific incidence 
of asthma from birth to the age of 44 in men and 
women across several countries, and to evaluate the 
main factors influencing asthma incidence in young 
adults� This study demonstrated that there are 
different patterns of asthma incidence in men and 
women� During childhood, girls had a significantly 
lower risk of developing asthma than did boys� 
Around puberty, the risk was almost equal in the two 
sexes, while after puberty, the risk in women was 
significantly higher than that in men�77
In a case control study of active duty and retired 
US military members, increasing BMI, younger 
age, gender, non-active duty beneficiary status and 
arthritis were significant independent predictors of 
asthma in this population�78 Similarly, Abraham et 
al� (2012) reported that gender, enlisted and Army 
personnel remained independent predictors of having 
a new obstructive pulmonary disease encounter�39 
Age and combat occupations were not statistically 
significantly associated with a post-deployment 
obstructive pulmonary disease diagnosis� The way in 
which these factors might interact with deployment 
exposures to influence respiratory health outcomes 
has not been thoroughly studied� This deserves 
further attention in larger epidemiological studies, 
particularly given emerging evidence of their 
influence on physical and psychological health�
Limitations
Due to the limited research regarding respiratory 
health of MEAO deployed Service members, studies 
of lower levels of evidence addressing issues of 
interest were discussed in this review, although 
findings were interpreted with caution and used as 
supporting rather than primary evidence sources�
A number of studies in this review were of cross-
sectional design; consequently, any respiratory 
health issues in existence before an exposure were 
not accounted� Without baseline data, it is not 
possible to accurately assess the impact of specific 
deployment exposures on a person’s respiratory 
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between the individual and combined impacts 
of environmental and psychological exposures 
on deployment, and any potential moderating or 
mediating effects of other factors on respiratory 
outcomes�
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